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Abstract
Abstract
The baculovirus expression system has been used to express four rabbit glucose 
transporter constructs. The constructs consist of: 1) a full length glucose transporter, 2) a full 
length glucose transporter with an N-terminal polyhistidine tag, 3) a construct expressing only 
the C-terminal half of the glucose transporter and 4) a construct expressing only the C-terminal 
half of the glucose transporter with an N-terminal polyhistidine tag. Protein expression levels 
were determined by immunoblot assay. The ability of expressed protein to bind ligand, at both 
the external and internal glucose transporter sites, was tested by photolabelling.
All four constructs were found to be adequately expressed using the baculovirus 
system. Photolabelling demonstrated measurable levels of ligand binding activity in three of the 
four constructs. Ligand binding activity in the polyhistidine tagged C-terminal construct was 
found to be different to previous results using a non-polyhistidine tagged construct (Cope et al., 
(1994)).
Cellular targeting of the constructs was observed by scanning confocal microscopy. 
Confocal microscopy demonstrated that both full length constructs were targeted to the plasma 
membrane. However, both C-terminal half constructs were observed to be aberrantly targeted 
throughout intracellular membranes.
Purification trials were carried out in order to test the affinity of the polyhistidine 
tagged proteins towards a chelating nickel Sepharose column. The level of purification was 
assessed by polyacrylamide gel electrophoresis, followed by silver staining. The full length 
polyhistidine tagged glucose transporter proved difficult to purify to homogeneity. This was 
because it was found to have a low affinity towards the chelating nickel Sepharose column. The 
column also bound some native insect cell proteins. The yield from the column was calculated 
to be 379 pg of HIS-GLUT1 / 500 ml of culture, this represented a 20% recovery of 
polyhistidine tagged protein from the original culture. The polyhistidine tagged C-terminal half 
construct displayed almost no affinity towards the column.
In related experiments, C-terminally mutated human GLUT1 constructs were expressed 
in CHO cells. The point mutations were made in order to further study the role of the 
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Glucose transport is a fundamental mechanism for all forms of life. The glucose 
transporter supplies the cell with glucose, which is necessary to sustain cell function. In 
the absence of a glucose transporter, passage of the polar glucose molecule across the 
cell membrane would be exceptionally slow.
Within the mammalian system several different forms of the glucose transporter 
exist; these are functionally identical and are termed isoforms. Glucose transporter 
isoforms possess different kinetic properties. Their cellular locations and functions are 
listed below (table 1.1).
Isoform / Principal 
location
Tissue
GLUT1 / erythrocyte Primary glucose transporter of foetal tissues, Placenta, Brain, 
Blood/tissue barrier, erythrocyte membranes.
GLUT2 / liver High capacity, low affinity glucose transporter present in 
liver, pancreatic 3-cells, small intestine and kidney.
GLUT3/brain Primary glucose transporter of neurons and nerve cells also 
expressed in placenta, kidney, liver and testes.
GLUT4 / muscle Muscle, heart and adipose tissue, insulin regulated.
GLUT5 - 
Fructose Transporter
Small intestine, brain, muscle and adipose tissue (muscle and 
brain low levels).
GLUT6 Non-functional pseudogene whose sequence is most closely 
related to that of -GLUT3, identified only in humans.
GLUT7 Hepatic microsomal glucose transporter (Liver).
Table 1.1, The table describes the cellular location and function of all 6 reported glucose 
transporter sequences. Adapted from Bell et a l , (1993).
The glucose transporter functions in a bi-directional, passive manner, carrying 
glucose down its concentration gradient. Glucose transporter, isoform 1, (GLUT1) is 
probably the best studied of all the glucose transporters. GLUT1 is abundant in brain 
tissue, transporting glucose as an energy source across the blood brain barrier. GLUT1 
is also present in many other cell types. Baldwin et a l, (1982) first isolated GLUT1 
protein from erythrocyte membranes, which contained 3 - 5% GLUT1. Erythrocyte 
membranes therefore provide a rich source of the GLUT1 protein for study. The cDNA
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encoding the GLUT1 isoform was isolated in 1985 by Mueckler et a l. Isolation of the 
cDNA was followed by the expression of this glucose transporter isoform in non-native 
expression systems. For example: Sarkar et a l9 (1988) expressed GLUT1 in Escherichia 
coli (Bacteria), Yi et al.t (1992) expressed GLUT1 in Spodoptera frugiperda cells 
(insect cells) and Kasahara and Kasahara, (1996) expressed GLUT1 in Saccharomyces 
cerevisiae (yeast).
Hiraki et al, (1989) showed that transformation of cultured cells can lead to an 
increased level of GLUT1 expression; GLUT1 expression is also increased during 
starvation, Haspel et al, (1986). This is advantageous because the transporter is 
kinetically asymmetric. The binding of intracellular peptides and metabolites appear to 
allosterically regulate GLUT1. Shi et a l , (1995) have identified two specific 
cytoplasmic proteins of 28 and 70 kDa, which are capable of reducing substrate binding 
to the internal GLUT1 site. Furthermore, Carruthers and Helgerson, (1989) and Hebert 
and Carruthers, (1986) have found that ATP can have an inhibitory effect on glucose 
transport, converting the GLUT1 protein to a low capacity glucose transporter.
Gould et al, (1991) have found that GLUT2 functions as a high capacity 
transporter with a much higher Km of 15 - 30 mM. Following the consumption of food, 
GLUT2 acts to lower elevated glucose concentrations rapidly, when other glucose 
transporters are saturated. GLUT2 is capable of transporting fructose with a Km of 67 
mM and is thought to be responsible for the influx of fructose into the liver. Burant et 
al, (1992) showed that GLUT5 is a specific fructose transporter and although not found 
in the liver is responsible for the influx of fructose through the small intestine. It has a 
Km for fructose of 6 mM. GLUT3 is found in abundance in tissues which require a high 
glucose demand, such as the tissues of the central nervous system. The GLUT3 isoform 
may well have evolved in tandem with the GLUT1 protein, Gould et al, (1991) 
demonstrated that GLUT3 has a low Km for glucose enabling the transporter to utilise 
low concentrations of blood glucose in hypoglycaemic conditions. Keller et al, (1989) 
showed that GLUT4 has a relatively low Km for glucose of 2 - 5 mM, this ensures that 
it functions close to its Vmax over the normal range of blood glucose concentrations. In 
the absence of insulin GLUT4 becomes localised within intracellular vesicles, this leads 
to the regulation of glucose uptake in cells expressing GLUT4. Following a meal, the
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release of insulin into the blood stream causes GLUT4 recruitment to the plasma 
membrane which allows for the rapid uptake of glucose into these cells.
This thesis is primarily concerned with the glucose transporter isoform one 
(GLUT1). It is the aim of this thesis to provide a better understanding of the glucose 
transporter (GLUT1) structure. This has been achieved by mutational analysis and by 
providing the foundations for starting ciystallographic analysis (2-dimensional electron 
diffraction crystallography or 3-dimensional X-ray crystallography). The thesis begins 
by examining point mutations made in the human GLUT1 protein, expressed in Chinese 
hamster ovary (CHO) cells. The thesis then examines four GLUT1 constructs expressed 
in insect cells. Two of the constructs have been modified to express six contiguous 
histidine residues (termed a polyhistidine tag) on the N-terminal end of the protein. The 
aim of this approach was to allow for the attempted purification of the GLUT1 protein 
on an immobilised nickel column, to which the polyhistidine tag has an affinity. This 
approach was considered to be a prerequisite for the undertaking of crystallisation and 
then crystallographic analysis.
1,2 The Origin of the Glucose Transporter
Maiden et al., (1987) have studied the sequences of the arabinose-H+ symporter 
and the xylose-H+ symporter of E. coli. The two proteins were found to be homologous 
to each other and also with the rat brain glucose transporter. On consideration of 
conservative substitutions between the sequences nearly 40% of the residues were found 
to be homologous. Furthermore, all three proteins lack an N-terminal signal sequence. 
Maiden et al, (1987) consider the similarities to be too great to have originated from 
convergent evolution and postulate that they may have originated from an ancient sugar 
transporter, which existed before the divergence of organisms to prokaryotes and 
eukaryotes. Maiden et al, (1987) also propose that the genes of the common ancestor 
arose from a gene duplication event. The first piece of evidence for this theory comes 
from hydropathy plot analysis. The hydropathy plot analysis of the human GLUT1 
glucose transporter is displayed in figure 1.1.
Szkutnicka et a l , (1989) have considered the evidence put forward by Maiden et 
al, (1987) and have studied 11 transporters; the yeast galactose, glucose, maltose and
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lactose transporters; the E. coli xylose and arabinose transporters; the human foetal 
muscle and erythrocyte glucose transporters and the rat brain and adipocyte glucose 
transporters. Amino acid identity between members of the group was found to be 
between 20 and 30% after alignment. The identity is even greater if conservative 
replacements are considered. This homologous group of transporters was termed the 
HGT superfamily and many sequence motifs are conserved between them. Interestingly 
though the lengths of the N and C-terminal tails differ significantly between transporters 
within the HGT superfamily. Szkutnicka et al., (1989) have also presented further 
evidence to corroborate the gene duplication theory. The GLUT1 glucose transporter is 
known to be glycosylated on the first extracellular loop. The yeast glucose transporter 
has been observed to carry an N-linked glycosylation motif in helix 7 in a position 
analogous to the GLUT1 protein, only contained in the second set of six transmembrane 
helices. All transporters in the HGT superfamily are observed to lack a cleavable 
N-terminal signal sequence and insert into the membrane after translation of the mRNA. 
On considering all of the evidence, ie. sequence homology, similarity of size, 
distribution of hydrophilic loops and the presence of repeated motifs in corresponding 
positions it was concluded by Szkutnicka et al., (1989) that members of the HGT
superfamily have a common ancestry as proposed by Maiden et al., (1987).
9 10111213 14 h b
400100 492200 300
Residue number
Figure 1.1, Hydropathy plot of the human GLUT1 glucose transporter. The hydropathy plot 
demonstrates repetition about a large central hydrophilic loop. There are several proposed models that 
predicted the transmembrane regions of the glucose transporter and are marked on the diagram, the letters 
hb represent the model proposed by Ducarme et al., (1996), h represents the model proposed by Mueckler 
et al., (1985) and b represents the model proposed by Fischbarg et al, (1993).
Page 4
Chapter 1 Introduction
The two halves of the glucose transporter appear to be symmetrical about a large, 
hydrophilic, cytoplasmic loop. The C-terminal amino acids (amino acids 480 - 492) are 
observed to be highly hydrophilic, whereas the N-terminal amino acids (amino acids 
1 - 20) are not. The observed symmetry, displayed in the hydropathy plot, suggests that a 
gene duplication event may have occurred in the evolutionary history of the gene.
However, one of the strongest pieces of evidence for a gene duplication event 
having occurred is the duplication of protein motifs between the N-terminal and 













































Figure 1.2 The Rabbit GLUT1 glucose transporter protein sequence. The above sequence displays 
the duplicated motifs. Matching motifs have been marked in the same colour. In this figure the glucose 
transporter has been split in two at amino acid 251.
The matching sequence and structural motifs above have been highlighted in the 
same colour, motifs such as these occur throughout the glucose transporter superfamily. 
Apart from the motifs repeating, they occur at the same relative positions in the two 
halves of the glucose transporter. Since the genes of the mammalian glucose transporters 
contain introns, which are missing in the yeast and bacterial genes, Szkutnicka et al., 
(1989) proposed that the duplication event which created the glucose transporter 
occurred very early in the evolution of the gene; either before yeast and bacteria 
eliminated introns or before eukaryotic cells acquired them. The human and rat glucose 
transporters are the only experimentally determined membrane proteins known to insert
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into membranes after translation, making it possible to functionally insert these 
eukaryotic transport proteins into the bacterial plasma membrane.
1.3 The Structure of the Glucose Transporter
Several putative structures have been proposed for the glucose transporter. The 
first, based on hydropathy profile analysis, was from Mueckler et al, (1985). The 
GLUT1 sequence was analysed according to the algorithm of Eisenberg et al (1984). 
This predicted transmembrane spanning segments from 21 non-overlapping amino acid 
residues with an average hydropathy index value of > 0.42. Mueckler et al, (1985) 
proposed a structure comprising of 12 transmembrane spanning a-helices, with the 
hydrophilic amino terminus, carboxy terminus and large central loop remaining within 
the cytoplasm of the cell. Mueckler et al, (1985) have suggested that the moderately 
amphipathic helices 3, 5, 7, 8 and 11 cluster to form an aqueous cleft through which 
glucose can traverse the lipid bilayer. The two dimensional representation of the model 
proposed by Mueckler et al, (1985) is displayed in figure 1.3 (on the following page).
Hresko et al., (1994) carried out a series of experiments using scanning 
glycosylation mutagenesis which supported the model proposed by Mueckler et 
al, (1985). This work involved the insertion of the glycosylated exofacial domain of 
GLUT4 into each of the putative hydrophilic soluble domains of an aglyco-GLUTl 
construct. The constructs were expressed in Xenopus oocytes and the cytoplasmic or 
exofacial orientation of each soluble domain was inferred from its glycosylation state. In 
brief, insertion of the glycosylation signal into the predicted extracellular loops resulted 
in their glycosylation when expressed in Xenopus oocytes. However, insertion of the 
glycosylation signal into the predicted cytoplasmic loops did not result in glycosylation. 






Figure 1.3, The 2-Dimensional theoretical structure of the glucose transporter (modified from Bell 
et a l, (1993)). The above theoretical structure of the glucose transporter was originally proposed by 
Mueckler et al., (1985). Conserved residues are denoted by the single letter amino acid abbreviation. 
Coloured residues indicate residues discussed within the text.
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It is thought that the glucose transporter has a bilobal structure. Evidence for this 
comes from photolabelling studies carried out by Cope et al, (1994 (discussed later in 
this thesis)) and from the observation by Li and Tooth, (1987) using electron 
microscopy, that the structurally related Escherichia coli (E. coli) lactose permease 
appeared to form a bilobal structure.
Throughout this thesis the N-terminal half will refer to helices 1 - 6  and the 
C-terminal half will refer to helices 7 - 12, of the model proposed by Mueckler et al, 
(1985).
Alternative GLUT1 structural models have been proposed. The first of the 
alternative models was that of Fischbarg et al., (1993). The model was based on 
antibody binding studies. Fischbarg et al, (1993) generated an antibody to the highly 
conserved sequence lie 386 - Ala 405 which, according to Mueckler et al, (1985), 
should lie on the endofacial surface of GLUT1. Fischbarg et al, (1993) suggested that 
the antibody had a specific affinity towards the exofacial surface of the glucose 
transporter since it acted to accelerate 2-deoxy-D-glucose uptake. The increase in 2- 
deoxy-D-glucose uptake was only observed when the antibody was added to the 
extracellular surface of Xenopus oocytes expressing GLUT1. Fischbarg et al, (1993) 
then proposed a model based on an arrangement of 16 antiparallel (3-strands, forming a 
(3-barrel (a porin like structure).
However, the glycosylation studies carried out by Hresko et al, (1994) 
contradict the model proposed by Fischbarg et al, (1993), in this model, glycosylated 
domains are predicted to lie on the cytoplasmic side of the membrane. Moreover, the 
(3-barrel model cannot account for the high a-helical content of the protein as predicted 
by Alvarez et al, (1987) and Chin et al, (1987). These two groups performed, 
respectively, fourier transform infrared spectroscopy (FTIR) and circular dichroism 
analysis on the purified erythrocyte transporter. These experiments, discussed in detail 
below, indicate the structure to be largely a-helical with the helices, on average, aligned 
perpendicular to the plane of the lipid bilayer. For these reasons, the model by Fischbarg 
et al, (1993) has been largely rejected from further serious consideration.
Alvarez et al, (1987) have also predicted by FTIR analysis a significant amount 
of |3-strand and random coil conformation. It was not possible in their study to 
determine whether P-tums were present. Alvarez et al, (1987) suggested that the
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12 transmembrane a-helical structure proposed by Mueckler et al, (1985) should be 
refined to include more P-structure.
Alvarez et al, (1987) noted that other proteins, with similarities to the glucose 
transporter have also been determined to contain significant levels of P-structure. For 
example, the E. coli lactose permease has an approximate a-helical content of 70% and 
a p-structure content of 25%. Proton exchange experiments carried out by Alvarez et al, 
(1987) demonstrated that 80% of the glucose transporter exchanges protons within the 
first lh of the experiment. This demonstrates that the majority of the protein is freely 
accessible to water and would be consistent with the presence of an aqueous water 
channel within the protein. Other transmembrane proteins, such as rhodopsin, 
bacteriorhodopsin and the calcium ATPase have been found to exchange protons much 
more slowly than the GLUT1 protein.
Chin et a l, (1987) have performed circular dichroism analysis on the GLUT1 
protein and have made slightly different predictions for the structure of GLUT1 than 
Alvarez et al, (1987). Circular dichroism analysis predicts that the GLUT1 protein is 
composed of approximately 82% a-helices, 10% p-tums and 8% other random 
structure, with no p-strands. The high percentage of a-helix suggests that non­
transmembrane hydrophilic segments also form a-helical structure. This is because the 
82% of a-helix cannot be accounted for by the 12 transmembrane a-helices alone.
In the presence of excess D-glucose the helical content was found to decrease, 
resulting in a corresponding increase in random coil and p-tum content. The binding of 
the endofacial ligand cytochalasin B also resulted in a decrease in the helical content. 
Although the above studies differ slightly on the exact p-structure composition, they do 
agree on there being a p-structure content.
Ducarme et al, (1996) have developed an a/p-structure model which proposes 
10 transmembrane spanning a-helices and 4 transmembrane spanning p-strands. 
Ducarme et al, (1996) proposed that the GLUT1 protein could form two channels, of 
which one channel would be responsible for glucose transport. This model is consistent 
with fourier transform infrared spectroscopy satisfying both the a-helix and p-strand 
content with the a-helices being perpendicular to the lipid bilayer. The model is less 
consistent with circular dichroism results, as circular dichroism did not predict the
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presence of p-strands. If the two large extra-membrane loops, the carboxy and the amino 
termini, are a-helical then the a-helical structure in this model is approximately 65% 
and the transmembrane proportion of p-strands is approximately 8%.
The primary protein sequence was re-analysed by Ducarme et al, (1996) using 
the methods of Eisenberg et al., (1984) and Jahnig, (1990). Predicted transmembrane 
regions were determined to be a-helical or p-stranded. The proposed model is displayed 
in figure 1.4.
Figure 1.4, The glucose 
transporter modelled as a 
14 transmembrane
protein containing
P-structure. Taken from 
Ducarme et al., (1996) the 
key describes glycosylation 
studies by Hresko et al., 
(1994). GLUT1 was 
mutated to contain 
glycosylation consensus 
sequences within each of 
the predicted
extramembrane loops. The 
key is interpreted as 
follows: a: the protein
becomes glycosylated and 
is functional; b: the protein 
is not glycosylated and is 
non-functional; c: the
protein becomes
glycosylated and is non­
functional; d: the protein is 
not glycosylated and is 
functional. Glycosylation 
will only occur at the 
extracellular surface of the 
protein. The letter C displays the results of cysteine analysis and the glutamine 282 mutation is marked. 




























The model proposed by Ducarme et al, (1996) is consistent with the scanning 
glycosylation mutagenesis experiments performed by Hresko et al., (1994). It is also 
consistent with antibody analysis carried out by Fischbarg et al, (1993), the sequence 
lie 386 - Ala 405 being accessible to antibody on the extracellular side.
Ducarme et al, (1996) have proposed that the C-terminal half forms a channel 
capable of transporting glucose and that the N-terminal half forms an independent 
channel, incapable of transporting glucose. Ducarme et al, (1996) have suggested that 
the N-terminal channel acts as a water channel; the large extra-membrane loop 
functioning as a steric or electrical gate, preventing small ions from passing through the 
channel. In the model proposed by Ducarme et al, (1996), the external loops are too 
short to form a gate for a single channelled protein, because the channel diameter would 
be too large. However, a two channelled protein would form a C-terminal channel (lie 
272 - Val 492) of just the right diameter to accommodate the glucose molecule and may 
sterically or electrically restrict the flow of small ions. This is consistent with the 
experimental data derived from analysing point mutations, the majority of which that 
affect glucose transport being mapped to the C-terminal portion of the protein.
A two-channelled glucose transporter is consistent with the observed symmetry 
of GLUT1 hydropathy plots and current theories of the origin of the glucose transporter 
from a gene duplication event. Ducarme et al, (1996) suggests that the glucose 
transporter could be a degenerate form of a co-transport channel, with the N-terminal 
half still interacting with the C-terminal half of the molecule, but no longer capable of 
co-substrate transport.
Further evidence, supporting the theory that the glucose transporter evolved from 
a co-transporter system arises from the observed similarity between the GLUT1 protein 
and proton linked sugar transporters found in the bacterium E. coli. Baldwin, (1993) 
reports that these proton symporters, which include the D-xylose / H* symporter, 27% 
identical, L-arabinose / fC symporter, 23% identical and galactose / H* symporter, 26% 
identical. Both the galactose and arabinose symporters bind and are photolabelled by the 
fungal toxin cytochalasin B. In conclusion, it is suggested that the glucose transporter 
may be a redundant proton symporter, the N-terminal region having co-transported 
protons linked to the uptake of sugar molecules. The redundant proton channel may now 
function simply as a water channel.
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Ducarme et al, (1996) have not predicted a 3-dimensional topographical model 
of the GLUT1 protein as no transmembrane a/p structure has yet been identified by 
X-ray crystallography. However, both theoretical and experimental analysis suggests 
that such a structure does exist in the acetylcholine receptor (Ortells and Lunt, (1996)). 
The acetylcholine receptor may eventually provide a topographical model on which to 
model a/p structure within the glucose transporter, should the 3-dimensional structure 
of the acetylcholine receptor be successfully determined.
Hodgson et al, (1992) have developed a model which is similar to that proposed 
by Ducarme et al, (1996) as it predicts a transporter consisting of two channels, one to 
transport substrate and the other a redundant co-transport channel. The model has a 
similar secondary structure to that proposed by Mueckler et al, (1985), however it 
predicts that helices 1 - 6  form the first channel and helices 7 - 1 2  form the second 
channel, helices 7 - 12  being involved in substrate translocation. Furthermore, the model 
predicts that more of the primary sequence is involved in a-helical structure than the 
model proposed by Mueckler et al, (1985). In accordance with Chin et al, (1987) the 
model does not predict any p-strands.
Widdas and Baker, (1991a) have proposed a model based on the secondary 
structure suggested by Mueckler et al, (1985). The model is based on a central core of 6 
helices (helices 1, 11, 8, 3, 5, and 6), which are structurally supported by the remaining 
helices (helices 12, 2, 4, 10, 7 and 9), figure 1.5.
Open conformationClosed conformation
00
Figure 1.5, Proposed model by Widdas and Baker, (1991a). The diagram, replicated from Widdas and 
Baker, (1991a) depicts both the open and closed conformation of the glucose transporter. The green 
coloured helices constitute both the rest of the binding site and supportive structure.
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Widdas and Baker, (1991a) proposed that the helices were capable of rocking 
about a central pivot. On one side of the membrane the helices would adopt the closed 
conformation and on the opposite side they would adopt the open conformation. Helices 
1, 8 and 11 would move away from the rest of the structure to expose the glucose 
transport channel. It was suggested that the energy for this movement was derived from 
the surface energy of water, as conformational changes of the magnitude envisaged were 
too large to be attributed only to thermal agitation of the protein. Widdas and Baker, 
(1991a) have carried out experiments that support this hypothesis. Alcohols, such as 
methanol and ethanol were used to lower the surface tension of the aqueous medium. 
Assays were carried out to measure glucose exit rates in whole erythrocytes suspended 
in the aqueous medium. It was shown that glucose exit rates were decreased on the 
reduction of surface tension. It was predicted that at 65% of normal surface tension the 
glucose transporter would cease to function.
Widdas and Baker, (1991b&c) have further suggested a mechanism by which the 
glucose transporter prevents the loss of potassium ions from within the erythrocyte. It 
was observed that several arginine residues were situated on the cytoplasmic surface of 
the glucose transporter. Due to arginine’s high pK value of 12.4, arginine is always 
positively charged at physiological pH. This would allow the arginine residue to form a 
positively charged shield which would repel potassium ions. It was noted that the 
shielding effect would depend on the radius of the ring surrounding the transport 
channel. Too large a radius would lead to an ineffective barrier. Baker et al, (1998) 
have presented experimental evidence which supports the hypothesised shielding effect 
of the arginine residues. Baker et al, (1998) demonstrated that exposure of the glucose 
transporter to the reagent 1,2-cyclohexanedione, which forms covalent bonds with 
arginine, resulted in a steady leakage of potassium ions from the erythrocyte.
The model proposed by Widdas and Baker, (1991a) suggests a possible energy 
source for the glucose transporter and a possible mechanism for excluding positive ions 
from entering the transport channel. However, analytical evidence for the structure of 
the glucose transporter seems in many cases to be contradictory and confusing. For 
example, the amount of helical structure present appears to depend on the method used 
to determine it. At present the model proposed by Mueckler et al, (1985) is a useful 
starting point for determining the structure of the glucose transporter.
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1.4 Independent Expression of the C-Terminal and N-Terminal 
GLUT1 Domains in Sf9 Cells
Cope et a l , (1994) expressed the two halves of the glucose transporter 
independently from one another in Spodoptera frugiperda cells (Sf9, Insect Cells). 
Independent expression of the two domains demonstrated the protein halves to be stable 
in the membrane, but incapable of cytochalasin B binding. However, concurrent 
expression of the two protein halves in the same cell resulted in a protein capable of 
cytochalasin B binding. The halves remained separate when subjected to electrophoretic 
analysis and were not covalently bound. This lead to the idea that the N-terminal domain 
of the protein could provide a packing surface for the C-terminal domain to rest against. 
Thus, allowing the C-terminal domain to take on its correct conformational state and 
form the ligand binding site essential for correct function.
Wu et al, (1996) have carried out a similar study to Cope et al, (1994) using the 
E. coli lactose permease proton symporter. The lactose permease has 12 hydrophobic 
transmembrane spanning a-helices. As with the glucose transporter both the N and C 
termini are on the cytosolic side of the membrane. The lactose permease was expressed 
in two halves in an E. coli expression system. The first construct expressed the 6 
N-terminal transmembrane helices and the second construct expressed the 6 C-terminal 
transmembrane helices. When the constructs were expressed individually both 
constructs were found to be unstable and did not catalyse active transport. However, 
cells expressing both constructs catalysed active lactose transport. Wu et al, (1996) 
discovered that the addition of five amino acid residues (Met-Thr-Met-Ile-Thr) to the N- 
terminal end of the C-terminal construct allowed for a stable C-terminal construct to be 
expressed independently of the N-terminal construct. Furthermore, this construct was 
able to catalyse down hill lactose transport. From these results it seems likely that the 6 
C-terminal transmembrane helices are responsible for lactose transport and the 6 
N-terminal transmembrane helices are responsible for proton translocation. A similar 
study was undertaken in this thesis which suggested that the C-terminal half of the 
glucose transporter was capable of ligand binding when polyhistidine tagged. Evidence 




Evidence presented by Cope et al, (1994) appears to be inconsistent with the 
3-dimensional arrangement of the helices presented by Fischbarg et al, (1993), Widdas 
and Baker, (1991a) and Mueckler et a l , (1985). The model proposed by Fischbarg et 
al, (1993) is inconsistent because the whole of the protein is involved in the 
transmembrane channel as is the model proposed by Widdas and Baker, (1991a). The 
model proposed by Mueckler et al, (1985) is inconsistent because the transmembrane 
channel is composed of helices in both the first and second halves of the molecule 
(helices 3, 5, 7,8 and 11). The study undertaken by Cope et al, (1994) strongly suggests 
that both halves of the glucose transporter interact to facilitate ligand binding. This 
would suggest that the functions of the two halves are likely to be coupled.
1.5 Point Mutational Analysis of the GLUT1 Glucose Transporter
In an attempt to assign a function to specific amino acids, extensive point 
mutation analysis has been carried out on the GLUT1 glucose transporter. The following 
studies describe mutations made to the glucose transporter. This work has increased our 
knowledge of the glucose transporter and has generated mutations, which may be useful 
for future crystallisation attempts.
1.6 Glutamine 161 Mutational Analysis 
- N-Terminal Control of Transport
A glutamine 161 mutation was made and studied by Mueckler et a l , (1994). 
Five transmembrane amino acids were chosen for scrutiny based upon their ability to 
hydrogen bond to the substrate, glucose and because of their complete conservation 
from GLUT1 through to GLUT5. The results of the study are displayed in table 1.2.
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Mutation 2-Deoxyglucose uptake 
(pmoles / oocyte / 30 min)
Transporter expression I 
(arbitrary units)
Wild-type 42.4 ±2.0 1.0
N 1001 38.7 ±6.3 1.1 ±0.3
N 100 S 37.9 ±5.1 0.8 ±0.2
0 161L 1.1 ±0.5 1.5 ±0.5
O 161 N 4.1 ± 1.2 2.1 ±0.7
Q 200 L 32.8 ± 3.5 1.8 ±0.5
Y 292 F 30.4 ±2.6 1.7 ±0.3
I Y 293 F 37.6 ±6.7 1.3 ±0.2
Table 1.2, Results of point mutation work, taken from Mueckler et al, (1994). Point mutational 
analysis demonstrates that Q 161 L is expressed above wild-type levels, yet, almost incapable of 
2-Deoxyglucose transport.
Table 1.2 shows that the only significant reduction in 2-Deoxyglucose uptake 
results from the mutation of glutamine 161. In this study the mutation of tyrosine 293 to 
phenylalanine had very little effect on transporter function. However, the mutation of 
tyrosine 293 to isoleucine has a profound effect on transporter function (section 1.7).
The non-conservative substitution of glutamine 161, for leucine, reduced 
transporter activity by 50 fold and the conservative substitution of glutamine 161, for 
asparagine, reduced transporter activity by 10 fold. The difference between the amino 
acids glutamine and asparagine is a single methylene group. From the experimental 
evidence, Mueckler et al, (1994) concluded that glutamine 161 must be involved in the 
exofacial binding site. It was argued that the conservative substitution of glutamine 161, 
anywhere other than in the exofacial binding site, would be unlikely to cause a massive 
change in tertiary structure which would be likely to affect substrate transport.
However, the reduced transport activity was not found to be due to a decreased 
substrate affinity, since there was no significant difference in the Km for the substrate. 
Therefore, it was hypothesised that the mutation must also affect a transport mechanism, 
such as conformational change, subsequent to substrate binding. This is consistent with 
the observation that the binding of glucose to erythrocyte GLUT1 is much faster than 
the rate of conformational change which leads to transport (ie. glucose binding is not the 
rate limiting step). The importance of glutamine 161 is highlighted by its high degree of 
conservation within the hexose transporter superfamily.
Page 16
Chapter 1 Introduction
Mueckler et al, (1985) have mapped glutamine 161 to helix 5 in the N-terminal 
half of the glucose transporter. Mueckler et al, (1994) conclude that glutamine 161 and 
therefore helix 5 constitute part of the substrate binding site, the site being otherwise 
composed of helices in the C-terminal half of the transporter.
Ducarme et al, (1996) have also mapped glutamine 161 to the N-terminal half of 
the glucose transporter. However, Ducarme et al, (1996) propose that the N-terminal 
half is intimately coupled to the transport activity of the C-terminal half, which could 
also explain the observed effects on transport activity. Alternatively, it is possible that 
the mutation of glutamine 161 is simply causing protein mis-folding which would 
interfere with conformational change but not glucose binding.
1.7 Tyrosine 292 and 293 Mutational Analysis - A Hydrophobic Patch
Mori et a l , (1994) have analysed several tyrosine mutations. The mutations 
made were Y 2921, Y 292 F, Y 293 I and Y 293 F. Table 1.3 summarises the results of 











CHO-K1 7.1 16.2 ±5.3 18.2 ±2.3 14.4 ±2.2
Wild-type 74.9 ±18.2 100 100 100
Y 292 F 72.7 ±23.6 147.6 ±60.7 103.5 ±8.6 100.3 ±29.7
Y 2921 75.1 ±19.2 118.7 ±15.8 53.8 ±7.3 129.0 ±35.3
Y 293 F 83.5 ±11.7 105.8 ±27.1 107.3 ±8.1 97.4 ±8.9
Y 293 I 10.3 ±2.8 126.2 ±34.9 4.5 ±2.1 134.8 ±3.4
Table 13 , Results of point mutation work, taken from Mori et aL, (1994). The mutation Y 293 I 
generates the most significant response. This mutation locks the transporter into an outward facing 
conformation, as demonstrated by ATB-BMPA and cytochalasin B binding. Mutating Y 2921 has a less 
pronounced effect, but still results in reduced cytochalasin B labelling at the internal site.
The results demonstrate that the tyrosine 293 to isoleucine mutation generates a 
stable form of the glucose transporter, which is locked in an outward facing 
conformation. This can be concluded because of the marked reduction in cytochalasin B 
(endofacial ligand) labelling accompanied by nearly normal ATB-BMPA (exofacial
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ligand) labelling. The tyrosine 292 to isoleucine mutation demonstrates a 2-fold 
reduction in cytochalasin B binding to the internal site.
Previous work by Barnett et al, (1973a&b), Barnett et al., (1975) and Holman 
and Rees, (1982) demonstrated that bulky alkyl groups substituted at the carbon 1 
position of D-glucose markedly reduce the binding of these glucose analogues to the 
glucose transporter. However, analogues with hydrophobic alkyl substitutions at the 
carbon 4 and carbon 6 positions of D-glucose were found to have a high affinity towards 
the glucose transporter; sometimes exceeding that of D-glucose. These studies suggested 
that the binding of D-glucose to the exofacial binding site of the glucose transporter 
resulted in carbon 6 being in close contact with a hydrophobic patch on the surface of 
the protein. Mori et al, (1994) have therefore postulated that the hydrophobic patch may 
be composed of phenylalanine 291, tyrosine 292 and tyrosine 293. It was further 
suggested that the hydrophobic patch closes behind the bound substrate and triggers the 
conformational change necessary for glucose transport. Although isoleucine is 
hydrophobic in nature, the residue is thought to be too small to form the correct 
conformation at this critical site. Disruption of the patch, as seen in the above data, 
results in a glucose transporter becoming locked in an outward facing conformation. The 
transporter is then left unable to close the external site and undergo conformational 
change. Study of tyrosine 293 has placed it in a theoretical location in, or near, the 
glucose binding site; the preceding amino acids to tyrosine 293 
(Q 282 QLSGINAVFYY 293) are thought to form hydrogen bonds with the substrate. 
This mutation would provide a useful construct for the study of the glucose transporter 
by X-ray crystallography, producing a transporter locked in a single conformation.
Both Mueckler et al., (1985) and Ducarme et al, (1996) have proposed models 
which are compatible with the above tyrosine mutations. Both models place the 
hydrophobic patch at the extracellular surface. Although there is variation in the exact 
position of the tyrosine residues, both models could fit the results as described above.
1.8 Proline 385 Mutational Analysis - A Helical Hinge
The sequence F 378 FEVGPGPIPW 388 is conserved in GLUT’S 1, 2, 3, 4 and 
7. Proline 385 is therefore in a proline rich region of the glucose transporter. In an
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a-helix the presence of the imino acid proline has the effect of breaking the hydrogen 
bonding pattern, so disrupting the helix. This is a useful property, enabling the helix to 
form flexible kinks.
Tamori et a l, (1994) substituted proline 385 with either glycine or isoleucine. As 
a result of the isoleucine substitution a marked reduction in transport activity was 
observed. Both mutants were capable of binding cytochalasin B with similar activities to 
the wild-type transporter. However, the binding of ATB-BMPA was perturbed in both 
mutants, the glycine mutant resulting in a 2-fold reduction in ATB-BMPA binding and 
the isoleucine mutant resulting in a complete abolition of ATB-BMPA binding. These 
data indicated that the mutated glucose transporter was locked in an inward-facing 
conformation.
Wellner et a l, (1995a) extended the work of Tamori et al, (1994) by studying 
mutations made to proline residues in putative transmembrane helices 6 and 10 
(according to the model proposed by Mueckler et al, (1985). It was observed that by 
individually point mutating six proline residues within helices 6 and 10 to alanine 
(P 187, P 196, P 205, P 383, P 385 and P 387) that there was no detrimental effect on 
glucose transporter activity. The study of a double mutant, mutating both P 383 and 
P 385 to alanine, also had no effect on glucose transport activity. However, by creating a 
triple mutant in which the three proline residues P 383, P 385 and P 387 were mutated to 
the polar amino acid, glutamine, 2-deoxy-D-glucose uptake was almost abolished. It is 
thought that this mutation may hinder the conformational flexibility of the glucose 
transporter, disrupting the helix at the hinge region, therefore reducing transport activity. 
The isoleucine mutation studied by Tamori et al, (1994) may also have a similar affect 
in disrupting the hinge region. Studies carried out by Wellner et al, (1995a) suggest that 
the glucose transporter can compensate for individual mutations of the 6 proline 
residues with a small hydrophobic residue, alanine. However, the larger amino acid 
glutamine clearly disrupts the function of helix 10. When Tamori et al, (1994) 
substituted proline 385 with glycine a reduction in ATB-BMPA binding was observed. 




1.9 Glutamine 282 Mutational Analysis - The External Binding Site
Hashiramoto et al, (1992) have identified glutamine 282 as being important in 
exofacial ligand binding. By mutating glutamine 282 to leucine, the group produced a 
glucose transporter with a reduced affinity to ligand at the exofacial site. Labelling of 
the mutated glucose transporter with the exofacial iigand ATB-BMPA was reduced by 
95% in comparison to the wild-type glucose transporter. However, the mutated glucose 
transporter was still capable of binding the endofacial ligand cytochalasin B to wild-type 
levels.
Mueckler et al, (1985) mapped glutamine 282 to the centre of helix 7, Ducarme 
et al, (1996) mapped glutamine 282 to the exofacial surface of helix 7. Both models 
place the amino acid in a region where it is capable of binding to ligand. Hashiramoto et 
al, (1992) postulate that according to the model by Mueckler et al, (1985) the binding 
of glutamine 282 to the substrate must cause a massive conformational change, lifting 
the centre of helix 7 out of the membrane towards the surface. Proteolysis evidence is 
available which appears to support a large conformational change during ligand binding. 
Holman and Rees, (1987) demonstrated this by subjecting erythrocyte membranes to 
thermolysin treatment in the presence of both ASA-BMPA and cytochalasin B, which 
bind to the exofacial and endofacial sites respectively. In the presence of ASA-BMPA at 
the external binding site there was very little cleavage of the transporter. However, in 
the presence of cytochalasin B at the internal binding site the transporter was cleaved to 
produce smaller protein fragments. Thermolysin appeared to cleave the transporter on 
the internal surface as there was virtually no thermolysin cleavage observed in resealed 
erythrocyte ghosts. It was concluded from this work that the binding of ASA-BMPA at 
the external site must have caused a major conformational change which protected the 
internal thermolysin cleavage site within the transporter structure. Similar results were 
obtained by Clark and Holman, (1990) using the exofacial ligand ATB-BMPA and 
trypsin. Clark and Holman, (1990) observed that the exofacial ligand ATB-BMPA 
protected the erythrocyte glucose transporter from trypsin cleavage. It was hypothesised 
that this was due to the adoption of an outward facing conformation by the glucose 
transporter therefore protecting the trypsin site.
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Hashiramoto et al, (1992) suggest that the alternation of the glucose transporter 
between two conformations, an outward and inward facing conformation, involves the 
upward and downward movements of helixes 7 and 12. This would act to relay the 
substrate between the external and internal sites.
1.10 Tryptophan 388 and 412 Mutational Analysis 
- The Internal Binding Site
Inukai et al, (1994) have focused on residues involved at the internal binding 
site of the glucose transporter. It has been observed that when photolabelling the glucose 
transporter with the endofacial ligand, cytochalasin B, the wavelength required for 
photoactivation is 280 nm. This is the wavelength required to activate an aromatic 
tryptophan residue, rather than the cytochalasin B molecule itself. Two tryptophan 
residues exist within helices 10 and 11, tryptophan 388 and tryptophan 412, 
respectively. Inukai et al, (1994) mutated tryptophan 388 and tryptophan 412 to leucine 
residues, both individually and as a pair. Cytochalasin B binding was reduced but not 
completely abolished by the individual point mutation of the tryptophan residues. 
However, analysis of the double mutant indicated that cytochalasin B binding was 30% 
of the wild-type level and cytochalasin B photolabelling was completely eliminated. 
Furthermore, the ability of the double mutant to transport glucose was reduced by 70% 
in comparison to the wild-type. These results suggest that the tryptophan residues are 
necessary in maintaining a high affinity towards cytochalasin B. Furthermore, the results 
suggest that the tryptophan residues lie in close proximity to the cytochalasin B binding 
site. Both Mueckler et al, (1985) and Ducarme et al, (1996) map these tryptophan 
residues towards the cytoplasmic surface of the glucose transporter.
1.11 Cysteine Residue Mutational Analysis
Wellner et al, (1992) have studied the effect of p-chloromercuribenzene sulfonic 
acid (a sulfhydryl reactive agent) interaction with cysteine 421 and cysteine 429. 
Experiments with the impermeant sulfhydryl reagent p-chloromercuribenzene sulfonic 
acid demonstrated that cysteine 429 is exposed to the external surface of the glucose
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transporter, whereas cysteine 421 is protected by the plasma membrane. These findings 
are consistent with both of the models proposed by Mueckler et al, (1985) and Ducarme 
et al, (1996). Wellner et al, (1994) studied the effect of point mutating each of the six 
cysteine residues in the glucose transporter and found that no individual cysteine residue 
was essential for glucose transporter activity. Even the double mutation C 201 G and C 
207 S had no effect on transport activity. Wellner et al, (1994) concluded that the 
cysteine residues do not have an essential function in maintaining the glucose 
transporter tertiary structure.
1.12 Antibody Analysis
Davies et al, (1990) have carried out an extensive study using antibodies to map 
specific regions of the glucose transporter. Antibodies were raised towards regions of 
the glucose transporter determined by Mueckler et al, (1985) to be extramembranous. 
Seventeen of the nineteen antibodies raised against peptides recognised the denatured 
protein by immunoblotting. However, only six antibodies recognised the native 
membrane bound protein, even after deglycosylation. Four of these antibodies mapped 
to the large intracellular cytoplasmic loop and the other two antibodies were to the 
cytoplasmic C-terminal tail. Previous studies by Davies et al, (1987a&b) have 
demonstrated the C-terminal tail to be cytoplasmic. Binding to the N-terminal tail in the 
native state was not achieved in either study. This may be due to the N-terminal tail 
being buried in, or associated with the membrane. It was not possible to determine why 
the antibodies did not recognise other extracellular regions of the glucose transporter 
and several possibilities exist, including: a) The extracellular regions are not as 
predicted and b) The extracellular regions form a complex structure not allowing 
antibody recognition.
Point mutation analysis has examined the function of individual amino acids. 
However, several experiments have been performed in order to determine the function 
of large areas of amino acid sequence. These have included the deletion of the 
C-terminal amino acids and the construction of chimeric proteins.
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1.13 C-Terminal Deletion Analysis of GLUT1
The C-terminal tail of the glucose transporter has been demonstrated to be 
essential for glucose transport. This has been tested by several groups, who have 
performed C-terminal deletion analysis on the final 43 amino acids of the glucose 
transporter. Deletions made are displayed in figure 1.6 and are discussed in the 
following text.
The smallest C-terminal deletion was made by Lin et al., (1992). Lin et al., 
(1992) introduced a stop codon at amino acid 480, which was found to have no effect on 
glucose transport activity. The introduction of a stop codon at 470 and 469 by Due et al.,
(1995) and Muraoka et al., (1995) respectively, also had no effect on the function of the 
glucose transporter. However, the progressive deletion of the C-terminal tail by the 
introduction of stop codons at residues 468, 467 and 466 by Muraoka et al., (1995) 
resulted in the reduction of glucose transport activity. Indeed, transport activity is greatly 
reduced by the introduction of a stop codon at residue 468 (deleting 25 C-terminal 
amino acids) and almost completely abolished by the introduction of a stop codon at 
residue 467 (deleting 26 C-terminal amino acids). Binding of the exofacial ligand 
ATB-BMPA to the two mutants with 25 and 26 C-terminal amino acids deleted was 
perturbed. However, it was still possible for cytochalasin B to bind to the internal 
binding site with near to wild-type activity.
Figure 1.6, The C- 
terminal portion of the 
glucose transporter.
Modified from the picture 
of Bell et al., (1993) 
displaying the last 6 
transmembrane a-helices 
and the C-terminal tail. 
Residues at which stop 
codons were introduced 







Amino Acids From Amino Acids From Effect of Deletion on





468 25 Decreased activity
467 26 Decreased activity
466 27 Decreased activity
454 39 Decreased activity
451 42 Decreased activityI 450 43
Table 1.4, GLUT1 C-terminal amino acid deletions. C-terminal amino acid deletions summarised from 
the text.
The introduction of stop codons at residues 454 and 451 by Oka et a l, (1990) 
and Due et al., (1995), respectively, produce data consistent with the results of Muraoka 
et al., (1995). In conclusion, deletion of the C-terminal amino acids may result in a 
significant conformational change within the protein, giving rise to a glucose transporter 
locked in an inward facing conformation.
Furthermore, Due et al, (1995) have examined the effect of adding 31 amino 
acids to the C-terminus of the glucose transporter. These amino acids were derived from 
the human insulin C-peptide protein. Due et al, (1995) reasoned that if the C-terminal 
tail is important for conformational change of the protein, the addition of extra amino 
acids to the C-terminal tail might impair the ability of the glucose transporter to undergo 
conformational change. Due et al, (1995) found that the addition of the C-peptide 




1.14 Chimeric Protein Analysis
Katagiri et a l , (1992) reported that the substitution of 39 C-terminal GLUT1 
amino acids, with those of GLUT2, result in a chimeric protein with transport kinetics 
resembling those of GLUT2. The substituted amino acids are displayed in figure 1.7.
4 5 4  3 9  4 6 8
R a b b it  GLUT1; FKVPE/ TKGRTFDEIASGFR//QGG
Human GLUT2; ........... / . . . K S . E . . . AE. Q/ / KKS
Figure 1.7, A GLUT1 / GLUT2 chimera. The final 39 amino acids o f GLUT1 were substituted with the 
corresponding amino acids o f GLUT2. Amino acid E454 corresponds to the 40th residue from the 
C-terminus. Identical residues are represented by a dot, residues that vary are displayed as the single letter 
amino acid code.
Due et al, (1995) created a GLUT1 / GLUT4 chimera, composed of GLUT1 
amino acids 1 - 463 and then GLUT4 amino acids 480 - 509. The resulting chimera had 
the same kinetics as the GLUT4 protein. This suggests that the C-terminal tail is capable 
of regulating the kinetic properties of the glucose transporter and could therefore be 
responsible for the functional differences between the different isoforms. Dauterive et 
al, (1996) have studied similar chimeric constructs and have assigned further functions 
to the C-terminal tail of the glucose transporter.
Dauterive et al, (1996) emphasise that GLUT1 is capable of a unique kinetic 
property termed ‘accelerated exchange’. When the Vmax for uptake is measured with 
internal and external glucose concentrations in equilibrium, the Vmax is found to be 
much higher than when uptake is measured in the absence of internal glucose (zero trans 
entry).
Dauterive et al, (1996) created two chimeric proteins. The first protein was a 
GLUT1 / GLUT4 chimera composed of GLUT1 amino acids 1 - 444 and then GLUT4 
amino acids 461 - 509. The second protein was a GLUT4 / GLUT1 chimera composed 
of GLUT4 amino acids 1 - 460 and then GLUT1 amino acids 445 - 492. Table 1.5 
displays the kinetic data obtained from the chimeric constructs.
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GLUT1 575 ± 88 10.7 ±2.0 1450 ±373 43.9 ±6.5
GLUT1 cterm 4 296 ±45 8.0 ±0.6 302 ±45 16.7 ±3.5
GLUT4 cterm 1 480 ± 69 9.5 ±3.3 461 ±25 23.3 ±3.4
GLUT4 76 ± 7.5 8.8 ±2.1 124 ±25 19.1 ±3.3
Table 1.5, Kinetic data from GLUT1 / GLUT4 chimeras.rTie first two columns disp ay the Vmax and
Km in the absence o f intracellular glucose and the final two columns display the Vmax and Km in 
equilibrium conditions. GLUT1 can be seen to lose the property of equilibrium exchange when its 
C-terminal region is replaced with that of GLUT4.
When the GLUT1 protein is made chimeric with the GLUT4 C-terminus the 
property of accelerated exchange is lost and the Vmax reduced. When the GLUT4 
protein is made chimeric with the GLUT1 C-terminus (GLUT4 1 - 460, GLUT1 445 - 
492) the Vmax is raised to GLUT1 levels but the property of accelerated exchange is not 
conferred upon the GLUT4 protein. Although, it appears that the C-terminal tail has 
some importance in controlling transporter kinetics, for accelerated exchange to occur 
the GLUT1 C-terminal domain must interact with other specific sequences not present 
within the GLUT4 protein.
1.15 Mechanisms of Glucose Transport
It is thought that the glucose transporter oscillates between two conformations, 
an inward facing and an outward facing conformation. This is proposed to occur both in 
the presence and absence of substrate, although the latter case is difficult to confirm 
experimentally. Two possible mechanisms of transport have been considered by 
Helgerson and Carruthers, (1989). These are the one site (simple) carrier and the two 
site (fixed site) carrier. The simple carrier describes a transporter mechanism, where 
sugar influx and sugar efflux binding sites are mutually exclusive, the sites being 
exposed in an alternating fashion. The fixed site carrier describes a transport mechanism 
in which sugar influx and sugar efflux binding sites can exist simultaneously. Helgerson 
and Carruthers, (1989) found that in rat erythrocytes the mechanism of transport is a
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better, but not perfect fit to the fixed, two site carrier mechanism. Their results have lead 
them to reject the simple, one site carrier model.
Zottola et al, (1995) have proposed a transport mechanism consistent with past 
and current experimental evidence. The model is based on the oligomeric structure of 
the glucose transporter. Jung et al., (1980) suggested that the human erythrocyte glucose 
transporter adopts a tetrameric form in the native state. Further to the study carried out 
by Jung et al, (1980) Hebert and Carruthers, (1992) have suggested that the GLUT1 
glucose transporter functions as a complex of four GLUT1 protein monomer units, 
whose substrate binding properties are linked by reductant-sensitive noncovalent subunit 
interactions. Zottola et al, (1995) have now proposed a new mechanism based on the 
GLUT1 homotetramer and propose that a carrier can be thought to comprise of one or 
more members of an ‘E1-E2’ catalytic subunit, figure 1.8, cycling between two 
conformational states. The ‘E l’ state exposes the substrate export site and the ‘E2’ state 
exposes the substrate import site. No single subunit can exist in both El and E2 states 
simultaneously, ie. a simple carrier mechanism. Their view is that current evidence rules 
against the possibility of the glucose transporter existing as a simple carrier type 
transporter. The proposed E1-E2 catalytic subunit is displayed in figure 1.8.
Figure 1.8, An El E2 catalytic 
subunit (taken from Zottola et 
al., (1995). The diagram shows a 
section across two of the four 
subunits that form the 
hypothetical glucose transporter 
homotetramer. The El E2 
catalytic subunit is formed by two 
associated glucose transporters. 
Two El E2 subunits may then 
associate to form a homotetramer. 
In the homotetramer form the 
transporter acts as a fixed site 
carrier and in the monomeric 
form as a simple carrier.
120 A
glucose outside
c a t a l y t i c  d o m a i n
inside
« ir® ® 2 e g L ^ e i
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Zottola et a l, (1995) suggest that the transporter exposes its E1-E2 sites 
simultaneously (fixed site carrier) and not sequentially (simple carrier) existing as a 
homotetramer. When one subunit exists in the El state the adjacent subunit must adopt 
the E2 state, thus the transporter would contain two El conformers and two E2 
conformers at all times. If the E2 site binds substrate then the adjacent El site must 
undergo the antiparallel conformational change, regardless of the occupancy state. The 
linked glucose transporter units now act as simple carriers when in the monomeric form. 
However, when the transporter is in the tetrameric form the whole unit acts as a fixed 
site carrier, presenting both import and export sites simultaneously. They conclude that 
the tetrameric form of the transporter satisfies all of the currently available experimental 
evidence. The units appear to act allosterically, as they suggest the dimeric form of the 
transporter is some 10 fold less active than the tetrameric form. This is possible because 
in the tetrameric form the transporter could bypass slow relaxation steps, acting as a 
simultaneous carrier, where sugar import is coupled with the regeneration of other sugar 
import sites in one step. The subunits are thought to be connected by noncovalent 
interactions promoted or stabilised by intramolecular disulfide bridges. On exposure to 
reductant the tetramer breaks up into dimers, demonstrating the disulfide bridge to be 
essential for oligomerization.
Zottola et al., (1995) have further shown that Xenopus oocyte expressed GLUT1 
is not affected by dithiothreitol, suggesting that oocyte GLUT1 is in the dimeric, rather 
than a tetrameric form. This would explain why Xenopus oocyte expressed GLUT1 
binds glucose with a 10 fold lower affinity than erythrocyte GLUT1 or CHO cell 
expressed GLUT1.
Wellner et al., (1995b) disagree with Zottola et al, (1995) and have carried out 
experiments to disprove the homotetramer theory. They have demonstrated that the 
individual replacement of cysteine residues has no effect on transporter kinetics when 
measured in Xenopus oocytes. They conclude that individual disulfide bonds do not 
appear to be essential to catalytic activity. The simultaneous change of three cysteine 
residues in the N-terminal half to either serine or glycine residues had no effect on 
2-deoxy-D-glucose uptake. However, it could not be excluded that multimeric assembly 
could take place by a different mechanism. The substitution of three cysteine residues 
within the C-terminal half for serine residues, or the substitution of all six cysteine
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residues throughout the transporter resulted in only a slight decrease in catalytic activity. 
Wellner et al., (1995b) concluded that if oligomerization occurs by disulfide bridges 
within the membrane, they contribute little towards the intrinsic catalytic activity of 
GLUT1.
L16 Regulation of the Glucose Transporter - Cytosolic
Carruthers and Helgerson, (1989) and Hebert and Carruthers, (1986) have 
demonstrated that the ATP is capable of binding to an intracellular site on the human 
erythrocyte glucose transporter. Furthermore, the binding of ATP appears to be 
stereoselective and to act in modifying the function of the glucose transporter. It appears 
that in the presence of ATP, GLUT1 is converted into a low capacity glucose transporter 
and in the absence of ATP, GLUT1 is converted into a high capacity glucose 
transporter. The nucleotides AMP, ADP, UTP, ITP and GTP were unable to mimic the 
action of ATP. However, the nucleotides AMP and ADP were capable of acting as 
competitive inhibitors of ATP binding. The glucose transporter lacks any detectable 
ATPase activity and is not phosphorylated by ATP. These authors suggest that ATP may 
modify the function of the glucose transporter by allosteric interaction. Studies 
undertaken using C-terminal peptide antisera indicate that ATP binding either causes 
subtle changes in carrier structure, or that bound ATP directly interferes with IgG 
binding. Partial enzymatic digestion of azido-ATP photolabelled GLUT1 protein 
localises the cytoplasmic ATP binding site to the same domain responsible for the 
cytoplasmic binding of cytochalasin B and the same extracellular domain responsible for 
the binding of ATB-BMPA (residues 270 - 456). Three ATP binding domain consensus 
sequences have been identified within the glucose transporter and are located between 




Figure 1.9, ATP can complex with 
the erythrocyte glucose transporter 
to alter the function of the protein 
(taken from Carruthers and 
Helgerson, (1989). The GLUT1 
protein (GT) can exist either 
dissociated or complexed with ATP, 
ADP or AMP. When ATP is 
complexed with the carrier, a low 
capacity transporter exists. In all 
other situations a high capacity 
transporter prevails. High level 
production o f ATP therefore favours 
low capacity glucose transport.
Shi et al, (1995) have further investigated the effects of exposing Clone 9 cells 
(a non-transformed rat liver cell line) to inhibitors of oxidative phosphorylation. 
Chemicals such as azide or cyanide result in an increase in glucose uptake. This increase 
is observed after exposure of clone 9 cells to azide for a period of 1 - 2 h. The increase 
in glucose transport activity is not associated with any other glucose transporter isoform, 
as Clone 9 cells are known to exclusively express GLUT1. Neither is the increase in 
activity linked to an increase in cellular or plasma membrane levels of GLUT1.
However, longer exposure times of up to 24 h result in an increase in GLUT1 mRNA
levels. Shi et al, (1995) monitored the increase in glucose transporter activity by 
cytochalasin B binding. Clone 9 cells possess 3 classes of binding sites; a D-glucose / 
cytochalasin B sensitive site (site I), a cytochalasin E sensitive site (site II) and a site 
which is insensitive to cytochalasin E (site III).
Shi et al, (1995) observed that exposure of Clone 9 cells to azide resulted in an 
increased Vmax for glucose while the Km for glucose remained unaltered. Azide 
treatment resulted in an increased binding of cytochalasin B at site III. The evidence 
suggested that site III is an altered form of GLUT1, inactivated by molecular association 
with a cytoskeletal component. Shi et al, (1995) proposed that the GLUT1 glucose 
transporter in Clone 9 cells is deactivated in the normal state by a protein with an 
affinity towards the cytosolic carboxy terminus of GLUT1. In the presence of azide the
High Capacity 






regulatory protein would become disassociated from the glucose transporter, allowing 
the glucose transporter to become functional.
Shi et al, (1995) have identified three proteins with apparent molecular weights 
of 28, 70 and 85 kDa in Clone 9 cell cytosol. These proteins have been found to 
specifically bind to the cytoplasmic, carboxy terminal domain, of the glucose 
transporter. The 85 kDa protein was found to be a phosphoprotein which bound only to 
GLUT4. Both the 28 and 70 kDa proteins bound to GLUT1, although the 70 kDa 
protein bound with a higher affinity to GLUT4 than GLUT1. The function of these 
proteins in Clone 9 cells is at present unclear.
1.17 Regulation of the GLUT1 Glucose Transporter - Hormonal
The GLUT1 glucose transporter is the most widely distributed glucose 
transporter isoform and is not often thought of as being under hormonal control. 
However, it has long been known that cultured mammalian cells expressing only 
GLUT1 can produce relatively fast, profound changes, in glucose transport activity. 
Such increases in transport activity can be accounted for by translocation of GLUT1 
from an intracellular pool to the plasma membrane. Baldwin et al, (1994) has described 
some of these control mechanisms which affect the GLUT1 glucose transporter.
The GLUT1 glucose transporter is known to be abundant in the plasma 
membrane of secretory epithelial cells from the mammary glands of lactating rats. No 
other glucose transporter isoforms are present within these cells. Levels of GLUT1 
glucose transporter remain low during pregnancy but increase rapidly with the onset of 
lactation. Removal of the litter, from the mother, results in a rapid loss of glucose 
transporter levels, which return to pre-birth levels 24 h later. These changes are not 
associated with changes in the level of GLUT1 mRNA, hence the control appeared to be 
post-transcriptional. Cells cultured with the hormone prolactin demonstrated a 5 fold 
increase in GLUT1 protein over a 2 day period but the hormones cortisol and insulin 
had no effect. These data demonstrated that prolactin was required for the initiation of 
GLUT1 expression in lactogenesis.
Confocal microscopy performed on haemopoietic cells demonstrated the 
presence of an intracellular pool of GLUT1. The intracellular GLUT1 pool could be
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translocated to the plasma membrane under the influence of the hormone interleukin 3. 
GLUT1 translocation was also found to be affected by certain oncogenes (ie. v-abt). 
GLUT1 translocation appears to be an important step in preventing the cell from 
undergoing apoptosis.
1.18 Glycosylation of Human GLUT1
The human erythrocyte glucose transporter (GLUT1) is glycosylated on 
asparagine 45 (Asn 45, the N-linked consensus recognition site is Asp - X - Ser / Thr) 
which is located in the first extracellular loop (figure 1.3). Asano et al, (1991) 
Asano etal., (1993) and Feugeas et al, (1990) have suggested that GLUT1 
glycosylation plays an important role in GLUT1 function and should therefore be taken 
into consideration when expressing GLUT1 in non-native expression systems. Studies 
have shown that there is only one glycosylation site on the GLUT1 protein, this 
glycosylation site is thought to increase the affinity for glucose and therefore increase 
the rate of glucose transport. Asano et al., (1993) further investigated the role of 
glycosylation in protein targeting and protein stability. Asano et al, (1993) observed 
that the majority of glycosylation deficient GLUT1 was located in intracellular vesicles 
and was not targeted to the plasma membrane. Furthermore, deglycosylation resulted in 
GLUT1 protein with a reduced stability. Wild-type, glycosylated GLUT1, was observed 
to have a half-life of 25 - 28 h, while de-glycosylated GLUT1 had a half-life of 16 -18 
h. In conclusion, glycosylation has been shown to affect transporter location and 
stability, these factors may in turn modify the transporter activity.
1.19 Glycosylation in the Svodovtera frueiverda Expression System
This thesis examines GLUT1 expression in Spodoptera frugiperda cells (Sf9 
cells). Since the glycosylation state of the glucose transporter affects its activity some 
aspects of glycosylation patterns observed in Sf9 cells are considered.
N-Linked glycosylation is known to occur in the endoplasmic reticulum of insect 
cells and has been thoroughly studied (King and Possee, (1992)). In both mammalian 
cells and insect cells, protein glycosylation is inhibited by the presence of tunicamycin.
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It is known that mammalian cells cany out extensive modifications to the 
oligosaccharide moiety. This typically includes the addition of fucose and sialic acid 
residues, forming complex branched oligosaccharides. Insect cells lack the ability to 
extensively process the oligosaccharide moiety, and have only veiy low levels of fucose, 
galactose and sialic acid transferases. Glycoproteins, expressed in insect cells, typically 
contain a high proportion of mannose residues in the oligosaccharide moiety. 
Recombinant glycoproteins expressed in the insect cell system are sensitive to the 
enzymes endoglycosidase H, N-glycosidase F and N-glycanase which remove immature, 
high mannose type, oligosaccharides. Because glycosylation is less extensive in insect 
cells those recombinant proteins which are extensively glycosylated in the native 
system, exhibit a lower apparent molecular weight when expressed in insect cells.
1.20 Expression of the Mammalian GLUT1 Glucose Transporter
The mammalian GLUT1 glucose transporter has been expressed in a number of 
systems including: Bacterial (E. coli), Yeast (Saccharomyces cerevisiae), Insect 
(Spodoptera frugiperda), Amphibian (Xenopus oocytes) and non-native Mammalian 
(Chinese Hamster Ovary (CHO)) cell systems. The latter two examples, Xenopus 
oocytes and CHO cell systems are often used for point mutational analysis of the 
glucose transporter. This is because these cell systems extensively glycosylate the 
glucose transporter. The former cell systems are better suited to over-expression of the 
glucose transporter as they are capable of producing higher yields of the expressed 
protein. Unfortunately, as described in the previous section, these systems do not 
undertake extensive post translational modifications, such as glycosylation.
Several membrane glycoproteins have been previously expressed in the insect 
cell system. These include the following: a) The rabies virus glycoprotein G 
(a transmembrane glycoprotein expressed in Spodoptera frugiperda cells) has been 
demonstrated to be fully antigenically reactive (Prdhaud et al, (1989)) and b) The 
influenza virus haemagglutinin (an integral membrane protein expressed in Spodoptera 
frugiperda cells) was found to have a fully cleaved signal peptide and N-linked 
glycosidic modification (Kuroda et al, (1986)). This result demonstrates that insect cell
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expressed glycoproteins can be fully functional and can be translocated correctly to the 
plasma membrane and even undergoing signal peptide cleavage.
1.21 Expression of GLUT1 in the Insect Cell, Spodovtera frusiperda
Yi et al, (1992) have demonstrated that the human erythrocyte GLUT1 protein 
can be over expressed in the insect cell system using Spodoptera frugiperda (Sf9) cells. 
Sf9 cells were infected with the baculovirus, Autographa califomica nuclear 
polyhedrosis virus (AcNPV). This was genetically altered to express the human GLUT1 
protein instead of the viral coat protein. Infected cells were observed by confocal 
immunofluorescent microscopy using an anti-GLUTl FITC conjugated antibody. 
Fluorescence was observed after just two days of infection. The glucose transporter 
protein was observed to be located at the plasma membrane, and within intracellular 
membrane structures. There was no GLUT1 protein observed within the nucleus. 
Immunoblot analysis confirmed the presence of GLUT1 and demonstrated that all of the 
GLUT1 protein was associated with cellular membranes (GLUT1 was completely 
absent from the soluble fractions). Insect cell expressed human GLUT1 had an apparent 
molecular weight of 45 kDa, which was only slightly reduced with endoglycosidase F 
treatment. This indicates that only restricted glycosylation of GLUT1 had occurred in 
insect cells. After a four day infection period, the glucose transporter was found to 
constitute 8% (1.44 nmol / mg membrane protein) of the total membrane protein, as 
determined by immunoblot analysis. The protein was stable and found to accumulate 
until cell lysis. The level of expression achieved by Yi et al.t (1992) was comparable 
with other membrane glycoproteins expressed in the insect cell system.
A precise measurement of glucose transport activity was not possible because 
insect cells underwent cell lysis during the viral infection cycle and an endogenous 
glucose transporter was present. Fortunately though, the endogenous Sf9 glucose 
transporter does not cross react with the anti C-terminal GLUT1 antibody or bind 
cytochalasin B (Yi et a l9 (1992)). The Kd for the binding of cytochalasin B to Sf9 cell 
membranes expressing human glucose transporter was 284 nM. This was almost 
identical to the Kd observed for cytochalasin B binding to human erythrocyte ghosts 
(282 nM Yi et al., (1992)). Binding was inhibited by the addition of D-glucose but not
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L-glucose, demonstrating that the glucose transporter was still capable of 
stereoselectivity and that the transporter was likely to adopt its native conformation. The 
amount of biologically active protein, as determined by cytochalasin B assay, was less 
than 20% of the total protein determined by immunoblot assay. However, the insect cell 
expression system still provides sufficient active protein for further biological 
experimentation.
1.22 Expression of GLUT1 in the Bacterium, E. coli
In comparison with the Sf9 baculovirus expression system, the E. coli expression 
system is capable of producing large quantities of protein rapidly and economically. 
Unfortunately, E. coli undertakes very little post-translational modification and the 
expressed glucose transporter is not glycosylated in this system. Glucose transporter 
protein expression in the bacterium E. coli has been investigated by Sarkar et a l, (1988).
Sarkar et a l, (1988) have expressed the human erythrocyte glucose transporter, 
GLUT1, in a strain of E. coli (SR425) deficient in all known pathways of glucose 
transport. Transport studies revealed that the transformed cells were capable of 
transporting 2-deoxy-D-glucose and D-glucose 4 -5  times faster than control cells. 
Unlabelled D-glucose, cytochalasin B and mercuric chloride inhibited uptake of 
radiolabelled substrate. Uptake of radiolabelled substrate was not inhibited by 
L-glucose. The expressed glucose transporter was detected by immunoblotting with an 
anti C-terminal antibody and an antibody directed against amino acids 225 - 238, in the 
cytoplasmic loop. The apparent molecular weight of the expressed protein was 
determined to be 34 kDa, a molecular weight similar to de-glycosylated human 
erythrocyte glucose transporter. This demonstrates that the human erythrocyte glucose 




1.23 Expression of GLUT1 in the Yeast, Saccharomvces cerevisiae
The use of a yeast expression system for the expression of the GLUT1 protein 
has been investigated by Kasahara and Kasahara, (1996). This is a useful expression 
system as it again offers the advantages of rapid economical protein expression.
Kasahara and Kasahara, (1996) have successfully expressed the rat GLUT1 
glucose transporter in the yeast Saccharomyces cerevisiae. Observation by confocal 
immunofluorescence microscopy revealed that the majority of the GLUT1 protein was 
located within intracellular structures. Very little glucose transport activity was observed 
in intact cells. However, glucose transport activity was observed in a reconstituted 
system, resulting in Vmax and Km values similar to those measured in human 
erythrocytes. Incubation of yeast expressed GLUT1 with N-glycosidase F did not affect 
the apparent molecular weight of 40 kDa, indicating there to be little or no 
glycosylation. In comparison, incubation of human erythrocyte GLUT1 with 
N-glycosidase F reduced the apparent molecular weight of the native protein to 40 kDa. 
In conclusion, the yeast expression system fails to target the GLUT1 glucose transporter 
correctly or to glycosylate the protein. Otherwise, the glucose transporter protein 
appears to be a fully functional, unglycosylated, glucose transporter. Different cells 
appear to target the glucose transporter in different ways, it appears that protein 
targeting is very much cell dependent. Simons et al, (1997) are continuing this work, 
attempting to perfect the expression of GLUT1 in yeast by exploring a range of yeast 
expression vectors and yeast host strains. Simons et al., (1997) have also modified the 
GLUT1 protein to express a C-terminal polyhistidine tag. The aim is to utilise the 




1,24 Affinity Purification of Proteins using a Polyhistidine Tag
Many proteins have now been purified using the approach of immobilised metal 
ion affinity chromatography (IMAC). To achieve this a polyhistidine tag is genetically 
engineered into the protein; the modified protein is then expressed in the chosen 
expression system. The protein is usually engineered to express a sequence of six 
contiguous histidine residues at either the N-terminal or C-terminal end of the protein. 
Carlsson et al, (1996) have determined that proteins carrying as few as four or five 
contiguous histidine residues can be purified using this technique. Carlsson et al,
(1996) observed that although longer histidine tails often reduced the level of gene 
expression, they do increase the level of binding between the polyhistidine residues and 
the chelated metal ions. In most circumstances the use of four or more histidine residues 
will assure a strong metal / protein interaction.
Waeber et al, (1993) were the first group to purify a membrane bound protein 
using nickel chelate affinity chromatography, the protein was the E. coli glucose 
transporter. The E. coli glucose transporter combines vectorial transport with the 
phosphorylation of the translocated substrate. Waeber et al, (1993) modified the 
membrane bound glucose transporter of E. coli by the addition of 10 amino acids to the 
C-terminus, these ten residues contained six contiguous histidine residues. The addition 
of ten amino acids to the C-terminus was found to have no effect on either protein 
stability or activity. In practice slightly more modified protein was expressed in 
comparison with the control. Following the addition of the polyhistidine tag there was a 
slight increase in the apparent molecular weight. About 90% of the glucose 
phosphotransferase activity could be solubilized at pH 8.9 using 2% Triton. Virtually 
pure glucose transporter protein was eluted from an immobilised metal ion column at 
pH 5.0. A minor contaminating protein with an apparent molecular weight of 67 kDa 
was removed by gel filtration chromatography. Following purification, 70% of the 
glucose transporter’s phosphotransferase activity was retained. The high affinity of this 
polyhistidine tagged glucose transporter to the chelated nickel column indicates that the 




Waeber et al, (1993) have also attempted to purify the E. coli 
phosphotransferase transporter for mannose. Polyhistidine tags were placed at the 
N-terminus and C-terminus of the IIDMan subunit and the N-terminus of the IICMan 
subunit. The constructs demonstrated the importance of correctly positioning the tag for 
optimum surface exposure. Although all of the constructs were fully active, only the 
construct with the polyhistidine tag at the most hydrophilic end was capable of being 
successfully purified on an immobilised nickel column. Polyhistidine tags placed too 
close to transmembrane regions may become sequestered in the detergent micelle, 
becoming inaccessible to the immobilised nickel ions.
Pourcher et al, (1995) have expressed, solubilized and purified the E. coli 
melibiose permease. They engineered six contiguous histidine residues onto the 
C-terminal end. The construct was over-expressed in E. coli and the membranes were 
solubilized in the presence of a novel detergent, 3-(laurylamido)-N,N’- 
dimethylaminopropylamine oxide (LAPAO), derived from the commercially available 
detergent SB 12. The modified melibiose permease was purified to > 90% purity on an 
immobilised nickel ion column. During purification the detergent system was changed 
for n-dodecyl (3-D-maltoside in order to maintain the activity of the permease. The 
permease was then purified to homogeneity on a Macro-Prep Q anion exchange resin. 
The results showed that the permease was more than 80% functional and that the 
addition of the C-terminal polyhistidine tag had no effect on the function of the protein.
Loddenkotter et al., (1993) have purified the mature chloroplast triose 
phosphate-phosphate translocator in a functional state. The chloroplast triose phosphate- 
phosphate translocator was expressed in a yeast system. The protein was originally 
derived from spinach. Its function is to export triose phosphates across the chloroplast 
membrane into the cytosol. It has an apparent molecular weight of 29 kDa, which 
increased to 30 kDa on the addition of the six contiguous histidine residues on the 
C-terminal end of the protein. The translocator was localised to the rough endoplasmic 
reticulum and mitochondrial membrane when expressed in yeast and was solubilized by 
n-dodecyl maltoside in the presence of high concentrations of inorganic phosphate. The 
addition of inorganic phosphate helped to preserve functional transport activity during 
purification. The polyhistidine tagged protein was finally eluted from the column using
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100 mM imidazole, resulting in a protein > 95% pure. The transport characteristics of 
the polyhistidine tagged translocator were similar to that of the wild-type protein.
Weinglass and Baldwin, (1996) have studied the purification of polyhistidine 
tagged GLUT1 expressed in insect cells. Site directed mutagenesis was used to insert six 
contiguous histidine residues onto the C-terminal end of human GLUT1 cDNA. The 
mobility of the histidine tagged construct on a polyacrylamide gel was reported to be 
reduced. The functional activity, assessed by cytochalasin B binding, was determined to 
be the same as the wild-type protein. The histidine tagged protein was efficiently 
solubilized in the detergent octyl glucoside. The solubilized fraction was loaded onto a 
chelating nickel column, which resulted in the retention of most of the recombinant 
protein. Analysis of the eluted material by polyacrylamide gel electrophoresis 
demonstrated the protein to be more than 90% pure.
In many of the above examples 100% purity was not obtained using metal ion 
affinity chromatography and the use of a second column was required to achieve protein 
homogeneity. However, the use of metal ion chromatography in membrane protein 
purification has proved to be a useful technique.
1.25 Membrane lipids
Solubilization and purification of integral membrane proteins by liquid 
chromatography results in the membrane proteins becoming delipidated. This will be an 
important consideration when purifying the glucose transporter because membrane 
proteins depend on a lipid environment to maintain their own structure; a lipid presence 
should be maintained throughout the purification procedure. The composition of the 
lipid used for reconstitution into a lipid bilayer can have a marked effect on the catalytic 
activity of the membrane bound transporter. For example, Tefft et al, (1986) have 
determined that the activity of the glucose transporter was affected greatly by the lipid 
bilayer head group composition. Furthermore, Connolly et al, (1985a&b) have studied 
the effect of cholesterol content in a lipid bilayer. High levels of cholesterol were found 
to be inhibitory to glucose transport.
Ambudkar and Maloney, (1986) have demonstrated that during the solubilization 
of the bacterial anion exchange transporter, it was necessary to maintain a lipid
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environment to prevent the inactivation of the transporter protein. Ambudkar and 
Maloney, (1986) also observed that the addition of 10 - 20% glycerol during purification 
improved the activity of the anion exchange transporter. These are important factors to 
consider for the purification of the glucose transporter to ensure that a fully functional 
transporter is obtained. Evidence suggests that a balanced mixture of lipids should allow 
for the protection and reconstitution of the glucose transporter, during and following 
purification.
1.26 Determined Crystal Structures for Membrane Bound Proteins
To date, very few integral membrane proteins have been crystallised and 
subjected to 3-dimensional analysis, such as X-ray crystallography. This is due to the 
difficulties involved in obtaining pure integral membrane proteins which will form high 
quality crystals composed of molecules orientated in the same direction. The very first 
integral membrane protein to be analysed by X-ray diffraction crystallography was 
bacteriorhodopsin, isolated from the purple membrane of the bacterium Halobacterium 
halobium.
Blaurock, (1982) has reviewed the initial work carried out on the 
bacteriorhodopsin structure. Bacteriorhodopsin is a light driven proton pump. Its 
function is to convert the light energy captured into a transmembrane proton gradient. 
The transmembrane proton gradient can then be used to generate ATP. 
Bacteriorhodopsin can be isolated from Halobacterium halobium purple membranes as 
a more or less pure protein, contained in flat sheets of membrane as opposed to closed 
vesicles. Two properties aid further study of the protein: a) Bacteriorhodopsin retains its 
structure while under vacuum and during desiccation and b) Bacteriorhodopsin forms a 
crystalline array extending into the plane of the membrane. Therefore, bacteriorhodopsin 
almost satisfies the basic requirements for X-ray crystallographic analysis and is almost 
a pure crystalline protein in the natural state. The problem is to obtain crystalline arrays 
where all of the bacteriorhodopsin molecules within the membrane fragments are in 
alignment. Desiccation of natural membranes results in crystalline arrays which are not 
in alignment. Therefore, methods of producing crystals other than by uncontrolled
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desiccation were investigated. Several methods were tried including a method 
employing a limited and gradual dehydration process.
Despite the initial success of isolating and growing crystals of bacteriorhodopsin, 
it proved difficult to obtain high resolution ciystallographic information as the crystals 
were shown to have a disordered structure. From the initial analysis of 
bacteriorhodopsin it was determined that the protein contained a high level of a-helical 
structure which was more or less perpendicular to the plane of the membrane.
Henderson and Unwin, (1975) originally used electron microscopy to determine 
the position of the helices in bacteriorhodopsin to a resolution of 7 A. This was later 
refined by Baldwin et al, (1988) to 2.8 A using the technique of ciyo-electron 
microscopy.
Bacteriorhodopsin was finally crystallised by Schertler et al, (1993) and formed 
ordered orthorhombic crystals. The crystals were nucleated on benzamidine and 
diffracted to a resolution of 3.6 A. However, the crystallographic data has yet to be 
analysed. Schertler et al, (1993) took the isolated purple membranes and solubilized 
them in 1% Triton X-100 for 14 h, at 34°C, in the dark. The debris was removed by 
centrifugation and the detergent exchanged for 0.5% octyl glucoside on a DEAE 
Sephacel column. The protein was concentrated and 4% benzamidine hydrochloride 
added. Crystals were obtained by vapour diffusion at 4°C, for 40 - 60 days. The 
benzamidine provided a surface for the initiation of bacteriorhodopsin crystallisation in 
the orthorhombic form; this had proved difficult to obtain as bacteriorhodopsin 
persistently formed pseudohexagonal crystals. The pseudohexagonal crystals were found 
to form disordered crystalline arrays resulting in poor diffraction data. The formation of 
orthorhombic crystals provided high resolution diffraction data.
Following work on bacteriorhodopsin Michel, (1982) crystallised the 
photosynthetic reaction centre from the bacterium Rhodopseudomonas viridis. Bacterial 
membranes were broken up by sonification and subjected to a sucrose density gradient. 
The photosynthetic membranes formed a broad band at approximately 35% sucrose. The 
membranes were then solubilized in the detergent A^jV-dodecyldimethylamine iV-oxide 
and pure reaction centres were obtained in a single step purification, using molecular 
sieve chromatography. Crystals were obtained by vapour diffusion under high salt 
conditions and grew to an appropriate size within three weeks. The crystals were found
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to diffract X-rays to beyond 2.5 A resolution. The crystallised reaction centres were 
demonstrated to be photochemically active by Zinth et al, (1983). The X-ray diffraction 
data was finally solved and the reaction centre structure was determined by Deisenhofer 
et al, (1984, 1985) to a resolution of 3 A. The high quality of the electron density map 
allowed for the unambiguous chain tracing, even in the absence of amino acid 
information. This study demonstrated that at least one membrane protein could be 
crystallised and its 3-dimensional structure solved.
A novel method of crystallisation was conceived by Ostermeier et al, (1997) to 
overcome the difficulties in crystallising a hydrophobic transmembrane protein. The 
protein used was Cytochrome C oxidase sourced from the soil bacterium Paracoccus 
denitrificans. Cytochrome C oxidase is a transmembrane helical protein which catalyses 
the final electron transfer step to molecular oxygen, while translocating protons across 
the membrane. Ostermeier et al, (1997) generated anti-cytochrome c oxidase 
monoclonal antibodies. The monoclonal antibodies were over-expressed in the 
bacterium E. coli, allowing for the addition of a biotin tag to the protein sequence. 
Following purification of the Cytochrome C oxidase the monoclonal antibodies were 
used to promote crystallisation of the protein. The monoclonal antibody Fv fragments 
were thought to increase the size of the polar surface of the protein, thereby increasing 
the chances of obtaining highly ordered ciystals (crystallisation was thought to have 
initiated from the polar region). Iwata et al, (1995) originally diffracted a crystal of the 
four subunits of cytochrome c oxidase to a resolution of 2.8 A. In an attempt to refine 
the crystal information further Ostermeier et al, (1997) diffracted a crystal of 
cytochrome c oxidase, subunits I and II to a resolution of 2.5 A. It seems likely that this 
technique could also be used to crystallise other membrane bound proteins such as the 
glucose transporter.
Walz et al, (1994) have purified the membrane protein aquaporin 1 which is a 
specialised water pore found in the plasma membrane of human erythrocytes. Human 
erythrocytes were alkali stripped and solubilized in Triton X-100. Following filtration, 
samples were loaded onto a POROS Q/F column. Samples were eluted with a sodium 
chloride gradient in the presence of 0.1% Triton X-100. Octyl glucopyranoside and 
purified E. coli lipids were then added to the peak elution fraction, which corresponded 
to pure aquaporin. 2-dimensional crystals of aquaporin were produced and subjected to
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cryo-electron microscopy (the microscope stage being liquid helium cooled to 4.2 K). 
Walz et al, (1997) have calculated the structure of the 2-dimensional crystals to a 
resolution of 6 A. From sequence analysis the aquaporin molecule was predicted to 
contain six transmembrane helices. This was borne out during analysis and fitted all the 
obtained data, which determined the structure to contain six tilted helices with a 
right-handed twist. The right-handed twist is a feature commonly observed in soluble 
proteins. Aquaporin was known to form a homotetramer when reconstituted into lipid 
vesicles, the cytoplasmic side of the tetramer was found to protrude further from the 
membrane in comparison to the extracellular side. The C-terminus has been identified as 
the most prominent cytosolic protrusion. Furthermore, near and far ultraviolet circular 
dichroism analysis of a homologous protein to aquaporin, the MIP26 protein, predicts 
that 20% of the protein is P-structure. However, higher resolution information is 
required to determine the precise structure of the transmembrane spanning helices. 
Higher resolution information will aid in an understanding of the mechanism by which 
the aquaporin molecule is capable of selectively transporting water across the human 
erythrocyte membrane.
Polyhistidine tags have also been used successfully with soluble proteins to 
purify and produce high quality crystals for X-ray diffraction studies. Narayana et al,
(1997) attached six contiguous histidine residues at the N-terminal end of the mouse 
cAMP-dependent protein kinase (cAPK) catalytic subunit. The protein was purified on 
an immobilised nickel column and separate isoforms of the recombinant catalytic 
subunit were isolated on a Mono-S column. Isoform II, phosphorylated at three sites was 
taken for crystallisation, which took 6 weeks at 4°C. The crystals diffracted to a 
resolution of 2.2 A, allowing the complete determination of the protein structure.
Experiments have shown that membrane proteins can be purified and then 
crystallised. X-ray crystallographic studies on the GLUT1 protein should therefore be 
possible. Boulter and Wang, (personal communication, 1997) are close to starting 
studies for possible crystallisation conditions of human erythrocyte GLUT1. Boulter and 
Wang, (personal communication, 1997) have managed to purify GLUT1 in a stable 
monodisperse, detergent solubilized form, which exhibits cytochalasin B binding in 
solution. The GLUT1 protein was solubilized in a maltoside detergent over a period of 
five weeks. Co-purifying lipids and enzymic deglycosylation of GLUT1 have been
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examined and crystallisation experiments are now in progress. However, because this 
method utilises native GLUT1 protein, mutations within the protein cannot be 
introduced. This may hinder the progress of crystallisation studies and will prevent the 
investigation of mutational effects.
1.27 Aims of the Project
- An Investigation of Glucose Transporter Structure and Function
At the onset of this project in 1994 no other group had attempted to express a 
polyhistidine tag on the N-terminal end of the GLUT1 glucose transporter with the 
intention of purifying the protein on a chelating nickel Sepharose column. At that time 
the technique of metal chelate chromatography on recombinant membrane bound 
proteins was in its infancy and only a few groups had used the technique for this 
purpose. One such group was Waeber et al, (1993). They successfully purified the 
E. coli glucose transporter by expressing a polyhistidine tag on the C-terminus of the 
protein. Waeber et al, (1993) have also had success in purifying the E. coli mannose 
transporter using a polyhistidine tag. Furthermore, Loddenkotter et al, (1993) have 
polyhistidine tagged the chloroplast triose phosphate-phosphate translocator and 
purified it using an immobilised metal ion liquid chromatography system. The evidence 
suggests that it is possible to purify membrane bound proteins using a polyhistidine tag 
purification system.
By 1994, the expression of human and rabbit GLUT1 protein in Spodoptera 
frugiperda cells had been characterised by Yi et al, (1992) and Cope et al, (1994), 
respectively. The expression of human GLUT1 in E. coli had been examined by Sarkar 
et al, (1988) and Kasahara and Kasahara, (1996) were soon to look at the expression of 
rat GLUT1 in Saccharomyces cerevisiae. However, following the observations made by 
Asano et al, (1993) of glycosylation deficient GLUT1 it was decided that a system 
expressing glycosylated protein was required. The current project was initiated to 
investigate the expression and properties of two novel glucose transporter constructs in 
Spodoptera frugiperda cells. The constructs expressed an N-terminal polyhistidine tag 
on: a) The rabbit GLUT1 glucose transporter and b) A C-terminal half construct of the 
Rabbit GLUT1 glucose transporter (transmembrane regions 7 - 1 2  according to the
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model proposed by Mueckler et al, (1985)). Protein purification was undertaken using 
the technique of immobilised metal ion affinity chromatography. During purification a 
lipid presence was maintained as it was reported by Ambudkar and Maloney, (1996) that 
complete delipidation of the anion exchange transporter deactivated the protein. 
Following studies by Tefft et al, (1986) and Connolly et al, (1985a&b) a balanced lipid 
composition was chosen as it had been determined to be important for transporter 
function.
During the course of the present study Weinglass and Baldwin, (1996) published 
a short report on the attempted purification of a C-terminally polyhistidine tagged 
human GLUT1 construct. The construct had been expressed in insect cells. Further 
reference to the similarities and differences of the work carried out by Weinglass and 
Baldwin, (1996) will be made in the final discussion.
C-terminal half constructs of the GLUT1 glucose transporter were studied for 
glucose analogue binding activity with and without the addition of a polyhistidine tag. It 
was theorised that a smaller construct may be more suitable for crystallisation and X-ray 
crystallographic analysis, forming a more compact simpler crystal structure. The 
properties of these mutants were also considered to be important. Photolabelling studies 
on the C-terminal half constructs were carried out in an attempt to determine the 
conformation of the constructs. Wu et al, (1996) have studied C-terminal constructs of 
the lactose permease proton symporter. The lactose permease is a very similar protein to 
the glucose transporter, it has 12 transmembrane helices with both the N and C-terminal 
ends on the cytosolic side of the membrane. Wu et al, (1996) have observed that a 
C-terminal construct, with an additional 5 amino acids, was capable of ligand binding. 
The glucose transporter C-terminal construct was examined to determine if it had similar 
properties to the lactose permease C-terminal construct.
Mori et al, (1994) studied a tyrosine 293 to isoleucine mutation. This mutation 
caused the construct to become locked in an outward facing conformation. A construct 
which was conformationally locked in either an inward or outward conformation may be 
more suitable for structure determination by crystallography. A locked transporter would 
not undergo continuous conformational change and may make the formation of an 
ordered crystal structure more likely. If the deletion of the N-terminal portion of the
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glucose transporter caused the glucose transporter to become locked in one 
conformation then this would also be a useful construct to purify.
The thesis also investigates the effect of a novel set of GLUT1 point mutations. 
The point mutations were made in the C-terminal tail of human GLUT1. The mutated 
GLUT1 cDNA was expressed and tested in CHO-K1 cells. This follows on from work 
undertaken by Katagiri et al, (1992) and Muraoka et al, (1995), where both groups 
undertook deletion analysis studies on the C-terminal tail of GLUT1. These studies 
indicated that the C-terminal tail was important for the correct function of the glucose 
transporter. Both Carruthers and Helgerson, (1989) and Shi et al, (1995) have carried 
out studies that suggest the function of the glucose transporter can be modified by the 
binding of intracellular molecules to the C-terminal region, possibly the C-terminal tail. 
These studies also suggest that this region is important in controlling the function of the 
glucose transporter.
Targeting of the expressed constructs was examined using the technique of 
confocal microscopy. Experiments were undertaken to determine if there were any 
differences on the addition of a polyhistidine tag.
It is hoped that this thesis will provide information on purified GLUT1 stability 
and its properties in detergent that will be important to consider for future 3-dimensional 
crystallographic analysis of the GLUT1 glucose transporter.
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2.0 Materials and Methods 
Materials
2.1 General Laboratory Chemicals
Unless otherwise indicated, general laboratory chemicals and solvents were 
obtained from the Sigma-Aldrich Company Ltd. (Poole, Dorset), Bio-Rad Laboratories 
Ltd. (Hemel Hempstead, Hertfordshire), Fisons Scientific UK Ltd. (Loughborough, 
Leics.), or BDH Laboratory Supplies (Merck Ltd., Poole, Dorset). Radiolabelled 
2-Deoxyglucose (40 Ci / mmol), 35S-dATP (1000 Ci / mmol), y-32P ATP (3000 Ci / 
mmol) and Cytochalasin B (18.1 Ci / mmol) were supplied by Amersham International 
pic (Little Chalfont, Buckinghamshire). The photolabel 2-JV-4-(l-azi-2,2,2- 
trifluoroethyl)benzoyl-1,3-[3H]bis-(D-mannos-4-yloxy)-2-propylamine (ATB-[2-
3H]BMPA) (~10 Ci / mmol) was synthesised by Prof. Geoffrey Holman (University of 
Bath, Bath) (Clark and Holman, 1990). Optiphase Safe™ scintillation fluid was from 
Fisons chemicals (Loughborough, Leics.). Thesit® (C12E9) and Zwittergent® 3-12 
(SB 12) were supplied by Boehringer Mannheim UK Ltd. (Lewes, East Sussex) and 
Octyl-p-D-glucopyranoside (Octyl glucoside) was from Alexis Corporation (Bingham, 
Nottingham). The protease inhibitor 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF) 
was supplied by Calbiochem-Novabiochem (UK) Ltd. (Nottingham). X-ray film was 
supplied by Fuji Photo Film Co. Ltd. (Japan).
2.2 CHO-K1 Cell Culture
Chinese hamster ovary (CHO-K1) clones expressing mutated GLUT1 were 
kindly provided by Muraoka (Kobe University, Japan). Cryogenic vials (2.0 ml) were 
from Coming Costar Corporation (Cambridge, MA). Hams F12 culture medium was 
from ICN Biomedicals Ltd. (Thame, Oxfordshire). Foetal Bovine Serum (FBS), 
Geneticin® (G418 Sulphate), DMSO, lx Trypsin (0.25% (1:250), prepared in GIBCO 
solution A), Nunclon™ cell culture flasks and culture dishes were supplied by
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GibcoBRL Life Technologies Ltd. (Paisley, Renfrewshire). Phosphate Buffered Saline 
(PBS) (Dulbecco ‘A’) was supplied by Oxoid (Unipath Ltd., Basingstoke, Hampshire). 
All other materials were supplied by Sigma.
2.3 Insect Cell Culture
Spodoptera frugiperda ovarian cells (Sf9 cells) and Trichoplusia ni egg cells 
(Highfive™ Cells ) were kindly provided by Dr Adrian Wolstenholme (University of 
Bath, Bath, UK). TCI00 insect cell medium was from the Sigma-Aldrich Company Ltd. 
(Poole, Dorset). Culture flasks and Foetal Bovine Serum (FBS) were supplied by 
GibcoBRL Life Technologies Ltd. (Paisley, Renfrewshire). Cryogenic vials (2.0 ml) 
were from Coming Costar Corporation (Cambridge, MA). All other materials were from 
Sigma.
2.4 Molecular Biology Materials and Chemicals
T4 DNA Ligase, calf intestinal phosphatase (CIP) and all restriction enzymes 
were supplied by New England Biolabs (Hitchin, Hertfordshire). Baculovirus 
expression vectors and linearised AcMNPV DNA were from Invitrogen® Corporation 
(Leek, The Netherlands). DNA binding columns for plasmid purification were supplied 
by Qiagen Ltd. (Crawley, West Sussex). Agar was supplied by Difco Labs (Detroit, 
Michigan, USA) and LB Broth base, (Luria broth base (10 g /1 enzymatic casein digest, 
5 g / 1 yeast extract and 5 g / 1 of NaCl)) was from the Sigma-Aldrich Company Ltd. 
(Poole, Dorset). 5-bromo-4-chloro-3-indolyl-p-D-thiogalactoside (X-gal) was supplied 
by Calbiochem-Novabiochem (UK) Ltd. (Nottingham). 1 Kb DNA ladder, Agarose and 
low melting point agarose was obtained from GibcoBRL Life Technologies Ltd. 
(Paisley, Renfrewshire). y-32P ATP was supplied by Amersham International Pic., all 
other materials were supplied by Sigma.
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2.5 Bacterial strains
Two bacterial strains were used, Epicurian Coli® SURE®, from Stratagene Ltd. 
and TOP 10 from Invitrogen® Corporation (Leek, The Netherlands). The bacterial 
phenotypes are listed below:
Epicurian Coli® SURE®: E\4\mcrA), D(mcrCB-hsdSMR-mrr)171, endAl, supE44, thi-1, gyrA96, 
relAl, lac, recB, red, sbcC, umuC:Tn5 (kan1), wvrC, [F’ proAB, lacF ZDM15, TnlO, (tet1)].
TOPIO: F’ mcrA (lacF, TnlO(Tet')) mcrA D(mrr-hsdRMS-mcrBC) f80/acZDM15 D/acX74, deoR, 
recAl, araD139, D(ara-leu)l697, galU, galYL, rpsL, endAl, nupG.
2.6 cPNA and Baculoviruses
Rabbit GLUT1 cDNA was kindly provided by Dr Yoshitomo Oka (Tokyo, 
Japan). Baculoviruses expressing GLUT1 and C-TERM were kindly provided by 
Dr Diane Cope (University of Glasgow, Glasgow), as was the HIS-C-TERM DNA.
2.7 Antibodies
GLUT1 rabbit antiserum used for immunoblot analysis was obtained from East 
Acres Biologicals (Southbridge, Ma, USA). The antibody was raised against a peptide 
within the carboxy terminus of the rat brain glucose transporter. The antibody was used 
at a final dilution of 1:4000 in TBS Tween containing 1% BSA.
GLUT1 rabbit antiserum used for immunoprecipitation was kindly provided by 
Dr Samuel Cushman (National Institutes of Health, Bethesda, USA). The antiserum was 
raised against a synthetic peptide corresponding to residues 480 - 492 in the C-terminal 
portion of the molecule.
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2.8 Protease Inhibitors
Antipain, aprotinin, pepstatin A and leupeptin (from Sigma) were made as a 500 
pg / ml stock and added to a final concentration of 1 pg / ml.
AEBSF (from Calbiochem) was made as a 100 mM stock and used at a final 
concentration of 100 pM.
Throughout this thesis, the phrase ‘protease inhibitors’ is defined as the addition of 
antipain, aprotinin, pepstatin A, leupeptin and AEBSF (at the above final concentrations) 
to the required buffer.
Photolabelling was carried out using a Rayonett RPR-100 photoreactor 
containing RPR-3000 lamps. Electrophoresis was performed using either the Protean® II 
xi slab cell Bio-Rad system or the Mini Atto System (Atto Corporation). Protein transfer 
was performed using the Multiphor II Nova Blot electrophoretic transfer unit 
(Pharmacia Biotech).
2.9 General Buffers and Solutions
All buffers were made up using either double distilled or distilled water and are 
listed at their final concentrations.




1.25 mM MgS04 
136 mMNaCl 
pH 7.4
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Sodium phosphate buffer 
5 mM Na2HP04 
pH 7.4
Phosphate buffered saline (PBS) 





1.5 M Tris 
0.4% (w/v) SDS 
pH 8.8
Stacking buffer 
0.5 M Tris 
0.4% (w/v) SDS 
pH 6.8
Sample buffer 
115 mM Tris 
10% (v/v) Glycerol 
2% (w/v) SDS
5% (v/v) p-Mercaptoethanol 
4 pg / ml (w/v) Bromophenol Blue 
pH 6.8
Running buffer 
25 mM Tris 
192 mM Glycine 
0.1% (w/v) SDS 
pH 8.3
BCA (Bichinchoninic acid) Protein Assay
Reagent A
1% (w/v) bicinchoninic acid Reagent B
2% (w/v) sodium carbonate 4% (w/v) copper sulphate
0.16% (w/v) sodium tartrate
0.4% (w/v) sodium hydroxide
0.95% (w/v) sodium bicarbonate
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HiTrap and DEAE Cellulose Column Buffers and Solutions
IMACO 
10 mM Tris 
0.5 M NaCl 
10% (v/v) Glycerol




20% (v/v) Glycerol 
250 mM Sodium Chloride
1.5 m g/m l Lipids
1.5% (w/v) Octyl glucoside 
20 mM Imidazole
1 pg / ml Protease inhibitors 
pH 7.9
Elution buffer 
10 mM Hepes 
20% Glycerol 
250 mM Sodium Chloride
1.5 m g/m l Lipids
1% (w/v) Octyl glucoside 
300 mM Imidazole
1 pg / ml Protease inhibitors 
pH 7.9
IMAC200 
10 mM Tris 
0.5 M NaCl 
10% (v/v) Glycerol 
200 mM Imidazole
1 pg / ml Protease inhibitors 
pH 7.4
Wash buffer 
10 mM Hepes 
20% (v/v) Glycerol 
250 mM Sodium Chloride
1.5 m g/m l Lipids 
1% (w/v) Octyl glucoside 
20 mM Imidazole
1 pg / ml Protease inhibitors 
pH 7.9
Dialysis buffer





0.1 M Nickel Sulphate
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Molecular Biology Solutions
TBE
2 mM EDTA 
100 mM Tris 
83 mM Boric acid
Agarose gel loading buffer 
5% (v/v) Glycerol 
10 mM EDTA
0.01% (w/v) Bromophenol blue
Hybridisation buffer 
10 mM Tris 
100 mM NaCl 
5 mM EDTA 
pH 7.5
Miniprep solutions:
Plasmid Prep Mix 
25 mM Tris pH 8.0 
10 mM EDTA 
15% (w/v) sucrose 
2 mg / ml Lysozyme
TE Buffer 
10 mM Tris 
1 mM EDTA 
pH 8.0
Lvsis buffer 
0.2 M NaOH 
1% (w/v) SDS
Antibiotics
Ampicillin was used in liquid culture at 100 pg / ml. In order to reduce satellite 
formation on agar plates, ampicillin was used in conjunction with methicillin at the 
following concentrations: Ampicillin 20 pg / ml, Methicillin 80 pg / ml.
Ethidium bromide
A 10 mg / ml ethidium bromide solution was made in double distilled water and 
filter sterilised using a Sartorius Minisart 0.2 pM filter (Sartorius, Gottingen, Germany). 
Ethidium bromide was stored in a foil wrapped bottle at room temperature.
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2.10 Chinese Hamster Ovary (CHO-K1) Cell Culture
Cell Culture
Chinese Hamster ovary cells were routinely cultured in Hams fl2 medium, 
supplemented with 10% (v/v) foetal bovine serum (Myoclone Super Plus), 1% (v/v) L- 
glutamine (200 mM in tissue culture grade water) and 2% (v/v) penicillin / streptomycin 
solution (5000 units penicillin and 5 mg streptomycin per ml in 0.9% (w/v) NaCl). 
Geneticin (G418) sulphate was included in the culture medium at a concentration of 
150 mg / 500 ml, to select for growth of transfected cells. Foetal bovine serum was heat 
inactivated by incubation at 56°C for 30 minutes prior to use. CHO-K1 cells were 
maintained at 37°C in a 5% CO2 humidified atmosphere.
Passaging Cells
Cells were passaged on reaching confluence (approximately every 3-4 days, 
depending of seeding density). Media and PBS were pre-warmed to 37°C before use. 
Cells were first washed using 3 ml of sterile PBS and then freed from the dish matrix by 
the addition of 1 ml of trypsin (2.5 g / litre of trypsin in GIBCO solution A) and 1 ml of 
PBS. Cells were trypsinated for 5 minutes followed by the addition of 10 ml of culture 
medium. Cells were pelleted at 350 g in a bench top centrifuge and resuspended in 
culture medium. Cells were counted and seeded at 100,000 cells per 100 mm dish.
Cryogenic storage
Confluent cells were washed, trypsin treated and suspended in culture medium. 
Cells were centrifuged at 350 g in a bench top centrifuge and resuspended in cryogenic 
storage medium (10% (v/v) dimethyl sulfoxide (DMSO) in foetal bovine serum). 
Aliquots of 2 ml were taken, placed in to cryogenic vials, and the cryogenic vials placed 
in a liquid nitrogen vapour phase cooler for 24 h. Cells were then fully immersed in 
liquid nitrogen for long term storage.
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2.11 CHO-K1 Cell Glucose Transport Assay
Cells were grown to confluence in 35 mm dishes and then harvested for use in a 
2-deoxyglucose transport assay. The culture medium was aspirated (into 10% (v/v) 
bleach) and the cells washed three times with 2 ml of Kreb-Ringer Hepes buffer at 37°C 
(136 mM NaCl, 4.7 mM KC1, 1.25 mM CaCfe, 1.25 mM MgSC>4, 10 mM Hepes buffer, 
pH 7.4). The cells were incubated in 450 pi of Kreb-Ringer Hepes buffer at 37°C until 
assayed.
Assays were performed by the addition of 50 pi Kreb-Ringer Hepes buffer 
containing 0.3 pCi 2-deoxy-D-[2,6-3H]glucose and 2-deoxy-D-glucose, to a final 
concentration of between 0.05 and 10 mM. Cells were assayed for 1 minute at 37°C and 
the assay terminated by washing four times with ice cold phosphate buffered saline 
(PBS (12.5 mM Na2HP04*12H20, 154 mM NaCl, pH 7.2)). The cells were removed 
from the assay dish by the addition of 500 pi of 0.1 M NaOH and mixed with 7 ml of 
scintillant (Optiphase Safe™). The samples were then counted in a Packard 1500 
TRI-CARB liquid scintillation counter. The data obtained was fitted to the equation 
Y = Vmax x X / (Km + X) using GraphPad PRISM™ for the PC; Vmax represents the 
maximum rate of transport and Km represents the concentration of ligand required to 
reach half maximal binding.
2.12 Insect Cell Culture
Cell Culture
Spodoptera frugiperda ovarian cells (Sf9 cells) and Trichoplusia ni egg cells 
(Highfive™ Cells ) were routinely cultured in TCI00 medium, supplemented with 10% 
(v/v) foetal bovine serum and 2% (v/v) penicillin / streptomycin solution (5000 units 
penicillin and 5 mg streptomycin per ml in 0.9% (w/v) NaCl). Foetal bovine serum was 
heat inactivated by incubation at 56°C for 30 minutes prior to use. Insect cells were 
incubated at 28°C, in both monolayer cultures and suspension cultures. Stock cultures 
were typically maintained in 75 cm2 flasks as monolayers.
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Passaging Cells
Cells were passaged on reaching confluence (approximately every 4-5 days, 
depending of cell type and seeding density. Highfive™ cells were observed to have a 
slower growth rate than Sf9 cells). TCI00 Media was pre-warmed to 28°C before use. 
Cells were first examined to ensure they were healthy and uncontaminated. Monolayer 
cells, were washed using 10 ml of supplemented TCI00 medium and then suspended in 
20 ml of supplemented TCI00 medium. Cells were freed of the supporting matrix by 
washing the cell monolayer with medium and were seeded in fresh 75 cm flasks at
500,000 -1,000,000 cells / flask.
Cryogenic storage
Near confluent cells were washed and suspended in supplemented TCI00 
medium. Cells were checked for density and high viability (about 90% viable). Cells 
were centrifuged at 350 g in a bench top centrifuge and resuspended in cryogenic 
storage medium (TCI00, 10% foetal bovine serum, 10% (v/v) DMSO at 4°C) at a 
density of 1.5 x 106 cells / ml. Aliquots of 2 ml were taken and placed in to cryogenic 
vials, which were then placed in a liquid nitrogen vapour phase cooler for 24 h. Cells 
intended for long term storage were immersed in liquid nitrogen.
2.13 Molecular Biology Methods
Many of the techniques described can be found in the laboratory manual: 
‘Molecular Cloning, A Laboratory Manual’ (Sambrook et al. 2nd Edition, Cold Spring 
Harbor Laboratory Press, 1989), unless otherwise stated.
2.13 Growth and Maintenance of Bacterial Cultures
Short term storage of bacterial strains was at 4°C on Lennox L agar. Long term 
storage was at -80°C, in liquid culture, containing 40% (v/v) glycerol. Ampicillin 
resistant colonies were selected using 20 pg of ampicillin / ml and 80 pg of 
methicillin / ml.
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2.14 Ethanol Precipitation
Ref: Sambrook et a l, (1989).
0.1 volumes (ie. to 1 ml add 100 pi) of 3 M sodium acetate, pH 5.2 and 2 
volumes of 100% ethanol at -20°C were added to the DNA solution and mixed 
thoroughly. The mixture was incubated for 20 minutes, at -20°C and centrifuged for 20 
minutes at 13,400 g in a bench top microcentrifuge (Micro Centaur). The supernatant 
was discarded and the pellet washed in 70% ethanol (-20°C). Following removal of the 
70% ethanol the pellet was air dried at room temperature and resuspended in double 
distilled water. For the precipitation of small amounts of DNA, 1 pi of 20 mg / ml 
glycogen was added, as a carrier, at the start of the protocol.
2.15 Ammonium Acetate / Iso-propanol DNA Precipitation
Ref: Sambrook etal., (1989).
Sufficient EDTA was added to the DNA solution to chelate any divalent cations 
present, lpl of 20 mg / ml glycogen (Boehringer Mannheim, special quality for molecular 
biology) was added as a carrier, followed by 0.4 volumes of 5M ammonium acetate. Two 
volumes of propan-2-ol were added to the DNA solution and mixed thoroughly. The 
mixture was incubated at room temperature for 10 minutes and the DNA pelleted in a 
microcentrifuge at 13,400 g for 10 minutes. The supernatant was discarded and the pellet 
washed in 70% ethanol (at -20°C). Following removal of the 70% ethanol the pellet was 
air dried at room temperature and resuspended in double distilled water.
2.16 Small Scale (Miniature) Plasmid DNA Preparations (Plasmid 
Miniprep)
Ref: Sambrook et a l , (1989). Adapted from the method of Bimboim and Doly, (1979).
10 ml of L-broth with ampicillin (100 pg / ml) were inoculated from a single 
bacterial colony. The inoculum was incubated at 37°C for 16 h at 200 rpm on a rotary 
shaker. Following incubation, 2 ml of culture were transferred to a microcentrifuge tube 
and pelleted by centrifugation at 13,400 g for 5 minutes. The supernatant was discarded
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and the pellet resuspended in 40 pi of ice cold plasmid prep mix (25 mM Tris, 10 mM 
EDTA, 15% (w/v) sucrose, 2 mg / ml lysozyme, pH 8.0). Following a 5 minute 
incubation on ice, 80 pi of 0.2 M NaOH and 1% (w/v) SDS were added, mixed and left 
on ice for 5 minutes. 40 pi of 3 M potassium acetate was added, gently mixed and 
incubated on ice for 5 minutes. The mixture was centrifuged for 5 minutes at 13,400 g 
and the supernatant removed to a clean microcentrifuge tube containing 300 pi of 100% 
ethanol at -20°C. The supernatant was thoroughly mixed by tube inversion and placed at 
-20°C for 20 minutes. The mixture was centrifuged at 13,400 g for 10 minutes and the 
supernatant discarded. The pellet was washed in 200 pi of 70% ethanol (-20°C) and 
allowed to air dry at room temperature. The pellet was resuspended in 30 pi of TE 
buffer, pH 8.0, followed by the addition of 10 pi of 8 M LiCl. The mixture was left on 
ice for 1 h and then pelleted in a microcentrifuge for 5 minutes at 13,400 g. The 
supernatant was transferred to a clean microcentrifuge tube containing 60 pi of TE 
buffer, pH 8.0. 200 pi of 100% ethanol (-20°C) was added to the supernatant, mixed by 
tube inversion and incubated at -20°C for 20 minutes. The mixture was centrifuged at 
13,400 g for 10 minutes and the supernatant discarded. The pellet was washed in 200 pi 
of 70% ethanol (-20°C) and allowed to air dry at room temperature. Finally the resulting 
plasmid DNA was resuspended in 25 pi of distilled water.
2.17 Small Scale Plasmid PNA Preparations Oiagen
Ref: Qiagen Plasmid Handbook.
Qiagen miniprep spin columns were used to prepare high quality plasmid DNA 
for sequencing. Plasmid DNA was prepared as described in the manufacturer’s protocol 
(Qiagen Ltd. UK, catalogue number 27104). 10 ml of L-broth with ampicillin (100 pg / 
ml) were inoculated from a single bacterial colony. The inoculum was incubated at 37°C 
for 16 h at 200 rpm on a rotary shaker. Following incubation, 2 ml of the culture was 
transferred to a microcentrifuge tube and pelleted by centrifugation at 13,400 g for 5 
minutes. The bacterial pellet was resuspended in 250 pi of buffer PI (100 pg / ml RNase 
A, 50 mM Tris-HCl, 10 mM EDTA, pH 8.0 at 4°C). 250 pi of buffer P2 (200 mM 
NaOH, 1% SDS at room temperature) were added and the mixture was incubated on ice 
for 5 minutes. 350 pi of buffer N3 at 4°C was added, incubated on ice for 5 minutes and
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centrifuged for 10 minutes at 13,400 g. The supernatant was taken and applied to a 2 ml 
Qiaprep mini spin column. The spin column was centrifuged for 1 minute at 13,400 g 
and the flow-through discarded. The column was then washed with 750 pi of buffer PB 
and centrifuged for 1 minute at 13,400 g and the flow-through discarded. A second 
column wash was performed using 750 pi of buffer PE, the column was then 
centrifuged for 1 minute at 13,400 g and the flow-through discarded. Plasmid DNA was 
finally eluted from the column with 100 pi of double distilled water.
2.18 Large Scale Plasmid DNA Preparations Qiagen
Ref: Qiagen Plasmid Handbook.
Large scale preparations (500 pg) of plasmid DNA were produced using a 
Qiagen Maxi DNA binding column as described in the manufacturer’s protocol (Qiagen 
Ltd. UK, catalogue number 12162). 250 ml of culture media was inoculated with the 
appropriate bacterial colony and incubated for 16 h at 37°C on a rotary shaker 
(200 rpm). Bacterial cells were pelleted by centrifugation at 4°C for 15 minutes at
6,000 g using a Sorvall high speed centrifuge. The bacterial pellet was resuspended in 
10 ml of buffer PI (100 pg / ml RNase A, 50 mM Tris-HCl, 10 mM EDTA, pH 8.0 at 
4°C) and mixed with 10 ml of buffer P2 (200 mM NaOH, 1% SDS at room 
temperature). The mixture was incubated at room temperature for 5 minutes. 10 ml of 
buffer P3 (3 M potassium acetate, pH 5.5 at 4°C) was added to the mixture and 
incubated on ice for 20 minutes. The cell lysate was then centrifuged at 4°C for 30 
minutes at 30,000 g and the supernatant removed. A Qiagen maxi column was 
equilibrated with 10 ml of buffer QBT (750 mM NaCl, 50 mM Mops, 15% ethanol, 
0.15% Triton X-100, pH 7.0) at room temperature and the (cell lysate) supernatant 
applied to the column. The column was then washed twice with 30 ml of buffer QC (1.0 
M NaCl, 50 mM Mops, 15% ethanol, pH 7.0 at room temperature) and eluted with 15 
ml of buffer QF (1.25 M NaCl, 50 mM Tris-HCl, 15% ethanol, pH 8.5 at room 
temperature). The DNA was precipitated using 0.7 volumes of iso-propanol (at room 
temperature) and centrifuged at 15,000 g for 30 minutes at 4°C. The supernatant was 
carefully removed and the pellet washed in 15 ml of 70% ethanol (at -20°C). The pellet 
was air dried and resuspended in 500 pi of double distilled water.
Page 59
Chapter 2 Materials and Methods
2.19 Restriction Endonuclease Digestion of DNA
Ref: Fuchs, R. and Blakeskey, R. (1983). Up-to-date information was taken from the 
New England Biolabs catalogue.
Restriction digests were carried out according to the manufacturer’s 
recommended reaction conditions. Typically this was incubation at 37°C for 90 minutes 
in the appropriate reaction buffer. Digestion was confirmed by running a sample on an 
0.8% TBE buffered agarose gel. Restriction enzymes were removed from the digested 
DNA using ammonium acetate / iso-propanol precipitation.
2.20 Agarose Gel Electrophoresis
Plasmid DNA was electrophoresed in 0.8% agarose gels. Gels were made and 
run in Tris-borate (TBE) buffer (100 mM Tris, 100 mM boric acid, 2 mM EDTA, 
pH 8.3) containing ethidium bromide at 1 pg / ml. Samples were mixed with loading 
buffer (final concentration, 5% (v/v) glycerol, 10 mM EDTA, 0.01% (w/v) 
Bromophenol blue), loaded and electrophoresed at 50 V / cm (50 mA). Bands were 
visualised under an ultraviolet transilluminator, and images captured using a Polaroid 
instant camera. Gel background was reduced by soaking the gel in TBE buffer for 4 h at 
room temperature.
2.21 DNA Extraction from Agarose Gels
Ref: Sambrook et al.9 (1989).
DNA for gel purification was restriction digested and electrophoresed on a 
0.5% low melting point agarose gel. The agarose gel was made in TBE buffer, loaded 
and electrophoresed at 4°C and at 25 V / cm. The agarose gel was run until the 
appropriate band was separated from any other contaminating bands. The band was 
visualised under UV light and identified using molecular weight markers. The 
appropriate band was then excised from the gel using a fresh scalpel blade.
The agarose containing the required band was cut, crushed and soaked on ice for 
20 minutes in 15 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). The gel
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matrix was removed by centrifugation through a glass fibre filter. The sample volume 
was reduced by butan-l-ol extraction. An equal volume of butan-l-ol was added to the 
sample, mixed, allowed to phase separate and the organic (top) phase was removed and 
discarded. This procedure was repeated until a sample volume of about 500 pi was 
obtained. The sample was phenol extracted by the addition of an equal volume of phenol 
/ chloroform, vortexed and phase separated by centrifugation for 2 minutes at 6,700 g. 
The upper, aqueous phase was then removed to a clean microcentrifuge tube and the 
DNA was ethanol precipitated. Finally, the DNA fragment was analysed on an agarose 
gel.
2.22 Ligation
Ref: Sambrook et al., (1989).
Vector DNA was treated with calf intestinal phosphatase (CIP) to prevent 
religation of the vector without insert. CIP buffer (50 mM NaCl, 10 mM Tris-HCl, 10 
mM MgCb, 1 mM dithiothreitol, pH 7.9) was added to the vector DNA and an 
appropriate amount of CIP added (1 unit CIP per pmol DNA ends). The mixture was 
incubated for 60 minutes at 37°C. CIP was inactivated by incubation at 75°C for 10 
minutes and removed by ammonium acetate / iso-propanol precipitation.
Vector and insert DNA were mixed (molar ration of 1:3) and T4 DNA ligase 
buffer added (50 mM Tris-HCl, 10 mM MgCb, 10 mM dithiothreitol, 1 mM ATP, 
25 pg / ml BSA, pH 7.5). The mixture was incubated at 16°C for 16 h. The ligated DNA 
was either stored at -20°C or used immediately for bacterial transformation.
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2.23 Oligonucleotide End Labelling
Ref: Sambrook et al., (1989).
The length of manufactured oligonucleotides were compared by radiolabelling 
the oligonucleotide with y-32P ATP using T4 polynucleotide kinase. The radiolabelled 
material was analysed on a 15% polyacrylamide gel.
1 pg of oligonucleotide was mixed with 10 units of T4 polynucleotide kinase, 
1 pCi y-32P ATP (3000 Ci / mmol) in T4 polynucleotide kinase buffer (70 mM Tris-HCl, 
10 mM MgCk, 5 mM dithiothreitol, pH 7.6). The mixture was incubated for 30 minutes 
at 37°C. A 15% polyacrylamide sequencing gel was prepared, the samples loaded and 
run for 2 h at 1500 V, 40 mA. The gel was visualised by autoradiography.
2.24 Oligonucleotide Mutagenesis
Ref: Sambrook et a l , (1989).
Oligonucleotides were manufactured by Seven Biotech Ltd. (Kidderminster, 
Worcestershire, UK.) and VHBio (Gosforth, Newcastle-upon-Tyne). To anneal 
complementary oligonucleotides, equal amounts were mixed in hybridisation buffer 
(10 mM Tris, 100 mM NaCl, 5 mM EDTA, pH 7.5) The melting temperatures of the 
oligonucleotides were calculated according to the following equation:
Melting temperature in °C = 4°C x G / C + 2°C x A / T 
Where G = Guanine, C = Cytosine, A = Adenine, T = Thymine.
The oligonucleotide mixture was heated to the melting temperature and allowed 
to cool slowly, final cooling was performed on ice. Unphosphorylated linkers were used 
in excess during ligation, in order to increase the probability of obtaining mutated host 
DNA.
2.25 Preparation and Transformation of Bacterial Cells
1 ml of an overnight 10 ml L-broth culture of E. coli TOP 10 cells were diluted 
into 100 ml of L-broth with 10 mM MgS04. The culture was grown with good aeration 
at 37°C, 200 rpm on a rotary shaker, until the optical density was equal to 0.2 - 0.4
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absorbance units, measured at 600 nm. The cells were pelleted by centrifugation at
3,000 g for 5 minutes at 4°C. The supernatant was discarded and the cells resuspended 
in 50 ml of 0.1 M CaCl2 at 4°C and then incubated on ice for 30 minutes. Cells were re- 
pelleted by centrifugation at 3,000 g for 5 minutes at 4°C. The supernatant was 
discarded and the cells resuspended in 1 ml of 0.1 M CaCl2. Cells were incubated on ice 
until they were transformed (according to the following protocol).
10 - 100 ng of DNA were added to 200 pi of competent cells and incubated on 
ice for 1 h. The cells were heat shocked at 42°C for 3 minutes and added to 2 ml of 
L-broth. The cells were then incubated for 1 h at 37°C and 100 - 200 pi aliquots were 
plated on selective medium. Plates were incubated at 37°C for 24 - 36 h.
When only small amounts of DNA were available for transformation Epicurian 
Coli® SURE® competent cells (Stratagene, La Jolla, California) were used according to 
the manufacturer’s instructions. 100 pi of Epicurian Coli® SURE® competent cells was 
mixed with 1.7 pi of 1.42 M P-mercaptoethanol and incubated on ice for 10 minutes. 
Between 0.1 and 50 ng of DNA were added to the competent cells and the mixture was 
incubated on ice for 30 minutes. Cells were then heat shocked at 42°C for 45 seconds 
and incubated on ice for 2 minutes. The transformed cells were added to 900 pi of 
L-broth and incubated at 37°C for 1 h on a rotary shaker at 200 rpm. 100 - 200 pi 
aliquots (of cells) were plated on selective medium and incubated at 37°C for 24 - 36 h.
2.26 Double Stranded DNA Sequencing using Sequenase Version 2.0
Ref: Sanger and Coulson (1975) and Sanger et al. (1977).
Sequencing was essentially performed as described by Sanger et a l (1977), with 
some modifications. The sequenase™ version 2.0 DNA sequencing kit was 
manufactured by United States Biochemicals (Cleveland, Ohio) and supplied through 
Amersham International pic (Little Chalfont, Buckinghamshire).
Sequencing plates were washed in 70% ethanol and the front plate coated with 
10 ml of dimethyldisaline and allowed to dry. The back plate was coated with 30 ml of 
binding solution (30 ml of 100% ethanol, 1.2 ml of 10% acetic acid and 200 pi of
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silane). Plates were washed in water and then 70% ethanol. A 6% polyacrylamide / urea 
sequencing gel was prepared.
10 pi (1 pg) of Qiagen mini prep DNA was taken and denatured in 
200 mM NaOH, 0.2 mM EDTA for 5 minutes at room temperature. The denatured DNA 
was ethanol precipitated and resuspended in 7 pi of double distilled. This DNA (the 
template) was annealed to 100 ng (1 pi) of primer in sequenase reaction buffer (40 mM 
Tris-HCl, 20 mM MgCfe, 62.5 mM NaCl, pH 7.5). The mixture was then heated to 95°C 
for 1 minute and immediately placed at 37°C for 15 minutes. The annealed template and 
primer were labelled by the addition of 1 pi of 0.1 M DTT, 2 pi of diluted labelling mix 
(dGTP, dCTP, dTTP), 0.5 jil (5 (iCi) 35S-dATP (1000 Ci / mmol) and 2 pi of diluted 
sequenase enzyme followed by a 5 minute incubation at room temperature. 3.5 pi 
aliquots of labelling mix were added to 2.5 pi of termination mix, ddGTP (ie. 80 pM 
dGTP, 80 pM dCTP, 80 pM dTTP, 80 pM dATP, 8 pM ddGTP, 50 mM NaCl), ddATP, 
ddTTP and ddCTP and incubated at 37°C for 5 minutes. The reaction was arrested using 
4 pi of stop buffer (95% Formamide, 20 mM EDTA, 0.05% Bromophenol Blue, 0.05% 
Xylene cyanol FF).
Samples were heated to 80°C for 5 minutes, quenched on ice and loaded on a 
pre-warmed sequencing gel. The gel was electrophoresed for approximately 2 h 
(depending on the length of sequence) at 1500 V, 30 mA, 40 W. The gel was then fixed 
in a 10% (v/v) methanol, 10% (v/v) acetic acid solution for 20 minutes, washed in 
distilled water for 20 minutes and oven dried at 80°C. The dried gel was then exposed to 
Kodak photographic film overnight (Kodak Scientific Imaging Film (18 x 43 cm), 
Eastman Kodak Company, USA).
2.27 Baculovirus Methods
2.27 Co-transfection of Viral DNA and Transfer Vector
Ref: The baculovirus expression system, King and Possee, (1992).
1 pg of recombinant transfer vector was mixed with 200 ng linearised AcMNPV 
DNA (supplied by Invitrogen®) in a polystyrene universal sterilin sample tube. 
LipofectAMINE™ (a 3:1 (w/w) liposome mixture of the polycationic lipid DOSPA
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(2,3-dioleyloxy-N-[2(Sperminecarboxamido)ethyl]-N,N-dimethyl-l-propanaminium 
trifluoroacetate) and the neutral lipid DOPE (dioleoyl phosphatidylethanolamine) 
supplied by GibcoBRL Life Technologies™) was diluted with 0.5 volumes of sterile 
double distilled water and added to the same volume of transfer vector / AcMNPV DNA 
mixture. The mixture was incubated at room temperature for 15 minutes. A 35 mm dish, 
seeded 24 h in advance with 1 x 106 cells, was washed twice with 1 ml of serum free 
TCI00 medium, cells should look healthy and be about 50% confluent. 1 ml of serum 
free TCI00 medium was added to the cells. The DNA / LipofectAMINE™ mixture was 
then pipetted into the dish, gently mixed and incubated at 28°C for 24 h. 1 ml of 
complete TCI00 (10% foetal bovine serum) medium was added to the dish and 
incubated for a further 48 h at 28°C. The medium was harvested and stored at 4°C for 
further analysis by plaque assay.
To confirm the success of co-transfection 1 ml of complete TCI00 containing 15 
pi X-Gal (2% (w/v) X-Gal in dimethylformamide, stored at -20°C) was added to the 
cells. After 24 h the dish was examined for a blue coloration to confirm transfection 
(pBBH based constructs only).
2.28 Purification of Virus by Plaque Assay
Ref: The baculovirus expression system, King and Possee, (1992).
The co-transfection medium was diluted in complete TCI00 medium using serial 
dilutions from undiluted to a 10‘3 dilution. A negative control using complete TCI00 
medium was also included. Sf9 cells were grown to 50% confluence in 35 mm dishes by 
seeding 24 h before use with 1 x 106 cells. Culture medium was removed from the 
dishes and the cells inoculated with 100 pi of putative viral inoculum. The dishes were 
incubated for 1 h at room temperature. An overlay was prepared (TCI00 medium with 
5% (v/v) foetal bovine serum, 1% (v/v) penicillin / streptomycin solution, 1% (w/v) low 
melting point agarose) and incubated at 37°C. The inoculum was carefully removed and 
2 ml of overlay were pipetted into each dish. When the overlay had solidified, 1 ml of 
complete TCI00 medium was pipetted onto the overlay. The dishes were incubated at 
28°C in a humidified plastic box for five days.
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Plaque assays were analysed using X-Gal and neutral red staining, in order to 
visualise all viral plaques. Recombinant plaques formed from derivatives of the pBBH 
vector were blue and occlusion body negative. Recombinant plaques formed from 
derivatives of the pAC360 vector were colourless and occlusion body negative. 
Non-recombinant plaques were colourless and occlusion body positive.
To visualise recombinant plaques formed from pBBH vector derivatives the 
following protocol was used: Culture medium was removed from the overlay and 
replaced with 1 ml of complete TCI00, containing 0.03% (w/v) X-Gal (15 pi / ml of 2% 
(w/v) X-Gal Lennox in dimethylformamide) and incubated at 28°C for 3 h. 1 ml of 
sterile PBS containing 0.025% (w/v) neutral red stain (50 pi / ml of 0.5% (w/v) neutral 
red stain solubilized in sterile double distilled water) was added and the incubation 
continued for a further 3 h. The stain was removed, the dishes inverted and the plaques 
allowed to develop in the dark for at least 2 h. Recombinant plaques were blue and 
occlusion body negative, while wild-type plaques were clear and occlusion body 
positive.
To visualise recombinant plaques formed from pAC360 vector derivatives the 
following protocol was used: Culture medium was removed from the overlay and 
replaced with 1 ml of sterile PBS containing 0.025% (w/v) neutral red stain was added 
and incubated for 4 h. The stain was removed, the dishes inverted and the plaques 
allowed to develop in the dark for at least 2 h, the plaques become clearer if left 
overnight. Recombinant plaques were clear and occlusion body negative, while wild- 
type plaques were clear and occlusion body positive.
Identified plaques were confirmed by microscopic analysis. Several well isolated 
putative recombinant plaques were selected for further analysis.
2,29 Plaque Purification
Ref: The baculovirus expression system, King and Possee, (1992).
Putative recombinant plaques were selected using a sterile glass Pasteur pipette. 
The plug of agarose containing viral particles was placed in a sterile bijou bottle 
containing 4 ml of TCI00 medium and vortexed to disperse the virus particles in the
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medium. Plaque picks were stored in the dark at 4°C (recombinant viral particles have 
been reported to be light sensitive (personal communication with Dr A. Wolstenholme)).
The plaque assay was repeated using serial dilutions from 0 to a 10'3 dilution. As 
a control, 2 dishes were inoculated with medium only. Cells were infected, incubated 
and stained according to protocol 2.28. Plaques were examined microscopically in order 
to identify contaminating wild-type virus. Pure plaques were picked and the plaque 
purification protocol was repeated until there were no wild-type plaques detected.
2.30 Titration of Viral Stocks by Plaque Assay
Ref: The baculovirus expression system, King and Possee, (1992).
The viral titre, measured in plaque forming units per ml (pfu / ml), was 
determined by modification of the plaque assay protocol. Serial dilutions of the viral 
stock, between 10'3 - 10'7 dilutions, were prepared in complete TCI00 medium. 35 mm 
dishes of 50% confluent cells were inoculated with 100 pi of diluted virion. The 
inoculum was removed and the overlay applied, cells were incubated for 5 days and 
stained with X-Gal only (when determining the titre of pBBH derived vectors). Plaques 
were counted and the single dilution showing the maximum number of countable 
plaques was used to determine the titre.
2.31 Production of Small Virus Stocks
Ref: The baculovirus expression system, King and Possee, (1992).
25 cm2 flasks were prepared 24 h in advance by seeding with 1.5 x 106 cells, 
resulting in 50% confluence. The medium was removed and the cells inoculated with 
400 pi of plaque picked inoculum for 1 h at room temperature. The inoculum was 
discarded and replaced with 5 ml of complete TCI00 medium and the flasks were 
incubated at 28°C for up to 7 days. Cells were microscopically observed during 
infection to ensure purity and viral infectivity. Culture medium containing viral particles 
was removed to sterile universal sample tubes and stored in the dark at 4°C. Recovered 
medium was used to infect cells for recombinant protein analysis.
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2.32 Viral infection of Insect Cells for Recombinant Protein Analysis
Ref: The baculovirus expression system, King and Possee, (1992).
25 cm flasks were prepared 24 h before use as described in protocol 2.31. The 
medium was discarded and the cells infected with 400 pi of viral inoculum. Cells were 
incubated with inoculum for 1 h, after which the inoculum was replaced with 5 ml of 
complete TCI00 medium. Cells were incubated at 28°C for four days and the infection 
was monitored microscopically.
Cells were scraped from the flask surface, into the medium, using a cell scraper. 
The cells were pelleted in an Ole Diche bench top centrifuge at 20,000 g for 5 minutes. 
The cells were resuspended in 1.5 ml of TES buffer with protease inhibitors (10 mM 
Tris, 5 mM EDTA, 250 mM Sucrose, pH 7.2) and homogenised with 20 strokes from an 
electric teflon homogeniser. Membranes were centrifuged at 20,000 g and resuspended 
in 1 ml of TES buffer with protease inhibitors. Samples were assayed to determine 
protein concentration and were analysed by immunoblotting with a C-terminal 
polyclonal GLUT1 antibody. This determined whether putative recombinant viruses 
were producing the relevant protein.
2.33 Production of High Titre Viral Stocks
Ref: The baculovirus expression system, King and Possee, (1992).
Once a recombinant virus expressing the required protein had been identified a 
large viral stock was made for use in all further experiments.
A 250 ml spinner culture was prepared and grown until the cell density reached 
5 x 105 cells / ml. Cells were infected with a low multiplicity of infection (MOI 
(0.1 - 0.2 pfu / cell)) as estimated by plaque assay. The required amount of inoculum 
was added to the spinner culture and the culture returned to stir at 28°C. Infected 
cultures were incubated for 7 days and the infection was monitored microscopically. 
Supernatants were separated from the cells by centrifugation at 6,000 g for 15 minutes at 
4°C in a Sorvall high speed centrifuge. Supernatants containing the recombinant virions 
were stored in the dark at 4°C. Two aliquots of virus were subsequently removed and
Page 68
Chapter 2 Materials and Methods
cryogenically stored in liquid nitrogen. Samples were flash frozen on dry ice soaked in 
ethanol (-72°C), and then placed under liquid nitrogen (-196°C).
2.34 Production of Recombinant Protein for Further Experimentation
Ref: The baculovirus expression system, King and Possee, (1992).
Both Highfive cells and Sf9 cells were grown in spinner culture 
(5 x 105cells/ml) or monolayer culture (grown to 50% confluence). Cells were 
infected with a low multiplicity of infection (0.1 pfu / cell (personal communication 
with Dr A. Wolstenholme suggested that protein expression was more effective with a 
low MOI, leading to two rounds of viral infection in culture)). Highfive cells and Sf9 
cells were incubated at 28°C for 3 days or 4 days respectively. Cells were then 
recovered from culture, monolayer cells were freed from the surface by use of a cell 
scraper, all cells were pelleted by centrifugation at 6,000 g for 15 minutes at 4°C in a 
Sorvall high speed centrifuge.
Cells were resuspended in 5 mM sodium phosphate buffer (pH 7.4) with 
protease inhibitors and homogenised with 40 strokes from an electric teflon 
homogeniser. Membranes were centrifuged at 541,000 g (100,000 rpm in a Beckman 
Ultracentrifuge using a TLA-100.3 rotor) for 15 minutes at 4°C. Homogenisation and 
centrifugation was repeated twice more, in order to wash the membranes of soluble 
proteins. Membranes were resuspended in 5 mM sodium phosphate buffer with protease 
inhibitors and assayed to determine their protein concentrations.
2.35 Protein Analysis Methods
2.35 BCA Protein Assay
Protein concentrations were determined by the Pierce BCA (bicinchoninic acid) 
system for protein assay. The standard protein curve was made up using 0 ,2 ,4 , 6, 8 and 
10 pg of BSA stock (1 pg / p i ), diluted with 5 mM sodium phosphate buffer or GLUT1 
dialysis buffer, depending on sample. 10 ml of reagent A (1% bicinchoninic acid, 2% 
NaCCV^O, 0.16% sodium tartrate, 0.4% NaOH, 0.95% NaHCOs) was mixed with
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200 pi of reagent B (4% (w/v) CuSCV^O), 200 pi of the mixture was added to each 
sample. Samples were incubated at 37°C for 30 minutes and the plate was read on a dual 
wavelength Labsystems Multiskan plate reader at 450 nm and 540 nm.
2.36 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Electrophoresis was performed using a modification of the method of 
Hashimoto et al, (1983), derived from the discontinuous buffer system of Laemmli, 
(1970). Samples were mixed with electrophoresis loading buffer (115 mM Tris, 10% 
(v/v) Glycerol, 2% (w/v) SDS, 5% (v/v) p-mercaptoethanol, 4 pg / ml (w/v) 
Bromophenol Blue, pH 6.8) and incubated at room temperature for 30 minutes before 
loading on the polyacrylamide gel. The polyacrylamide gel was run as either a 3 mm gel 
using the Protean II xi slab gel system (Bio-Rad) 16 x 20 cm plates or on the mini Atto 
gel system (6.5 x 9 cm gel size). Polyacrylamide gels were made, according to the 
manufacturer’s instructions, with either 10 or 12% aciylamide (acrylamide / 
bisacrylamide stock was 30% T, 2.7% C (National Diagnostics, Flowgen, Lichfield, 
Staffordshire)). Resolving gel buffer (1.5 M Tris, 0.4% (w/v) SDS, pH 8.8), stacking gel 
buffer (0.5 M Tris, 0.4% (w/v) SDS, pH 6.8), 10% (w/v) ammonium persulfate (Bio- 
Rad) and N,N,N’,N*-tetramethylethylenediamine (TEMED, Bio-Rad) were added to the 
aciylamide stock accordingly. Once assembled the upper and lower buffer chambers 
were filled with electrode buffer (0.025 M Tris, 0.1% (w/v) SDS, 0.192 M glycine, pH 
8.3) and the ‘wells’ loaded with sample suspended in electrophoresis sample buffer. The 
Protean II xi slab gel system was electrophoresed for approximately 16 h (until the 
dye-front approached the bottom of the plates) using a constant current of 25 mA and 
internal cooling. The mini Atto gel system was run for 114 h using a constant current of 
70 mA. High molecular weight electrophoretic standards (myosin 205 kDa, 
p-galactosidase 116 kDa, phosphorylase B 97.4 kDa, bovine albumin 66 kDa, 
ovalbumin 45 kDa and carbonic anhydrase 29 kDa) were obtained from Sigma.
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2.37 Visualisation of Protein on SDS-Polvacrvlamide Gels
Following electrophoresis gels were stained in 0.2% (w/v) coomassie blue R-250 
solubilized in fixative (30% (v/v) methanol, 10% (v/v) acetic acid) for 30 minutes at 
room temperature. Polyacrylamide gels were then destained in fixative, for 2 - 4 h.
2.38 Electrophoretic Transfer of SDS-PAGE Protein to Nitrocellulose
Samples were electrophoresed on the appropriate polyacrylamide gel, according 
to protocol 2.36. The polyacrylamide gel was taken, the stacking buffer removed and the 
gel soaked in transfer buffer (48 mM Tris, 0.0375% (w/v) SDS, 39 mM Glycine, 
pH 8.8) for 5 minutes. The electrophoretic cell consisted of 9 sheets of electrode paper 
(Pharmacia Biotech, St. Albans, Hertfordshire) soaked in transfer buffer, 1 piece of 
BioTrace® nitrocellulose blotting membrane (Gelman Sciences Ltd., Northampton) 
soaked in transfer buffer, a SDS-polyacrylamide gel and a further 9 sheets of electrode 
paper soaked in transfer buffer. The electrophoretic cell was placed between the plates 
of a Multiphor II NovaBlot electrophoretic transfer unit (Pharmacia Biotech). A current 
of 0.8 mA / cm2 was applied for 110 minutes, after which the nitrocellulose was rinsed 
in double distilled water before staining with 0.1% (w/v) Ponceau S in 3% (w/v) 
trichloroacetic acid. The position of the molecular weight markers were recorded.
2.39 Immunoblotting for GLUT1
Immunoblotting was carried out at room temperature on a shaking table.
The dried nitrocellulose was rehydrated in TBS - Tween (10 mM Tris, 0.9% 
(w/v) NaCl, 0.1% (v/v) Tween 20, pH 7.4) before blocking with 5% (w/v) Marvel dried 
skimmed milk (Premier Beverages, Stafford) in TBS-Tween for 30 minutes. The milk 
was then discarded and the nitrocellulose washed in TBS-Tween. The nitrocellulose was 
incubated with the primary antibody at a dilution of 1:4000 in TBS-Tween, 1% (w/v) 
bovine serum albumin (BSA) for 90 minutes (the primary antibody was later re-used, 
being preserved by the addition of 0.03% (w/v) sodium azide and kept at 4°C). The 
primary antibody was removed and the nitrocellulose washed 6 times by 3 minute
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washes with TBS-Tween. The nitrocellulose was then incubated with the secondary 
antibody at a dilution of 1:4000 anti-rabbit IgG conjugated to horseradish peroxidase in 
TBS-Tween with 1% (w/v) BSA, for 30 minutes. Following six 3 minute washes with 
TBS-Tween, the nitrocellulose was either incubated for 1 minute with Amersham’s ECL 
detection reagent, or for 1 minute with Pierce’s chemiluminescent detection reagent 
(detection reagents were used according to the manufacturer’s instructions). The 
detection reagent was discarded and the nitrocellulose was placed between two 
transparent acetate sheets, before exposure to autoradiography film (Fuji medical X-ray 
film (13 x 18 cm) Fuji Photo Film Co. Ltd., Tokyo, Japan). The exposure time was 
adjusted until an image was visible on developed film.
2.40 Photolabelling of Membranes Expressing GLUT1
Homogenised insect cell membranes were (insect cell membranes or erythrocyte 
ghosts) resuspended in sodium phosphate buffer of Kreb-Ringer Hepes with protease 
inhibitors at 4°C and adjusted to a 1 ml volume. Membranes were incubated for 10 
minutes with or without zinc sulphate, on a rotating wheel, before the addition of 
photolabel. Membranes were labelled with either 250 pCi of ATB-[2-3H]BMPA (5 pCi 
/ pi) or 2 pCi of 3H-cytochalasin B (0.5 pCi / pi), which was added to each sample and 
the samples mixed on a rotating wheel. Samples were incubated for 5 minutes with 
photolabel before irradiation for minutes in a Rayonett RPR-100 photochemical 
reactor containing RPR-3000 lamps. Following irradiation the membranes were 
centrifuged at 13,400 g in a microcentrifuge, the supernatant discarded and the 
membranes resuspended in 1 ml of ice cold 5 mM sodium phosphate buffer containing 
protease inhibitors. The membranes were then washed a further two times, in order to 
remove free radioactivity. The membranes were solubilized in 1 ml of 2% (w/v) Thesit 
in 5 mM sodium phosphate buffer with protease inhibitors and incubated on ice for 20 
minutes, before centrifugation at 13,400 g to remove the insoluble matter. The 
supernatant was subjected to GLUT1 immunoprecipitation (50 pi anti-serum conjugated 
to 5 mg protein A Sepharose beads) for two h at 4°C on a rotating wheel. The 
immunoprecipitate was washed 6 times with 1 ml of 1% (w/v) Thesit in PBS with 
protease inhibitors. Bound proteins were removed from the beads by the addition of
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160 pi of electrophoresis sample buffer, 4% (w/v) SDS, for 30 minutes at room 
temperature. Samples were then analysed by SDS-PAGE, or by using the tricine gel 
system as described in protocol 2.42.
2.41 Photolabelling Gel Analysis
Photolabelled gels were stained with 0.2% coomassie blue, dissolved in fixative, 
(30% (v/v) methanol, 10% (v/v) acetic acid) for VA h to visualise and fix proteins. 
Photolabelled gel lanes were either cut to 6.5 mm slices or 3 mm slices, depending on 
the size of the gel, which were placed into scintillation counter vials and dried in an 
oven at 80°C for 2 - 3 h. Dried gel slices were solubilized in 30% (v/v) hydrogen 
peroxide with 2% (v/v) ammonium hydroxide in sealed vials for 2 h at 80°C. Samples 
were allowed to cool and 8 ml of scintillation fluid added (Optiphase Safe™). Samples 
were counted in a Packard 1500 TRI-CARB liquid scintillation counter using the tritium 
channel (0-12 KeV).
2.42 Tricine Gel Analysis
Tricine gels were electrophoresed on the mini Atto gel system (Atto corporation) 
and were used to resolve small photolabelled proteins. The gel was made up according 
to the method of Schagger, H. and Von Jagow, G., (1987). Mini Atto gel plates were 
assembled according to the manufacturer’s instructions. The separating gel was made to 
16% (w/v) acrylamide and 10% (v/v) glycerol in gel buffer (1M Tris-HCl, 0.1% (w/v) 
SDS, pH 8.45). The gel was polymerised by the addition of 0.033% (w/v) APS and 
0.04% (v/v) TEMED, the spacer gel was poured onto the separating gel before 
polymerisation occurred. The spacer gel was 10% (w/v) acrylamide, in gel buffer (1M 
Tris-HCl, 0.1% (w/v) SDS, pH 8.45) and was polymerised by the addition of 0.024% 
(w/v) APS, 0.04% (v/v) TEMED. The stacking gel was poured after spacer gel 
polymerisation and was composed of 3.8% (w/v) acrylamide in gel buffer (0.744 M 
Tris-HCl, 0.074 (w/v) SDS, pH 8.45), polymerisation was initiated by the addition of 
0.08% (w/v) APS, 0.08% (v/v) TEMED. The appropriate buffer chambers were filled 
with cathode buffer (0.1 M Tris, 0.1 M tricine, 0.1% (w/v) SDS, pH 8.25) and anode
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buffer (0.2 M Tris-HCl, pH 8.9). Samples were loaded in standard electrophoresis 
sample buffer and the gel run at a constant current of 50 mA, until the dye-front 
approached the bottom of the plates. Following electrophoresis the gel was analysed by 
the same method as other photolabelling gels in protocol 2.41.
2.43 Purification of GLUT1 from Human Erythrocytes
GLUT1 was purified from human erythrocytes as described by Baldwin and 
Leinhard, (1989). 450 ml of blood was taken and diluted with wash buffer (5 mM 
sodium phosphate, 150 mM NaCl, pH 8.0). Erythrocytes were pelleted at 3,300 g in a 
Sorvall centrifuge for 10 minutes. The supernatant and white cells were removed and 
the wash repeated a further two times. The cells were then lysed by the addition of lysis 
buffer (5 mM sodium phosphate, pH 8.0) and the membranes pelleted by centrifugation 
at 21,500 g for 25 minutes. Lysis was repeated a further 5 times and erythrocyte ghosts 
were stored at -80°C.
Membrane ghosts were protein depleted by the addition of a base solution 
(15 mM NaOH, 2 mM EDTA, 0.2 M dithiothreitol). The base mixture was added to 
40 ml of membranes to a final volume of 250 ml. The membranes were then centrifuged 
at 43,500 g for 15 minutes. The supernatant was discarded, the membranes washed once 
in 50 mM Tris, pH 7.4 at 2°C, and resuspended in the same buffer by homogenising 
with an electric teflon homogeniser. Protein depleted membranes were then stored at 
-80°C.
Protein depleted membranes were solubilized in 50 mM Tris-HCl, 2 mM 
dithiothreitol, 685 mM (1.45% (w/v)) octyl glucoside, pH 7.4, for 20 minutes and then 
centrifuged at 180,000 g for 1 h.
The solubilized fraction was applied to a DEAE cellulose column, 
pre-equilibrated in 50 mM Tris-HCl, 25 mM NaCl, 2 mM dithiothreitol, 34 mM octyl 
glucoside, pH 7.4. The sample was eluted using the same buffer and the eluate dialysed 
extensively against 50 mM sodium phosphate, 100 mM NaCl, 1 mM EDTA over 48 h. 
Finally, samples were analysed for purity by SDS-PAGE, protein assayed and used as an 
experimental control or protein standard.
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2.44 Cvtochalasin B Assays
Cytochalasin B assays were performed on either 250 pg of erythrocyte ghosts, 
120 pg of erythrocyte protein depleted membranes, 36 pg of purified erythrocyte 
membranes or 1 mg of insect cells expressing the appropriate recombinant protein. 
Tritiated cytochalasin B (18.1 Ci / mmol) was used from a 50 pCi / 100 pi stock in 
ethanol and diluted to 0.02 pCi / 5 pi with PBS. Unlabelled cytochalasin B was diluted 
from a 1 mM stock, solubilized in ethanol, to 2 pM with PBS and was used at a range of 
concentrations from 0.096 pM to 0.48 pM. Unlabelled cytochalasin B was substituted 
with 0.5 M D-glucose to test glucose inhibition. Cytochalasin E was used at a 
concentration of 32 pM, in order to block non-specific cytochalasin B binding sites. 
Erythrocyte assays were performed in a total volume of 310 pi. Insect cell assays were 
performed in a total volume of 1 ml.
Assay components were combined and incubated at room temperature for 15 
minutes. Membranes were pelleted at 13,400 g for 5 minutes and two 100 pi or 200 pi 
aliquots of supernatant were counted, depending on assay volume. The radioactivity 
detected in the supernatant represents unbound ‘free’ cytochalasin B. This was used to 
determine the amount of ‘bound’ and ‘free’ cytochalasin B. Results were plotted as a 
‘bound’ / ‘free’ versus ‘bound’ Scatchard plot, from which the Bmax and Kd was 
determined.
2.45 Confocal Microscopy
Confocal scanning light microscopy was performed using a BioRad confocal 
imaging system (MRC500) with a Nikon 60 times (NA 1.40) magnification lens. The 
fluorescein isothiocyanate (FITC) antibody was stimulated by blue light emission at 
488 nm (lOmW) from an argon ion laser. The fluoresced image was analysed using the 
MRC500 confocal microscope operating software CoMOS Version 7.0a (BioRad 
Microscience Ltd., 1991 -1994).
Spodoptera frugiperda cells were infected with virus 24 h and 36 h before use. 
Cells were combined and pelleted at 300 g in a bench top centrifuge. The supernatant 
was discarded and the cells were fixed in 7 ml 4% (w/v) paraformaldehyde in PBS for
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20 minutes at room temperature on a shaking table. Cells were washed 3 times in 7 ml 
of PBS and permeabilised in 7 ml of 0.1% (w/v) saponin in PBS for 45 minutes. 
Permeabilised cells were centrifuged at 300 g for 45 seconds and the supernatant 
removed. The cell pellet was transferred to a microcentrifuge tube.
Affinity purified anti-rabbit polyclonal GLUT1 antibody was diluted 1:100 in 
PBS containing 0.1% (w/v) saponin., 1% (w/v) BSA and 3% (v/v) goat serum. Cells 
were resuspended in 125 pi of diluted GLUT1 antibody (1.57 mg / ml) and incubated at 
room temperature for 90 minutes on a shaking table. Cells were then washed 3 times 
with 500 pi of 0.1% (w/v) saponin in PBS. Cells were diluted in a 1:100 dilution of 
FITC-labelled goat anti-rabbit IgG antibody (1.57 mg / ml fluorescein conjugated 
affinipure goat anti-rabbit IgG with minimal cross reaction to human, mouse and rat 
serum proteins (code: 111-095-144, Jackson Immuno Research Laboratories Inc. USA)) 
in PBS containing 0.1% (w/v) saponin, 1% (w/v) BSA and 3% goat serum to give a 
final volume of 125 pi. The cells were then incubated for 1 h, in the dark, on a shaking 
table. Following incubation, cells were washed 3 times in 500 pi of PBS containing 
0.1% (w/v) saponin and mounted onto a glass slide in 25 pi vector shield (Vector labs).
2.46 Purification of Egg Yolk Lipids
Ref: Personal communication with G. Schmitt, University of Bath.
Egg yolks were taken from six Chicken eggs and mixed with 3 volumes of a 
2 :1 chloroform : methanol mixture. The egg yolk / chloroform mixture was left for 
5 minutes at room temperature in order to solubilize the lipid fraction and the 
precipitated proteins were filtered out using a 0.45 pm filter. The solubilized lipids were 
then reduced in volume by rotary evaporation and loaded onto a silica column. The 
column was eluted using three column volumes of chloroform, followed by three 
column volumes of 1 : 1 chloroform : methanol and finally by three column volumes of 
1 : 9 chloroform : methanol. The solvent system resulted firstly in the elution of neutral 
lipids followed by the elution of increasingly polar lipids, for example phospholipids. 
Lipid fractions were analysed by thin layer chromatographic (TLC) analysis using the 
following solvent system: 65 parts chloroform, 35 parts methanol, 8 parts acetic acid, 4 
parts water. The TLC plate was visualised using a molybdenate stain
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(1.3 % molybdenum oxide in 4.2 M sulphuric acid) developed in an 80°C oven for 20 
minutes.
2.47 Solubilization and Purification of Histidine Tagged Proteins
Homogenised membranes (2 mg / ml) were solubilized in buffer (solubilization 
buffer: 10 mM Hepes, 250 mM NaCl, 20% (v/v) Glycerol, 1.5 mg / ml Lipids, 1.5% 
(w/v) Octyl glucoside, 20 mM Imidazole, protease inhibitors, pH 7.9 (lipids were type 
II-S lipids from Soybean, Sigma catalogue code P5638)), and homogenised with 20 
strokes from an electric teflon homogeniser and incubated on ice for 30 minutes. 
Following incubation, insoluble cell debris was removed by centrifugation at 20,000 g 
in a Beckman ultracentrifuge (TA100 rotor).
A 1 ml Pharmacia Biotech HiTrap Sepharose column was chelated with 10 ml of 
0.1 M nickel sulphate using a Pharmacia Biotech FPLC unit (Gradient Programmer 
GP-250). The column was washed with 4 ml of distilled water and pre-equilibrated with 
3 ml of wash buffer (10 mM Hepes, 250 mM NaCl, 20% (v/v) glycerol, 1.5 mg / ml 
lipids, 1% (w/v) octyl glucoside, 20 mM imidazole, protease inhibitors, pH 7.9), at a rate 
of 1 ml / min. Solubilized samples were loaded onto the column and 1.9 ml fractions 
collected. The column was washed with 10 ml of wash buffer and eluted with 5 ml of 
elution buffer (10 mM Hepes, 250 mM NaCl, 20% (v/v) glycerol, 1.5 mg / ml lipids, 1% 
(w/v) octyl glucoside, 300 mM imidazole, protease inhibitors, pH 7.9). Samples were 
dialysed against three 4 litre batches of GLUT1 dialysis buffer (50 mM Tris, 100 mM 
NaCl, 1 mM EDTA, pH 7.4) for a period of 48 h. Once dialysed, purified GLUT1 was 
stored at -80°C.
Protocol modifications
Preliminary experiments involved the use of a 5 ml Pharmacia Biotech HiTrap 
column eluted on a Pharmacia Biotech FPLC unit. The FPLC unit was programmed to 
generate a 25 ml wash followed by a 25 ml elution gradient from 0 to 200 mM 
imidazole. Columns run on the FPLC unit used the IMAC buffer system. The column 
was pre-equilibrated in IMAC 0 buffer and the sample loaded in the same buffer (10
Page 77
^e4uit&
Chapter 3 Glutl Point Mutations
3,0 GLUT1 Point Mutations 
Section 3.1 Introduction
Chinese hamster ovary (CHO) cells were transfected with one wild-type and 
3 mutated glucose transporter constructs. The transfected cells were supplied to the 
laboratory by Muraoka (Kobe University, Japan). The CHO cell clones expressed the 
following point mutations: glycine 466 mutated to glutamic acid (G466E), 
phenylalanine 467 mutated to leucine (F467L) and arginine 468 mutated to leucine 
(R468L). Muraoka et al, (1995) tested the CHO cells for glucose transporter expression 
using immunoblot analysis. Immunoblotting demonstrated the mutants to have similar 
expression levels (table 3.1).
i Western Blotting (%)
I
WT ! 100
G466E 106.6 ± 3.9 (n = 3)
F467L | 107.3 ±21.1 (n = 3)
R468L 126.0 ±17.8 (n = 3)
Non-Transfected 11.3 ± 1.4 (n = 3)
1
...................................................... i ii i  ■■ ■■■ ■ ■■' ■— — ■ m i -
Table 3.1, CHO cell glucose transporter expression levels. The levels o f mutated GLUT1 were 
assessed by comparison with expression of the wild-type GLUT1 protein in CHO-K1 cells. Immunoblot 
analysis demonstrated that similar expression levels were attained by each mutant (Reproduced from 
Muraoka et al, (1995)). The number of repeat experiments = 3 (n=3).
The location of the mutated amino acids can be seen in the 2-D representation of 
the GLUT1 glucose transporter on the following page, figure 3.1. For clarity only the 
C-terminal portion has been displayed. The mutated amino acids are located in the 
C-terminal hydrophilic tail of the glucose transporter.
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Figure 3.1, C-terminal portion of GLUTl. The diagram displays a modified version of the 
2-dimensional representation of the 12 a-helix transporter model, according to Mueckler et al, (1985). 
The 24th and 27th amino acids from the C-terminus are marked, as are the 466th, 467th, 468th and 469th 
amino acids from the N-terminus. The mutations G466E (Blue) F467L (Magenta) and R468L (Red) are 
denoted by the figures 466,467 and 468, respectively.
Katagiri et al., (1992), have determined the C-terminal region to be important for 
glucose transporter function. Katagiri et al, (1992) substituted the final 39 amino acids 
of GLUT1 with the corresponding amino acids of GLUT2. Analysis of the resulting 
chimera showed that the observed kinetics of GLUT2 had been conferred to the GLUT1 
/ GLUT2 chimera. The Km of GLUT1 for 2-Deoxyglucose was 1.5 mM. However, the 
Km of the chimeric protein for 2-Deoxyglucose was 10 mM, a 6.6 fold increase (Km of 
GLUT2 for 2-Deoxyglucose is 10 mM). Figure 3.2 on the following page displays the 
C-terminal region between amino acids F450 and G471.
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454 468
Human GLUT1; FKVPE/TKGRTFDEIASGFR//QGG-////-
Rabbit GLUT1; ........../ ................................ / / .  . . - / / / / -
Human GLUT2; ... /...KS.E...AE.Q//KKS-////-
Rat GLUT2; ... / .  . .KS....AE. . / /KKS-/// / -
Point mutations were made at G466, F467 and R468 as follows: G466»E, F467»L and R468»L.
Figure 3.2, The ‘critical’ regions at the C-terminus of several glucose transporters. Taken from 
Muraoka et al, (1995). The figure displays the sequence alignments of C-terminal amino acids in the 
‘critical’ region of the C-terminus. The ‘critical’ region describes the area where C-terminal deletions 
result in a progressive, significant loss of activity.
Muraoka et al, (1995) have produced several C-terminal deletion constructs. 
Study of the constructs showed that glucose transport was decrease by the removal of 24 
or 25 C-terminal amino acids. The 24th C-terminal amino acid corresponds to amino 
acid Q469.
The three point mutations studied in this thesis were at amino acids R468, F467 
and G466, which correspond to the 25th, 26th and 27th amino acids from the 
C-terminus, respectively. From figure 3.2, it can be seen that all of the amino acids in 
this region are conserved between human GLUT1 and rabbit GLUT1, indicating the 
region to be important for the function of the glucose transporter. The point mutation 
G466E exchanges the GLUT1 amino acid for the GLUT2 amino acid. Mutations F467L 
and R468L are situated at the region determined by C-terminal deletion to perturb 
transporter function.
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Section 3.2 
CHO Cell Transport Assays
CHO cells were assayed for uptake of 2-Deoxy-D-glucose and the results plotted 
in figure 3.3, the Km and Vmax values are displayed in table 3.2. Mori et al., (1994) 
have previously shown that non-transfected CHO-K1 cells transport 2-Deoxy-D-glucose 














Figure 3.3, Uptake studies in CHO cell mutants. The figure displays the combined GLUT1 transporter 
assay results, (the number of repeat experiments is = 4 (n=4) except for the wild-type were the number of 
repeat experiments is = 5 (n=5)). Error bars indicate the standard error of the mean. The data obtained was 
fitted to the equation Y = Vmax x X / (Km + X).
i j
Km (mM) ± SEM Vmax (nmoles/min/mg) 
± SEM
WT 1.49 ± 0.17 (n = 5) 52.84 ± 9.19 (n = 5)
G466E 1.62 ± 0.16 (n = 4) 53.15 ± 14.48 (n = 4)
F467L 3.31 ±0.77 (n = 4) 45.62 ±8.71 (n = 4)
R468L 0.91 ±0.11 (n = 4) 32.67 ±4.72 (n = 4)
Table 3.2, Km and Vmax values for mutated glucose transporters. The table displays the calculated 
Km and Vmax values for the mutated glucose transporters.
Page 82
Chapter 3 Glutl Point Mutations
Because the region of the C-terminus, R468 - G466, had previously been shown 
to be important by C-terminal deletion analysis it was thought that the introduction of 
point mutations would greatly affect the function of the glucose transporter. However, it 
was observed from the data, that there have been no substantial alterations in GLUT1 
kinetics. For example, the kinetics of GLUT2 have certainly not been conferred upon 
the GLUT1 protein. Nevertheless, slight variations in transporter Km were observed in
some mutants and have been 
demonstrated to be 
statistically significant, these 
results can be seen more 
clearly when plotted as 
follows in figure 3.4.
Figure 3.4, Km and Vmax 
comparison between mutants. The
Km comparison with WT 
transporter shows a significant 
variation in the measured Km of 
mutant F467L and R468L. The P 
value is significant if P = <0.05; ns 
= none significant; * = significant. 
Mutant G466E P = 0.5822; mutant 
F468L P -  0.0360; R468L P = 
0.0285. P values were derived from 
two tailed, unpaired t-test analysis, 
each mutant was compared with the 
wild-type GLUT1 data.
Mutant G466E does not have a significantly different Km value from the wild- 
type protein. However, t-tests have shown that there was a significant difference 

















Vmax comparison of mutated 
transporters
75-| Vmax 52.84 53.15 45.62 32.67
C 50-
* A
WT G466E F467L R468L
Mutant
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the wild-type protein. None of the Vmax values were found to be significantly different. 
This result further demonstrates the importance of the C-terminal region of the glucose 
transporter in kinetic control.
Section 3,3 
Discussion
The experiments carried out by Muraoka et al, (1995) and Katagiri et al, (1992) 
indicated that the C-terminal region is important for glucose transporter function, as the 
following two points show:
1) A 25 amino acid C-terminal GLUT1 deletion resulted in a Km of 0.92 ±0.14 mM 
and a Vmax of 20.2 ±1.15 nmoles/min/mg for 2-deoxy-D-glucose, similar to the 
R468L mutant (Muraoka et al, (1995).
2) A chimeric protein composed of GLUT1 with the GLUT2 C-terminus produces 
a transporter with GLUT2 kinetics (Katagiri et al., (1992).
The mutation of arginine 468 to leucine resulted in a significant reduction in the 
measured Km. Both arginine and leucine are large amino acids, having similar van der 
Waals volumes, being 148 and 124 A3, respectively. However, leucine is a non-polar, 
hydrophobic amino acid, whereas arginine is a hydrophilic amino acid carrying a 
positive charge at physiological pH. It is likely that this non-conservative substitution 
has altered the protein conformation in some way.
Phenylalanine 467 was exchanged for leucine. The phenylalanine 467 to leucine 
mutation did have the effect of lowering the glucose transporters affinity towards the 
substrate. Mutating glycine 466 to glutamic acid made no significant difference to 
transport activity.
In summary, the three point mutations studied did not substantially affect the 
function of GLUTl. It appears that glucose transporter function is controlled by a large 
region of protein (possibly the whole of the C-terminus) and that individual amino acids 
are less important. The overall structure would then influence the function of the 
transporter. C-terminal deletions and chimeric protein studies support this theory.
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4.0 Construction of Recombinant Baculovirus Transfer Vectors 
Section 4.1 Introduction
The insect cell system was chosen to express the modified glucose transporter 
constructs because:
a) A relatively large amount of protein can be readily produced
b) The system has been previously characterised, producing functional GLUT1
protein.
Insect cells are capable of targeting the full length glucose transporter to its 
correct location in the plasma membrane. Kuroda et al, (1990) have shown that limited 
glycosylation occurs in insect cells.
Foreign proteins are expressed in the insect cell system by a baculoviral transfer 
vector, which must be modified to contain the cDNA of interest. The baculovirus 
transfer vector is a plasmid containing an E. coli origin of replication, a multiple cloning 
site downstream of a viral promoter site and baculovirus specific recombination 
sequences. The cDNA of interest is inserted into the multiple cloning site, followed by 
the amplification of the resulting plasmid in E. coli. The transfer vector can then be 
recombined with wild-type baculovirus DNA within insect cells and viable virus will 
then replicate. Because the foreign cDNA will replace the gene for the polyhedrin coat 
protein, recombinant viral particles are unable to produce the polyhedrin coat protein. 
The polyhedrin coat protein is clearly visible under the light microscope making it 
possible to select for the recombinant virus from the non-recombinant wild-type virus.
Two of the transfer vectors used in this thesis are fusion vectors. The pBBH 
transfer vector fuses a polyhistidine tag onto the N-terminal end of the expressed 
protein, allowing for purification upon a chelating nickel Sepharose column. The 
pAC360 transfer vector fuses a short sequence of the polyhedrin gene onto the start of 
the protein. This transfer vector was used in an attempt to increase the level of 
expression of the foreign protein. In both constructs the GLUT1 123 base pair 
non-coding region was eliminated.
Page 85
Chapter 4 Construction of Expression Vectors
Rabbit cDNA encoding the glucose transporter, isoform 1 (GLUT1), was 
supplied to the laboratory by Asano, in the plasmid pUC19 (Asano et al., (1988)). The 














Figure 4.1, GLUT1 cDNA contained in the vector pUC19.
pUC19:GZ,t/77 served as the source DNA for all of the glucose transporter 
constructs. Table 4.1 defines the origin of these plasmids / viruses, the expressed protein 
sequence can be found in appendix 14.2.
Plasmid and Virus Generated by: Plasmid construct
Present thesis i  ] pLE12
Present thesis pBBH: GL UT 1 (pLEl 4)
Plasmid constructed by Cope i 994 j pBBH:C-Term
Virus produced in present thesis { ]
Produced by Cope et ail. (1994) | ] pVL1392: GLUTl  (Bacuiovirus E4.2)
Produced by Cope et al. ( j 994) I I pVL941 \GT52 (Bacuiovirus R12)
Table 4.1, History of vectors used within the present thesis. The production of pLE12 and pLE14 are
described in this thesis. The plasmid pBBH:C-Term was produced by Cope (1994), but the virus was
produced as described in this thesis. pVL\GLUTl (Baculovirus E4.2) and pVL\GT52 (Baculovirus R12)
were produced by Cope (1994).
The baculovirus transfer vector pLE12 codes for a GLUT1 fusion protein, 
expressing 15 amino acids from the polyhedrin coat protein. A 6 membered histidine 
sequence has been engineered into the first extracellular loop of GLUT1.
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The baculovirus transfer vector pLE14 codes for a fusion protein containing a 
leader sequence encoding a 6 membered histidine sequence, an enterokinase site and 
then the full length GLUT1 protein.
The baculovirus transfer vector pBBH:C-Term was generated by Cope (1994). 
The C-terminal portion of the glucose transporter was subcloned from the plasmid 
pVL941 :GT52, into the plasmid pBBH. The baculovirus transfer vector, pBBH:C-Term, 
expresses a leader sequence encoding 6 histidine residues, an enterokinase site and then 
the C-terminal portion of the GLUT1 protein. Baculovirus E4.2 expresses the full-length 
GLUT1 protein. Bacuiovirus R12 expresses the C-terminal portion of the GLUT1 
protein.
Section 4.2 
Construction of Plasmid pLE12 
PUC19 :GLUT1
p\JC\9:GLUTl, the starting material for all constructs developed can be clearly 






contains the GLUT1 
cDNA within two 
EcoRl sites. Base pairs 
0-123 represent the 5’
Epicurian Coli® SURE® competent cells (Supplied by Stratagene) were 
transformed with pUC19.GLUTI DNA and a large scale plasmid preparation was made 
using a Qiagen® maxi kit DNA binding column. As a diagnostic check, plasmid DNA 
was cut using Ncol and run on an agarose gel, with uncut DNA as a comparison. This 
confirmed the presence of two correctly sized bands, 3.653 kbp and 1.520 kbp. It was
EcoB
GLUTl
11 Ncol EcoKl 





I 123 1477 2487 pUC19
mHI BamUl
non-coding region and base pairs 1477-2487 represent the 3’ non-coding region.
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concluded that the pUC19:GZ,£/77 DNA was correct and of high quality and purity. A 
picture of the gel is displayed in figure 4.3.
Figure 4.3, Digestion of pUC19:(7L{/77 with 
Ncol to check for the presence of GLUT1 insert. 
A 0.8% agarose gel was loaded as follows: Lane M: 
1 kbp marker (supplied by GibcoBRL); lane 1: 3 pi 
pUC19:GLC77 cut with Ncol; lane 2: 1 pi 
p\JCl9:GLUTl; lane 3: 3 pi pLElO cut with Ncol; 
lane 4: 1 plpLElO.
Section 4.3 
Construction of pLElO from pAC360
The plasmid pAC360 (supplied by Invitrogen) was the starting point for producing 
pLElO. pAC360 is a fusion vector and codes for a small portion of the baculovirus 
polyhedrin coat protein, expressed at the N-terminal end of the cloned protein. The 
cloning site of pAC360 has only one restriction site, BamUl, displayed in figure 4.4. To 
take advantage of the two Ncol sites in the GLUT I cDNA (one of which cuts across the 
initiating ATG codon), the BamHI site of pAC360 was converted to an Ncol site by 
inserting a small linker oligonucleotide. The linker was designed to allow the GLUT I 
cDNA to be expressed in frame. The linker encoded BamUl ‘sticky’ ends. On insertion 
the original BamUl site was destroyed, leaving the Ncol site as the only constituent of 
the cloning site. The plasmid produced was then termed pLElO.
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The oligonucleotides (supplied by Seven Biotech) used to modify pAC360 were 
as follows:
Destroys BamHI site on insertion 
BamHI sticky end >1 Ncol Site ■I' BamHI sticky end 
GAT CAT GCC ATG GA
TA CGG TAC CT CTAG
The oligonucleotides were unphosphorylated to limit the formation of 
concatamers. BamHI linearised pAC360 and linker were ligated at room temperature for 
2 h. The ligated product was used to transform calcium chloride competent Top 10 
Escherichia coli (E. coli) cells. Following transformation 12 colonies were selected, 
amplified and the plasmid DNA extracted. DNA samples were cut separately with 
BamHI / Ncol and compared. Plasmids cut by Ncol were found to contain the mutagenic 
linker. Plasmids cut by BamHI do not contain the mutagenic linker. Only one out of 12 
colonies, clone 3, appeared not to have taken up the linker, figure 4.5.
DNA Cut with BamHI
DNA Cut with Ncol
Figure 4.5, Construction of pLElO from pAC360, demonstrating the absence of the BamHI 
restriction site. A 0.8% agarose gel was loaded as follows: Lane 1: pAC360; lane 2: clone 1; lane 3: 
clone 2; lane 4: clone 3; lane5: clone 4; lane 6: clone 5; lane 7: clone 6; lane 8: clone 7; lane 9: clone8; 
lane 10: clone 9; lane 11: clone 10; lane 12: clone 11; lane 13: clone 12; M: 1 kbp marker.
Because it was possible for the oligonucleotide to insert bi-directionally (ie. in 
reverse), 3 plasmids containing the linker, clone 10, clone 11 and clone 12, were 
sequenced. DNA sequencing confirmed that clone 12 contained the correct linker 
sequence.
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DNA sequencing also demonstrated the presence of aberrant linkers. The integrity 
of the oligonucleotide linkers was checked by end-labelling as described in the materials 
and methods section. End-labelling demonstrated the presence of more than one product 
(three major, and at least two minor products) indicating that the oligonucleotides were 
a mixture of products.
Section 4.4
Construction of pL E ll from pLElO
pLEl 1 is pLElO containing the GLUT1 cDNA, this is displayed in figure 4.6.
Figure 4.6, Plasmid map of 
p L E ll. This vector contains 
the GLUT1 cDNA in frame, in 
the correct orientation. The 
Ncol sites are found at either 
end of the GLUT1 cDNA, and 
a unique BamHI site exists in 
the first quarter of the cDNA.
Ncol cut pUCl9:GLUTl was extracted from a low melting point agarose gel. 
Ncol cut pLElO DNA was treated with calf intestinal alkaline phosphatase (CIP), to 
dephosphorylate the vector and prevent re-circularisation without insert.
pLElO was ligated with GLUT I insert, at room temperature for 4 h. Following 
ligation, the resulting DNA mixture was transformed into Stratagene Epicurian Coli® 
SURE® competent cells. This resulted in several hundred colonies from which 12 
colonies were selected, amplified and the plasmid extracted. The correctly inserted 
oligonucleotide was screened for by double digestion of the plasmid DNA with BamYll 
and EcoRI. Following the identification of the correctly inserted cDNA, DNA 
sequencing was performed to confirm the integrity of the insert, the sequence is 
displayed in figure 4.7. The GLUT1 cDNA was found to be inserted correctly.
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ATG, Fusion protein 
start codon




GAT CAT GCC ATG GA
Figure 4.7, Sequencing of pLE ll, clone 10.
Sequencing reactions were performed according to 
section 2.26 in Materials and Methods. Bacterial 
clone 10 was shown by sequencing to contain the 
correctly inserted GLUT I cDNA. The full sequence 
is read as follows:
CCTATAAAT (start of fusion protein) ATG CCG 
GAT TAT TCA TAC CGT CCC ACC ATC GGG 
CCG (linker) GAT CAT GCC (GLUT1) ATG GAA 
CCC AGC AGC AAG AAG GTG ACG GGC CGC 
CTC ATG CTG GCC GTG GGA GGA GCA G...
Clone 10 is seen to contain the GLUT1 cDNA in the correct orientation. The 
GLUT1 sequence matches the published sequence exactly. Clone 10 was termed pLEl 1 
and used in the next step, to produce the final vector pLE12.
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Section 4.5 
Construction of pLE12 from pLEll
This was the final stage in the construction of this baculovirus transfer vector 
and entailed the insertion of six codons, coding for histidine, into the unique BamHI site 
present in the GLUT1 cDNA (c.f. fig. 4.6). This was achieved by cutting the vector 
pLEl 1 with BamHI and inserting a small linker encoding the six histidine residues. The 
linker had BamHI sticky ends, destroying the BamHI site on insertion and was 
composed of the following oligonucleotides (Supplied by VHBio):
G ATC ACG CAC CAT CAC CAT CAC CAT CA
TGC GTG GTA GTG GTA GTG GTA GTC TAG
The histidine codons alternated between the two possibilities in the linker. It was 
hoped that this would result in improved expression by not requiring the repetitive use 
of any one type of tRNA molecule.
BamHI cut pLEll was ligated with the annealed oligonucleotides and 
transformed into Stratagene SURE® competent cells. This resulted in several hundred 
colonies, of which only 24 were picked for screening. Mini preparations were digested 
with BamHI. Only 2 out of the 24 clones were linearised during this screening step, 
indicating that 22 of the clones had taken up the linker, therefore destroying the BamHI 
site. The first five clones were manually sequenced confirming that three contained the 
linker inserted correctly, in frame. One contained the linker in reverse and one was a 
mis-sense construct. The sequence of the correct clone is displayed as text below:
GLUT1 »  TTT GGC TAC AAC ACT GGA GTC ATC AAC GCC CCC CAG AAG
GTG ATC GAG GAG TTC TAC AAC CAG ACG TG L in k e r  »  G ATC ACG
CAT CAC CAT CAC CAT CAC CA «  L in k e r  GLUT1 »  G ATC CAC CGC
TAT GGG GAG CGC ATC TTG CCC ACC A . . .
The linker can be seen to have inserted in the correct orientation and is intact. 
The GLUT1 bases sequenced either side of the linker match the published sequence 
exactly, indicating the cDNA to be intact. The bacterial colony producing this construct
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was amplified and the plasmid purified using a Qiagen® maxi kit DNA binding column. 
This clone was termed pLE12 and was used in subsequent experiments.
Section 4.6 
Construction of pBBHiGLUTL pLE14
The plasmid pBBH is a baculovirus transfer vector (supplied by Invitrogen). The 
cloned DNA is expressed as a fusion protein product with a polyhistidine sequence at 
the N-terminal end. This allows for the purification of the recombinant protein on a 
chelating nickel Sepharose column. A schematic diagram of pBBH is displayed in 
figure 4.8.
*==82
ATG (H is)6  EK
BlueBacHi
Figure 4.8, The baculovirus transfer vector 
p Bac Blue His. The transfer vector pBBH comes 
in three forms, allowing for protein expression in 
three different reading frames. GLUT I derived 
from p\JC\9:GLUTJ was inserted into the Ncol 
site of pBBH B to allow the expression of the 
GLUT1 cDNA in frame. The fusion protein 
added on the N-terminal end of the protein is 
displayed at the top of the vector. Following the 
initiating ATG start codon 6 histidine residues 
are expressed, with a short run of amino acids, 
before a recognition site for the enzyme 
enterokinase (Recognition sequence: Asp, Asp, 
Asp, Asp, Lys//). The multiple cloning site falls 
shortly after the enterokinase site. The diagram 
was taken from Invitrogen’s technical advice.
Ncol digested pUC\9:GLUTl was excised from a low melting point agarose gel. 
Ncol digested pBBH B DNA was treated with calf intestinal alkaline phosphatase (CIP) 
to dephosphorylate the vector and prevent re-cirularisation without insert. The GLUT I 
cDNA insert was ligated into the pBBH B transfer vector, at room temperature for 4 h.
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Following ligation, the resulting DNA mixture was transformed into Stratagene 
Epicurian Coli® SURE® competent cells. This resulted in several hundred colonies from 
which 12 colonies were selected, amplified and the plasmid extracted. The insert was 
detected by digestion with the restriction enzyme Ncol. DNA containing the GLUT1 
insert was seen to be cut twice with Ncol.
Clones 13, 14, 15, 18, 20, 23 and 24 were all shown to contain the GLUT1 
cDNA. The orientation of the GLUT1 insert was determined by digesting the clones
with BamHI. All clones which had been shown to 
contain an insert by digestion with Ncol, but which did 
not show an insert with BamHI (insert is actually too 
small to be seen on these gels) contain the GLUT I 
cDNA in the correct orientation. Clones 15, 23 and 24 
were all shown to contain correctly inserted GLUT I 
cDNA and clone 15 plasmid DNA was taken and the 
sequence confirmed using manual DNA sequencing, 
figure 4.9.
Figure 4.9, Sequencing of putative pLE14, clone 15. Sequencing 
reactions were performed according to section 2.26 in Materials and 
Methods. Sequencing demonstrated clone 15 to be correct. The 
GLUT1 cDNA has been inserted in the correct frame and 
orientation. The sequence read is an exact match to the published 
sequence. The full sequence read is as follows:
Fusion protein with polyhistidine tag » T TCT CAT CAT CAT CAT CAT CAT
GGT ATG GCT AGC ATG ACT GGT GGA CAG CAA ATG GGT CGG GAT CTG TAC GAC
GAT GAC GAT AAG GAT CCG AGC TCG AGA TCT GCA GCT GGT ACC GLUT1 » ATG
GAA CCC AGC AGC AAG AAG GTG ACG GGC CGC CTC ATG C
Clone 15 has been confirmed to contain the correct insert, in the correct 
orientation and reading frame. Clone 15 was termed pLE14.
G A T C
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Section 4.7 
Discussion
In summary, both constructs generated were sequenced and were determined to 
contain inserts in the correct frame and orientation. Furthermore, the inserts were 
determined to be faithful to the published sequence. These constructs were used in 
subsequent work. As additional information, extracts of published DNA sequences are 
contained in the appendix of this thesis.
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5.0 Expression of Proteins Encoded by Recombinant Baculovirus 
Transfer Vectors 
Section 5.1 Introduction
The p Bac Blue His (pBBH) range of baculovirus transfer vectors allowed for 
the co-expression of the p-galactosidase gene with the cloned gene of interest (as 
separate gene products). The enzyme P-galactosidase acts on the colourless artificial 
substrate X-gal (5 -bromo-4-chloro-3-indoy 1- p-D-galactoside) to produce an insoluble 
blue precipitate. This made it possible to select for recombinant viral particles by 
incubation with the chromogenic substrate X-gal. Recombinant viral plaques, expressing 
P-galactosidase, produce a blue coloration surrounding the viral plaque. Whereas wild- 
type virus, which has not recombined with the transfer vector, does not contain the 
p-galactosidase gene and is therefore unable to convert X-gal into the coloured product. 
Furthermore, infection with wild-type virus produces polyhedra which can be clearly 
seen under the microscope within the infected cell. Both the absence of polyhedra and 
the presence of a blue coloration leads to the rapid identification of putative recombinant 
viral plaques.
However, baculovirus transfer vectors based on the plasmids pVL1392, pVL941 
and pAC360 express only the proteins engineered into the cloning site. Putative 
recombinant viral plaques must be screened by microscopic observation in order to 
determine that plaques are polyhedrin negative.
Section 5.2 
Co-Transfection and Protein Expression of Recombinant Baculovirus 
Transfer Vectors pLE14 (HIS-GLUT1) and pBBH:GT52 (fflS-C- 
TERM) with AcMNPV in Sf9 Cells
The baculovirus transfer vectors pLE14 and pBBH:GT52 coded for the HIS- 
GLUT1 and HIS-C-TERM proteins, respectively. Both vectors were taken separately 
and mixed with linear AcMNPV DNA (wild-type baculovirus expressing the polyhedrin 
protein). Vector and AcMNPV DNA were co-transfected as described in the materials
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and methods section 2.27. Recombinant plaques were observed to be polyhedrin 
negative and to turn blue on the addition of the chromogenic substrate X-gal. 
Recombinant plaques were screened for expression of HIS-GLUT1 and HIS-C-TERM 
by immunoblotting (figure 5.1).
1 2 3 4 5 M
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Figure 5.1, Recombinant protein expression assessed by immunoblot assay. A 10% polyacrylamide 
gel was loaded as follows: Lane 1: 30 pg of Sf9 cells expressing HIS-GLUT1 (clone A); lane 2: 30 pg of 
Sf9 cells expressing HIS-GLUT1 (clone B); lane 3: 40 pg of Sf9 cells expressing HIS-GLUT1 (clone B); 
lane 4: 30 pg of Sf9 cells expressing HIS-GLUT1 (clone C); lane 5: 40 pg of Sf9 cells expressing HIS- 
GLUT1 (clone C); lane M: High molecular weight marker; lane 6: 30 pg of Sf9 cells expressing HIS- 
GLUT1 (clone D); lane 7: 60 pg of Sf9 cells expressing HIS-GLUT1 (clone D); lane 8: 30 pg of Sf9 cells 
expressing HIS-C-TERM (clone E); lane 9: 40 pg of Sf9 cells expressing HIS-C-TERM (clone E); lane 
10: 30 pg of Sf9 cells expressing HIS-C-TERM (clone F); lane 11: 30 pg of Sf9 cells expressing HIS-C- 
TERM (clone F); lane M: High molecular weight marker.
Optical densitometry analysis demonstrated that clones C and E, expressing the 
HIS-GLUT1 and HIS-C-TERM proteins respectively, expressed the most recombinant 
protein. Viral inoculum from clones C and E were taken for further plaque purification
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and experimental analysis. Viral stocks were made by spinner culture. Typical viral 
titres obtained are displayed in table 5.1, section 5.5.
Section 5.3 
Recombinant Protein Expression in Sf9 Cells
Recombinant viruses E4.2 and R12 were described by Cope et al, (1994) and 
express the GLUT1 and C-TERM protein products, respectively. Large viral stocks 
were made from the smaller stocks provided. Viral titres were calculated by plaque
assay.
Plaque purified recombinant virus was used to infect Sf9 cells. The cells were 
then analysed by immunoblot assay, figures 5.2 and 5.3.
Figure 5.2, Expression of recombinant 
proteins GLUT1 and HIS-GLUT1. A
10% polyacrylamide gel was loaded as 
follows: Lane 1: 40 pg of Sf9 cells 
expressing HIS-GLUT1 (clone 8); lane 2:
30 pg of Sf9 cells expressing HIS-GLUT1 
(clone 8); lane 3: 30 pg of Sf9 cells 
expressing GLUT1 (clone 31); lane 4:
30 pg of Sf9 cells expressing HIS-GLUT1 
(clone 32); lane 5: 30 pg of Sf9 cells 
expressing GLUT1 (clone 34); lane 6: 30 pg of Sf9 cells expressing GLUT1 (clone 35); lane 7: 100 ng 
human GLUT1; lane 8: 200 ng human GLUT1; lane 9: 400 ng human GLUT1; lane 10: 500 ng human 
GLUT1. Human GLUT1 standard is marked with the letter G.
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Figure 5.3, Expression of recombinant proteins 
C-TERM and HIS-C-TERM. A 10%
polyacrylamide gel was loaded as follows: Lane 1: 
30 pg of Sf9 cells expressing HIS-GLUT1; lane 2: 
30 pg of Sf9 cells expressing HIS-C-TERM; lane 
3: 30 pg of Sf9 cells expressing C-TERM; lane 4: 
15 pg of Sf9 cells expressing C-TERM. NB. 
Image has been background corrected to allow 
visualisation of all bands.
Figures 5.2 and 5.3 demonstrated that all of the plaque purified recombinant 
proteins are expressed in Sf9 cells. The difference in apparent molecular weight between 
the histidine tagged and non-histidine tagged proteins (the histidine tagged proteins run 
more slowly through the gel) is thought to be attributable to the presence of the 
polyhistidine tag, the enterokinase recognition sequence and the linker amino acids in 
the modified protein.
Section 5.4 
Co-Transfection of Transfer Vector pLE12 (G-HIS-LUT1) with 
AcMNPV and Bac-N-Blue DNA in Sf9 Cells
Co-transfection of pLE12 into Sf9 cells was attempted using linearised 
AcMNPV DNA. As a control, co-transfection was performed using the already 
successful transfer vector pLE14. Sf9 cells were co-transfected according to the 
materials and methods, section 2.27. Plaque assays performed on the putative viral 
inoculum did not reveal the presence of any recombinant viral plaques. However, since 
there were very few polyhedrin positive plaques present, it was conceivable that there 
was a problem with either the linear AcMNPV DNA or the Lipofectamine, or both. For 
this reason co-transfection was attempted using fresh triple cut Bac-N-Blue™ viral 
DNA (supplied by Invitrogen) which also had the advantage of reducing the number of 
non-recombinant viral plaques produced (non-recombinant viral plaques were reported 
by Invitrogen to be less than 10%). A 72 h incubation period exposure of the control
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cells, co-transfected with pLE14, to the chromogenic substrate X-gal resulted in the 
conversion of X-gal from a colourless solution into a blue solution. This result was 
consistent with the recombination of the control vector with viral DNA, producing a 
recombinant virus expressing p-galactosidase. This indicated that co-transfection had 
been successful in the control. However, when pLE12 polyhedrin negative recombinant 
plaques were screened for none could be identified (pLE12 could not be screened for 
using X-gal as the vector does not co-express p-galactosidase).
It is possible that the protein encoded by the vector pLE12 is toxic to the insect 
cells and caused cell death before protein expression. Alternatively there may have been 




Viral stock titres are displayed below in table 5.1. Stock viruses were used to 
infect cells at a low multiplicity of infection (moi), approximately 0.1 plaque forming 
units per cell (Chen et al, (1997)). Protein expression levels are discussed in chapters 6 
and 7.
Recombinant virus j Expression vector Recombinant
protein
Titre (pfu/ml) 
(Passage Number, S: 
suspension culture derived)
: ! 1
LE12 pLE12 G-HIS-LUT1 -
LE14 pLE14 HIS-GLUT1 1.2x10* (P6, S)
BBH\GT52 pBBH:Gr52 HIS-C-TERM i.ixici* (P6, s)
E4.2 pVL1392:GL£/77 GLUT1 1.7x10'’ (P5, S)
R12 PVL941 \GT52 C-TERM 1.36x16* (P5, S)
Table 5.1, Displaying viral origin and titre. pLE12 could not be co-transfected and so does not have a 
titre. Baculovirus vectors pLE14 and pBBH:GT52 were co-transfected as described (section 5.2) and their 
titres are displayed. Viruses E4.2 and R12 were produced from small lab stocks.
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Section 5.6 
Time Course of Expression - Immunoblot Analysis
In order to determine the optimal time period for expression of recombinant 
protein, a time course of expression was carried out. Samples were taken from a spinner 
culture at 0, 24, 48, 72, 96 and 168 h for analysis by immunoblot assay. Time courses 
were run using both Sf9 cells and Highfive cells. The resulting immunoblots are 
displayed in figures 5.4 and 5.5.





0 24 48 72 96 168 hours
Figure 5.4, Time course of HIS-GLUT1 expression using Sf9 ceils. Sf9 cell samples were taken at the 
appropriate time points (ie. 0, 24, 48, 72, 96 and 168 h) and run on a 10% polyacrylamide gel as follows: 
Lane 1: 100 ng human GLUT1 standard; lane 2: 75 ng human GLUT1 standard; lane 3: 50 ng human 
GLUT1 standard; lane 4: 25 ng human GLUT1 standard; lane 5: 10 ng human GLUT1 standard; lane 6: 0 
h post infection, HIS-GLUT1; lane 7: 24 h post infection, HIS-GLUT1; lane 8: 48 h post infection, HIS- 
GLUT1; lane 9: 72 h post infection, HIS-GLUT1; lane 10: 96 h post infection, HIS-GLUT1; lane 11: 168 
h post infection, HIS-GLUT1.
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Figure 5.5, Time course of HIS-GLUT1 expression using Highfive cells. Highfive cell samples were 
taken at the appropriate time points (ie. 0, 24, 48, 72, 96 and 168 h) and run on a 10% polyacrylamide gel 
as follows: Lane 1: 100 ng human GLUT1 standard; lane 2: 75 ng human GLUT1 standard; lane 3: 50 ng 
human GLUT1 standard; lane 4: 25 ng human GLUT1 standard; lane 5: 10 ng human GLUT1 standard; 
lane 6: 0 h post infection, HIS-GLUT1; lane 7: 24 h post infection, HIS-GLUT1; lane 8: 48 h post 
infection, HIS-GLUT1; lane 9: 72 h post infection, HIS-GLUT1; lane 10: 96 h post infection, HIS- 
GLUT1; lane 11: 168 h post infection, HIS-GLUT1.
The immunoblots have been analysed by densitometric analysis using a BioRad 
scanner with molecular analyst software. These results can be plotted graphically and 
are displayed in figure 5.6
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Time Course of H1S-GLUT1 
Expression in Sf9 Cells
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Figure 5.6, Graphical interpretation 
of HIS-GLUT1 time course in both 
Sf9 and Highfive cells. The optical 
density data were taken and plotted 
against hours post infection. The 
graphs clearly show maximum 
expression to be at 72 h post infection.
Immunoblot analysis demonstrated that maximum protein expression occurred at 
72 h (3 days) post infection. Cells expressing recombinant protein were therefore always 
harvested at 72 h post infection. Following 72 h post infection the levels of recombinant 
proteins went into a decline phase. This may be due to cell lysis followed by the 
subsequent release of proteases into the growth medium.
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Section 5.7 
Time Course of Expression - Microscopic Analysis
The progress of cell infection was also monitored microscopically. This gave an 
indication of the progression of viral infection and allowed for the observation of any 
wild-type baculovirus contamination. As a comparison a photograph of Sf9 cells, 
infected with wild-type baculovirus is displayed below, figure 5.7.
Figure 5.7, Sf9 cells infected with wild-type baculovirus. Cells were infected with wild-type 
baculovirus for 96 h and then observed under a light microscope. Occlusion bodies (polyhedrin) are 
clearly visible as small spherical objects seen within the cells, denoted by the letter P.
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Figure 5.8, Uninfected control cells. Uninfected Sf9 cells have a smooth surface and form spherical 
shapes during cell growth, cell C is an example of this. During cell division they become elongated and 
rod shaped, illustrated by cell R. The lower right hand comer of the picture shows a dead cell, cell D. 
Dead cells have an uneven, crenellated surface due to the breakdown of the plasma membrane.
Uninfected cells have the above healthy appearance, demonstrated by the cells 
marked C and R. Before infection with recombinant virus and during passaging, cells 
were checked to ensure they were viable and uninfected with recombinant or wild-type 
virus. The following figures 5.9a-d and 5.10a-d display a time course of infection in Sf9 
cells using two recombinant viruses, expressing HIS-GLUT1 and HIS-C-TERM 
respectively. Examples of infected cells are denoted by the letter I and healthy cells by 
the letter C. All of the cells infected with recombinant virus are observed to be 
uninfected with wild-type virus.
Page 105
Chapter 5 Recombinant Protein Expression
 i____
Figure 5.9a, Sf9 cells expressing HIS-GLUT1 24 hours post infection. The letter C illustrates a healthy 
cell.
Figure 5.9b, Sf9 cells expressing HIS-GLUT1 48 hours post infection. The letter I illustrates an 
infected cell.
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Figure 5.9c, Sf9 cells expressing HIS-GLUT1 72 hours post infection.
Figure 5.10d, Sf9 cells expressing HIS-GLUT1 96 hours post infection
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Figure 5.11a, Sf9 cells expressing HIS-C-TERM 24 hours post infection. The letter C illustrates a 
healthy cell.
■■■
Figure 5.11b, Sf9 cells expressing HIS-C-TERM 48 hours post infection. The letter I illustrates an 
infected cell.
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Figure 5.11c, Sf9 cells expressing HIS-C-TERM 72 hours post infection.
Figure 5.1 Id, Sf9 cells expressing HIS-C-TERM 96 hours post infection
Page 109
Chapter 5 Recombinant Protein Expression
The above time course shows that the cells began to look infected at 48 h post 
infection and are completely lysed at 72 h post infection. Infected cells have an uneven 
surface and become crenellated. Infected cells finally undergo cell lysis, this results in 
the breaking of the plasma membrane. The cell contents empty into the medium and cell 
proteases are released along with other biomolecules. The time course demonstrated the 
recombinant virus to be pure, having no wild-type baculovirus contamination.
Section 5.8 
Discussion
Immunoblotting was consistent with the recombinant viruses producing the 
required recombinant protein. Immunoblot time course analysis revealed that maximum 
recombinant protein expression was at 72 h post infection, following which there was a 
decline in the levels of recombinant protein. Microscopic analysis of infection revealed 
that the cells began to look infected by 48 h post infection and are almost all dead by 72 
h post infection. Microscopic analysis also revealed that the recombinant virus is pure 
and free of any wild-type baculovirus contamination. Time course analysis has 
determined the optimum time for recombinant protein recovery to be 72 h (3 days) post 
infection.
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6.0 Confocal Microscopy 
Section 6.1 Introduction
Confocal scanning light microscopy was used to analyse the expression of the 
four recombinant proteins: GLUT1, HIS-GLUT1, HIS-C-TERM and C-TERM, using a 
BioRad confocai imaging system (MRC500). Constructs were detected with affinity 
purified GLUT1 antibody which was in turn detected using a fluorescein isothiocyanate 
(FITC) conjugated antibody. Phase-contrast and immunofluorescent images were 
analysed in order to determine where the expressed proteins were targeted.
Section 6.2 GLUT1
Sf9 cells were infected for 24 and 36 h, following infection the cells were 
combined. Using the confocal microscope cells were selected for study at a point before 
cell lysis had occurred. Confocal microscopy images of GLUT1 are displayed in figure 
6.2. Uninfected control cells are displayed below (figure 6.1). The control does not show 
any cross reaction between the GLUT1 / immunofluorescent antibody complexes and 
native Sf9 cell proteins.
A B
Figure 6.1, Uninfected Sf9 cell control. Panel A displays the phase-contrast image, showing an 
uninfected cell and panel B displays the corresponding immunofluorescent image.
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Figure 6.2, Phase-contrast and 
immunofluorescent images of Sf9 
cells expressing GLUT1.. Panel A: 
phase-contrast image (the plasma 
membrane is indicated by the letter 
P and the nuclear membrane by the 
letter N); panel B: cell cross section 
immunofluorescent image (cell 1 
appears to be intact and expresses 
GLUT1 in the plasma membrane); 
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The confocal scanning light microscope images displayed a clear ring of 
fluorescence around the cell with a punctate surface distribution. This indicated that the 
GLUT1 protein was targeted to and inserted in the plasma membrane of the cell.
Confocal microscopy of the full length GLUT1 construct has demonstrated that 
there was good expression and correct targeting of the protein to the plasma membrane 
of the cell. This also inferred that Sf9 cells allowed for the correct folding of the glucose 
transporter.
Section 6.3 HIS-GLUT1
Sf9 cells were infected with the recombinant virus encoding the protein HIS- 
GLUT1 and the results of confocal scanning microscopy are shown in figures 6.3.
Confocal scanning light microscopy revealed a ring of fluorescence around the 
cell, thus demonstrating that the HIS-GLUT1 construct was also targeted to the plasma 
membrane. Distribution at the cell surface and internal structures was identical to that of 
the GLUT1 protein, cell surface distribution was punctate. This suggested that the HIS- 
GLUT1 protein was transported and targeted in an identical fashion to the GLUT1 
protein. This indicated that the addition of a polyhistidine tag (histidine residues, 
enterokinase site and 'spacer’ amino acids) does not affected the folding, targeting and 
insertion characteristics of the glucose transporter protein.
Page 113
Chapter 6 Confocal Microscopy
Figure 6.3, Phase-contrast and 
immunofluorescent images of Sf9 cells 
expressing HIS-GLUT1. Panel A: phase-contrast 
image (the nucleus is indicated in cell 1 by the 
letter N, the letter P denotes the plasma 
membrane); Panel B: cell cross section
immunofluorescent image (cell 1 appears intact 
and expresses HIS-GLUT1 in the plasma 
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Section 6.4 C-TERM
Sf9 cells were infected with the recombinant virus encoding the C-TERM 
protein. The cells were examined using immunofluorescent confocal microscopy. The 
phase-contrast and immunofluorescent images are displayed in figures 6.4.
’
Figure 6.4, Phase-contrast and 
immunofluorescent images of Sf9 cells 
expressing C-TERM. Panel A: phase contrast 
image (the letter N denotes the nuclear membrane 
and the letter P the plasma membrane); Panel B: 
cell cross section immunofluorescent image (only 
cell 1 is expressing C-TERM protein); Panel C:
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Targeting of the C-TERM protein was markedly altered in comparison to 
targeting of the full length glucose transporter; C-TERM protein appeared to be 
aberrantly targeted within the Sf9 cell. However, a significant proportion of the 
C-TERM protein was correctly targeted to the plasma membrane. The C-TERM protein 
had a punctate surface distribution.
Section 6.5 HIS-C-TERM
Sf9 cells were infected with virus coding for the HIS-C-TERM protein. The cells 
were examined using immunofluorescent confocal microscopy. Phase-contrast and 
immunofluorescent images of cells expressing the HIS-C-TERM protein are displayed 
in figures 6.5
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Figure 6.5, Phase-contrast and 
immunofluorescent images of Sf9 
cells expressing HIS-C-TERM. Panel 
A: phase contrast image (the letter N 
denotes the nuclear membrane and the 
letter P denotes the plasma 
membrane); Panel B: cell cross section 
immunofluorescent image; Panel C: 
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Despite the addition of a polyhistidine tag and spacer sequence (containing an 
enterokinase site and several amino acids from the baculovirus polyhedrin protein), the 
HIS-C-TERM protein appears to have been targeted in a similar fashion to the C-TERM 
protein, having a punctate surface distribution. A significant amount of C-terminal 
construct was expressed in the plasma membrane and was therefore correctly targeted to 
this location. A proportion of the protein was observed to be localised around the 
nucleus. It was proposed that this represented protein which had not been exported from 
the endoplasmic reticulum, a structure which is continuous with the nuclear membrane. 
The rest of the protein appeared to be contained within cytoplasmic membranes and was 
distributed throughout the cytoplasm.
Section 6.6 Discussion
Confocal scanning light microscopy demonstrated that all of the recombinant 
protein constructs were expressed in the Sf9 cell system. However, not all of the 
constructs were targeted in the same manner. All constructs demonstrated a similar 
plasma membrane surface distribution, described as punctate. In all constructs the 
modification of the N-terminal sequence, by the addition of the polyhistidine tag, had 
very little effect on the targeting of the recombinant protein.
GLUT1 sequestered in internal structures may be a result of overexpression of 
the recombinant protein. Overexpression may result in the transport machinery 
becoming saturated and incapable of handling the protein correctly. This may result in 
the sequestering of the protein in internal, membranous structures, near to the cell 
surface.
C-TERM protein was observed to be localised within cytoplasmic membranes 
and a band of strong fluorescence also surrounds the nucleus. The strong band of 
fluorescence surrounding the nucleus may represent protein that has not been 
transported out of the endoplasmic reticulm. This may be due to incorrect folding of the 
protein. It is possible that while correctly folded protein is translocated to the cell 
surface, C-TERM protein which folds more slowly may be retained within the internal 
structures of the cell.
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7.0 Expression Systems and the Quantitation of Expressed 
Recombinant Protein 
Section 7.1 Introduction
Recombinant protein expression was assessed by two techniques, 
immunoblotting and a cytochalasin B binding assay. Immunoblotting indicates the 
quantity of expressed protein present, whereas, the cytochalasin B assay assesses how 
much of this protein is functional. This chapter looks at expression based on 
immunoblot analysis. Furthermore, two different types of insect cells were compared for 
use in recombinant protein expression.
Section 7.2 
Expression of HIS-GLUT1 and GLUT1 in Sf9 Cells
Recombinant protein expression was assessed by quantitative immunoblot 
analysis. Expressed proteins were compared with human GLUT1 standards of known 
protein concentration. Purified human GLUT1 standard was obtained from human 
erythrocytes, using the method described by Baldwin and Leinhard, (1989). This method 
is known to give pure GLUT1 protein (as assessed by PAGE followed by silver 
staining) and measurement of the protein content by protein assay reports the 
concentration of reconstituted human GLUT1. Figure 7.1 compares the HIS-GLUT1 
and GLUT1 protein constructs with the purified human GLUT1 standard.
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Figure 7.1, Expression of recombinant virus expressing E4.2 and HIS-GLUT1. A 10%
polyacrylamide gel was loaded as follows: Lane 1: 40 pg clone 8, HIS-GLUT1; lane 2: 30 pg clone 8, 
HIS-GLUT1; lane 3: 30 pg clone 35, GLUT1; lane 4: 100 ng human GLUT1; lane 5: 200 ng human 
GLUT1; lane 6: 400 ng human GLUT1; lane 7: 500 ng human GLUT1.
The immunoblot was densitometrically analysed and the HIS-GLUT1 and 
GLUT1 proteins were compared to the human GLUT1 standard. The amount of 
recombinant protein present could then be calculated, the results of this calculation are 
displayed in table 7.1. The same procedure was followed for the HIS-C-TERM and 
C-TERM proteins, the immunoblots are displayed in figures 7.2 and 7.3.
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Figure 7.2, Expression of recombinant virus expressing HIS-C-TERM. A 12% polyacrylamide gel 
was loaded as follows: Lane 1: 40 pg, HIS-C-TERM; lane 2: 30 pg, HIS-C-TERM; lane 3: 10 pg, HIS-C- 
TERM; lane 4: 20 pg, HIS-C-TERM; lane 5: 100 ng human GLUT1; lane 6: 200 ng human GLUT1; lane 
7: 400 ng human GLUT1; lane 8: 500 ng human GLUT1.
Figure 7.3, Expression of recombinant 
virus expressing, HIS-GLUT1, HIS-C- 
TERM and C-TERM. A 12%
polyacrylamide gel was loaded as follows: 
Lane 1: 30 pg, HIS-GLUT1; lane 2: 30 pg, 
HIS-C-TERM; lane 3: 30 pg, C-TERM.
The C-TERM protein, displayed in figure 7.3, was compared with the already 
characterised HIS-GLUT1 and HIS-C-TERM proteins. Table 7.1 summarises the mean 
expression level of expressed recombinant proteins.
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Recombinant protein pg of recombinant protein 
/ mg of Sf9 cell protein
pmoles of recombinant protein / 1 
mg of Sf9 cell protein
HIS-GLUT1 ______ 24 ng / mg_______ 527 pmoles / mg (n=2)
GLUT1 ______ 32 ng / mg______ 700 pmoles / mg (n=l)
HIS-C-TERM _______12 ng / mg______ h 272 pmoles / mg (n=4)
C-TERM _______ 13 ng / mg______ 296pmoles / mg (n=l)
Table 7.1, Average recombinant protein expression. Summary of average expression figures for 
recombinant proteins.
The GLUT1 construct was observed to have the highest level of expression at 
700 pmoles of GLUT1 / mg of Sf9 cell protein. In comparison the HIS-GLUT1 
construct expressed lower levels of protein at 527 pmoles of HIS-GLUT1 / mg of Sf9 
cell protein. C-terminal expression was approximately half that of HIS-GLUT1 
expression, at 272 pmoles of HIS-C-TERM / mg of Sf9 cell protein and 296 pmoles of 
C-TERM / mg of Sf9 cell protein. However, as the quantity of oligomers was not taken 
into account during scanning, the apparently lower level of C-terminal construct 
expression was probably due to the formation of oligomers. This would result in the 
distribution of the protein to more than one region of the polyacrylamide gel.
A small variation in the level of protein expression was observed between the 
HIS-GLUT1 and GLUT1 proteins. However, because the number of repeat experiments 
were small it was not possible to determine if there were any significant difference in 
the level of expression. There was very little difference observed between the level of 
protein expression for both the HIS-C-TERM and the C-TERM proteins.
Section 7.3 
Comparison of Expression Between Highfive and Sf9 Cells
Two different types of insect cells were tested for the expression of recombinant 
protein, Spodoptera frugiperda ovarian cells (Sf9 cells) and Trichoplusia ni cells 
(Highfive cells). The following immunoblot (figure 7.4) demonstrates the increase in 
expression attained when using Highfive cells instead of Sf9 cells.
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kDa 1 2
m m Figure 7.4, Sf9 and Highfive cells
■ H expressing the protein HIS-GLUT1. A.f t 4
10% polyacrylamide gel was loaded as
97 ----- follows: Lane 1: 15 pg of Sf9 cells
66 ----- expressing HIS-GLUT1; lane 2: 15 pg of
m M
Highfive cells expressing HIS-GLUT1.
45 -----
MeanOD 0.574 1.107
Analysis of the immunoblot demonstrated a 1.9 fold increase in expression in 
Highfive cells when compared with Sf9 cells.
Section 7.4 
Discussion
The amount of protein expressed in insect cells has been determined by 
immunoblot analysis. However, there are several problems in using this method of 
protein determination. For example, comparing a heavily glycosylated protein with a 
moderately glycosylated protein; measuring accurately the optical densities on a film; 
controlling the amount of protein in varying forms of aggregation; determining the 
purity and protein concentration of the standard. Even with these difficulties this method 
has resulted in protein determinations which are comparable with literature values (Yi et 
al, (1992) and Cope etal., (1994)).
The use of Highfive cells demonstrated a significant increase in the level of 
recombinant protein expressed. However, Highfive cells grow at a much slower rate 
than Sf9 cells, therefore increasing the time required to culture the cells before viral 
infection.
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8.0 Cytochalasin B Studies on Expressed Recombinant Protein 
Section 8.1 Introduction
Cytochalasin B is a fungal toxin with a high affinity to the internal binding site 
of the GLUT1 protein. Cytochalasin B assays were carried out to determine the quantity 
of functional recombinant glucose transporter expressed in Sf9 cells. The cytochalasin B 
assay was originally developed by Lin et al, (1974). However, Baldwin et a l , (1982) 
and Yi et al., (1992) have since used the method of cytochalasin B equilibrium dialysis 
to successfully determine the glucose transporter content of human erythrocytes and 
insect cells, respectively. The method used in this thesis was modified from that of Jung 
and Rampal, (1977). Separation of the bound cytochalasin B and the free cytochalasin B 
was achieved by centrifugation.
Yi et al, (1992) have determined that cytochalasin B has no affinity towards the 
native insect cell glucose transporter. However, cytochalasin B is lipophilic in nature 
and therefore has an affinity towards the cell membrane lipid. Non-specific binding 
towards the cell membrane generated a background which could be corrected for by 
assaying uninfected Sf9 cells. Cytochalasin E was used to block any non-specific 
binding sites present. Binding is assumed to be stochiometric, ie. one cytochalasin B 
molecule binds to one glucose transporter molecule.
The cytochalasin B assay was tested by assaying purified human erythrocyte 
GLUT1. Once the literature values had been obtained for human GLUT1, the assay was 
used to determine the amount of recombinant glucose transporter expressed in insect 
cells. Assaying human GLUT1 also served to confirm the integrity of the purified 
human GLUT1 protein. The human GLUT1 protein was then used as a control against 
unknown GLUT1 concentrations during quantitative immunoblot analysis.
Cytochalasin B assays have been used throughout this thesis to determine the 
amount of functional GLUT1 and HIS-GLUT1 protein present. Cytochalasin B assays 
were also used during the purification of the HIS-GLUT1 protein, in an attempt to 
determine protein stability and the increase in protein activity on purification.
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Section 8.2 
Cytochalasin B Assays - Erythrocytes
Cytochalasin B assays were carried out according to the method described in the 
Materials and Methods section (2.44). Purified human GLUT1 was assayed to determine 
the integrity of the protein and to confirm that the assay was functioning correctly. The 
results are displayed in figures 8.2 and 8.3.
Erythrocyte Ghosts
Bmax = 649 pMoles GLITT1 / mg protein 
Kd = 160 nM
pmoles bound I mg protein
Figure 8.2, Cytochalasin B assay of 
erythrocyte ghosts. Cytochalasin B 
binding was analysed by Scatchard plot, 
95% confidence intervals have been 
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Figure 8.3, Cytochalasin B assay of 
stripped erythrocyte membranes.
Cytochalasin B binding was analysed 
by Scatchard plot, 95% confidence 
intervals have been displayed as an 
indication of error.
Cytochalasin B assays have determined that a suspension of erythrocyte ghosts 
(prepared according to Baldwin and Lienhard, (1989)) contained 649 pmoles of active 
GLUT1 / mg of protein. Alkali stripped erythrocyte membranes were found to contain 
2782 pmoles of active GLUT1 / mg of protein. The Kd of cytochalasin B binding to 
erythrocyte ghosts and stripped erythrocyte membranes were calculated to be 160 nM 
and 182 nM, respectively. The average molecular weight of human erythrocyte GLUT1 
has been calculated to be 55 kDa. From the average molecular weight it was calculated
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that the amount of GLUT1 in erythrocyte ghosts and stripped membranes was 36 pg of 
GLUT1 / mg protein and 153 pg of GLUT1 / mg protein, respectively. Glucose 
inhibition for erythrocyte ghosts and stripped membranes was 76% and 75%, 
respectively. Glucose inhibition figures demonstrated that the GLUT1 binding site 
recognises the natural ligand with a high affinity.
Figure 8.4, Cytochalasin B assay of 
reconstituted, purified, human GLUT1.
Cytochalasin B binding was analysed by 
Scatchard plot, 95% confidence intervals 
have been displayed as an indication of 
error.
Following the reconstitution of DEAE cellulose purified human GLUT1, 
cytochalasin B analysis reported that there were 3678 pmoles of active GLUT1 / mg of 
protein present, with a calculated Kd of 216 nM. This equated to 202 pg of active 
GLUT1 / mg of protein. Glucose inhibition was determined to be 91.5%. PAGE 
indicated that the reconstituted GLUT1 was more than 95% pure. Purified human 
GLUT1 was used as a standard during quantitative immunoblotting of insect cells. 
Baldwin et al., (1979) have reported Bmax and Kd values as follows: erythrocyte 
ghosts, Bmax 620 pmoles / mg and Kd 100 nM; stripped erythrocyte membranes, Bmax 
2200 pmoles / mg and Kd 140 nM; reconstituted GLUT1, Bmax 6700 pmoles / mg and 
Kd 130 nM. In the presence of 200 mM D-glucose, glucose inhibition was 80%. These 
values were similar to those obtained in this study, therefore it was concluded that the 
erythrocyte GLUT1 was fully functional.
Section 8.3 
Cytochalasin B Assays - Sf9 Expressed Protein
Sf9 cells expressing the HIS-GLUT1 and GLUT1 proteins were assayed for 
cytochalasin B binding. Background cytochalasin B binding was calculated by assaying
Reconstituted GLUT!
3
1 Bmax = 3678 pMotes GLUT1 / mo protein 
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uninfected Sf9 cells. The results of cytochalasin B binding to Sf9 cell membranes 
expressing the HIS-GLUT1 protein, with and without background subtraction, are 
displayed in figure 8.5.
Sf9 HIS-GLUT1, SET 1






HIS-GLUT1 with background 
HIS-GLUT1
background subtracted
■ Bmax = 316pmoles GLUT1 / mg membrane protein
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• Bmax = 266pmoles GLUT1 / mg membrane protein
• Kd = 357nM
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Figure 8.5, Sf9 HIS-GLUT1 Set 1 cytochalasin B binding assay, with and without background 
correction. Cytochalasin B binding was analysed by Scatchard plot, 95% confidence intervals have been 
displayed as an indication of error.
Without background correction, 1 mg of Sf9 cells expressing HIS-GLUT1 
bound 316 pmoles of cytochalasin B with a Kd of 370 nM. Following background 
correction, 1 mg of Sf9 cells expressing HIS-GLUT1 bound 266 pmoles of cytochalasin 
B with a Kd of 357 nM. Glucose inhibition was determined to be 82%. The data showed 
that 1 mg of uninfected Sf9 cell membranes bound 49 pmoles cytochalasin B / mg of 
membrane protein. The following cytochalasin B assays have been corrected for this 
background.
Results showed that following background correction, Sf9 cells expressing HIS- 
GLUT1 bound 266 pmoles of cytochalasin B / mg of membrane protein. The average 
molecular weight of recombinant GLUT1 in the Sf9 cell was calculated to be 46 kDa. It 
was estimated that 12 pg of HIS-GLUT1 were expressed / mg of membrane protein. 
Cytochalasin B binding was repeated using a second batch of cells and termed HIS- 
GLUT1 set 2, figure 8.6.
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Figure 8.6, Sf9 HIS- 
GLUT1 Set 2 
cytochalasin B assay, 
with background 
correction.
Cytochalasin B binding 
was analysed by 
Scatchard plot, 95% 
confidence intervals 
have been displayed as 
an indication of error.
1 mg of set 2 Sf9 cells expressing HIS-GLUT1 bound 381 pmoles of 
cytochalasin B with a Kd of 423 nM. It was estimated that 18 pg of functional HIS- 
GLUT1 were expressed / mg of membrane protein. Glucose inhibition was calculated to 
be 73%. The HIS-GLUT1 set 2 recombinant protein resulted in higher Bmax and Kd 
values in comparison to HIS-GLUT1 set 1. The differences seen in these data is due to 
cell variability. For this reason large batches of cells were prepared, analysed and used 
in several experiments. This allowed for comparison between experiments.
Wild-type GLUT1 protein was expressed in Sf9 cells as a control. The amount 
of cytochalasin B binding sites were assayed in the following experiment, figure 8.7.
Figure 8.7, Sf9 GLUT1 
Cytochalasin B assay, 
with background
correction. Cytochalasin 
B binding was analysed by 
Scatchard plot, 95% 
confidence intervals have 
been displayed as an 
indication of error.
Following background correction 1 mg of Sf9 cells expressing GLUT1 bound 
310 pmoles of cytochalasin B with a Kd of 889 nM. It was estimated that 14 pg of 
functional GLUT1 were expressed / mg of membrane protein. The glucose inhibition 
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Section 8.4 
Discussion
Table 8.1 summarises the results of the cytochalasin B assays. The expression 
levels achieved in Sf9 cells were similar to those achieved by Yi et al, (1992) when 
expressing GLUT1 (0.23 and 0.29 nmoles / mg) and Weinglass and Baldwin, (1996) 
when expressing C-terminally histidine tagged GLUT1 (0.33 nmoles / mg).
Protein Bmax (pmoles / mg) Kd (nM) Glucose inhibition 
(%)
Human erythrocyte ghosts 649 pmoles / mg 160 nM 76%
Stripped erythrocyte 
membranes
2782 pmoles / mg 182 nM 75%
Reconstituted GLUT1 3678 pmoles / mg 216 nM 91.5%
HIS-GLUT1 Set 1 266 pmoles / mg 357 nM 82%
HIS-GLUT1 Set 2 381 pmoles/mg 423 nM 73%
GLUT 1 310 pmoles / mg 889 nM 81%
H B B a B B B ^ a B B a B B a B a B s a B B B B D H H f e a a a B B a a a B a a B a B a a a B d f e ^ a t t S B B H
Figure 8.9, Summary of cytochalasin B assay results.
Glucose inhibition in all forms of the glucose transporter were of similar levels. 
This demonstrated that all forms of the transporter responded in an identical way 
towards the natural substrate, recognising glucose with a high enough affinity to 
displace cytochalasin B. This showed that the specificity of Sf9 GLUT1 and 
HIS-GLUT1 for the natural substrate has not been dramatically altered.
Yi et al, (1992) have reported a high level of inactive protein (80%) when 
GLUT1 was expressed in Sf9 cells. In the present study the levels of inactive Sf9 
expressed GLUT1 and HIS-GLUT1 protein were 55% and 39%, respectively (the total 
amount of GLUT1 construct having been determined by quantitative immunoblotting). 
The lower amount of inactive HIS-GLUT1 protein observed may be an effect of 
expressing a polyhistidine tag on the start of the protein, since no other changes to the 
protein structure have been made. The addition of the tag may enable the HIS-GLUT1 
protein to form a more stable structure. Carlsson et al., (1996) have reported a decrease 
in protein expression when using long polyhistidine tags. A decreased level of 
expression may allow for correct protein folding to occur, without saturation of the
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protein folding machinery. Alternatively, Yi et al, (1992) may have over estimated the 
total amount of GLUT1 protein present by immunoblot analysis. This would then give 
the impression that there was a high level of inactive protein.
Because cytochalasin B has a greatly reduced affinity towards the C-terminal 
constructs it was not possible to obtain accurate cytochalasin B binding data in this 
study. The amount of C-terminal recombinant protein could therefore only be judged by 
quantitative immunoblot assay.
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9.0 Time, Temperature and Metal-ion Dependent Aggregation 
Section 9.1 Introduction
During photolabelling studies it was observed that the GLUT1 protein constructs 
were sensitive to aggregation. Experiments were carried out in order to determine the 
cause of the aggregation. Although aggregates seemed to be very difficult to completely 
eliminate from experiments, several rules appeared to govern the level of aggregation 
which occurred. The factors hypothesised to affect aggregation are as follows:
1) The protein concentration of the sample
2) The temperature of the sample
3) ’ The metal ion (zinc ion) concentration (polyhistidine tagged proteins)
4) The length of time that the protein is held in non-native conditions
Section 9.2 
Protein Concentration and Temperature Dependency of Aggregation
It was observed that during photolabelling studies of erythrocyte GLUT1, high 
protein concentrations lead to an increase in the amount of aggregation observed. 
Photolabelling experiments using human erythrocyte membranes stored at a 
concentration of 440 pg / ml yielded a large tetrameric aggregation peak at 205 kDa, 
figure 9.1. The tetrameric peak was hypothesised to consist of four GLUT1 molecules. 
A reduction in the storage concentration of human erythrocyte membranes to 50 pg / ml 
resulted in the reduction of the aggregation peak, figure 9.2. Aggregation was thought to 
increase in more concentrated samples due to the closer proximity of protein molecules.
Neither of the HIS-C-TERM or the HIS-GLUT1 protein samples were as 
concentrated as the human erythrocyte GLUT1 protein. This would prevent much of the 
aggregation generated by this mechanism.
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Figure 9.1, Photolabelling high concentrations of 
erythrocyte GLUT1. 440 |ig / ml of human erythrocyte 
membranes were labelled. An intensely labelled 
tetrameric peak appears at approximately 205 kDa. This 
was attributed to the high protein concentration of the 
sample.








Figure 9.2, Photolabelling low concentrations of 
erythrocyte GLUT1. 50 pg / ml of human erythrocyte 
membranes were labelled. The error bars display the 
standard error of the mean (SEM). The amount of 
labelled tetramer is greatly reduced in this experiment. 
This was due to the lower storage concentration of the 
human erythrocyte GLUT1.
Furthermore, samples were never boiled in sample buffer before loading onto 
polyacrylamide gels because of reported increases in aggregation (personal 
communication with Dr A Clark and Dr J Yang). During photolabelling experiments 
samples were incubated on ice or at 4°C whenever possible to limit aggregation.
Section 9.3 
HIS-C-TERM Zinc Dependent Aggregation
It was hypothesised that zinc ions had the effect of increasing the aggregation 
levels of the HIS-C-TERM protein, the aggregation being moderated by the presence of 
the polyhistidine tag. The theory was tested by exposing the HIS-C-TERM protein to 
varying concentrations of zinc. The resulting protein mixture was analysed by 
immunoblotting, figure 9.3.
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Figure 9.3, Immunoblot analysis of zinc induced aggregation in the HIS-C-TERM protein. 30 pg
(13 pmoles) aliquots of homogenised Highfive cell membranes expressing HIS-C-TERM were incubated 
with varying concentrations of zinc for 15 minutes. A 12% polyacrylamide gel was loaded with the 
protein samples as follows: Lane 1: 41 nM zinc; lane 2: 82 nM zinc; lane 3: 123 nM zinc; lane 4: 164 nM 
zinc; lane 5: 205 nM zinc; lane 6: 410 nM zinc; lane 7: 1.25 p M  zinc; lane 8: 2.5 p M  zinc; lane 9: 50 pM  
zinc; lane 10: 75 p M  zinc; lane 11: HIS-C-TERM in 5 mM Phosphate buffer; lane 12: HIS-C-TERM in 
KRH buffer; lane M: High molecular weight marker.
Figure 9.3 was analysed densitometrically and the results displayed in figure 9.4.
Figure 9.4, Densitometric 
analysis of zinc induced 
aggregation in the HIS- 
C-TERM protein. The
high molecular weight 
marker can be seen to be 
present in similar amounts 
throughout the molecular 
weight range. The addition 
of 75 pM zinc resulted in 
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Immunoblotting demonstrated that the level of HIS-C-TERM aggregation 
increased with increasing zinc concentration. Imaging of the proposed octameric form of 
HIS-C-TERM was difficult. This was thought to be because it was present only in small 
amounts. However, photolabelling experiments demonstrated that the octamer and 
trimer bind the most radiolabel. This suggested that the HIS-C-TERM aggregates either 
have a higher affinity towards the radioligand than that displayed by the monomeric 
form of the protein or the protein binding the photolabel at 205 kDa was not the 
HIS-C-TERM protein. Densitometric analysis showed an even transfer of the molecular 
weight marker throughout the blot, indicating that the high molecular weight proteins 
were transferred as efficiently as the low molecular weight proteins.
It was observed that the addition of varying concentrations of zinc had very little 
effect on the peak height of monomeric HIS-C-TERM protein. However, two other 
regions of interest exist, the dimer (40 - 60 kDa) and timer / tetramer (60 - 116 kDa) 
regions. Aggregation in these regions showed a marked increase on the addition of zinc. 
The amount of aggregation was quantified by determining the ‘area beneath the curve’ 
(measured in arbitrary units) from the densitometric analysis. The ‘area beneath the 
curve’ between 40 - 116 kDa was calculated and plotted against the concentration of 
zinc. The relationship was found to fit a hyperbolic curve, figure 9.5.
Figure 9.5, Densitometric analysis of the 40 - 
116 kDa region. The area under the curve 
(arbitrary units) was background subtracted and 
plotted against zinc concentration.
Aggregation appears to be governed by a hyperbolic relationship, Ka 170 nM. At 
the Ka 1 zinc ion is bound to 2 HIS-C-TERM molecules which approximates to the 
point of maximum radio ligand binding as determined by photolabelling (photolabelling 
determined that there were 2.5 HIS-C-TERM molecules : 1 zinc ion at maximum ligand 
binding). It is thought that during photolabelling maximum radioligand binding was
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Chapter 9 GLUT1 Aggregation
achieved below the level of maximum aggregation. Maximum aggregation of the HIS- 
C-TERM protein may involve several ions of zinc per HIS-C-TERM molecule.
Section 9,4 
HIS-GLUT1 Zinc Dependent Aggregation
The HIS-GLUT1 protein was tested for increased levels of aggregation on the 
addition of zinc. The immunoblot is displayed in figure 9.6. It was observed that zinc 
increased the level of aggregation of the HIS-GLUT1 protein. No aggregation can be 
observed on this blot above 116 kDa due to the low quantities of protein present. The 
marker was demonstrated, by densitometric analysis (figure 9.7) to be present in equal 
amounts across the full molecular weight range of the blot. This indicated that protein 
transfer had been efficient throughout the molecular weight range.
Figure 9.6, Immunoblot analysis of zinc induced aggregation in the HIS-GLUT1 protein. 30 pg (13
pmoles) aliquots of Highfive cell membranes expressing HIS-GLUT1 were incubated with varying 
concentrations of zinc for 15 minutes. A 10% polyacrylamide gel was loaded as follows: Lane 1: 41 nM 
zinc; lane 2: 82 nM zinc; lane 3: 123 nM zinc; lane 4: 164 nM zinc; lane 5: 205 nM zinc; lane 6: 410 nM 
zinc; lane 7: 1.25 pM zinc; lane 8: 2.5 pM zinc; lane 9: 50 pM zinc; lane 10: 75 pM zinc; lane 11: HIS- 
GLUT1 in 5 mM Phosphate buffer; lane 12: HIS-GLUT1 in KRH buffer; lane M: High molecular weight 
marker.
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Figure 9.7, Densitometric 
analysis of zinc induced 
aggregation in the HIS-GLUT1 
protein. The high molecular 
weight marker can be seen to be 
present at similar levels 
throughout the molecular weight 
range of the gel. The addition of 
zinc results in the increased level 
of aggregation in comparison with 
the ‘no zinc’ control.
The immunoblot and densitometric scan clearly show an increase in the amount 
of proposed dimer at 97 kDa on the addition of zinc to the sample. In order to determine 
a relationship between the concentration of zinc and the level of aggregation, the ‘area 
beneath the curves’ in the region 60 - 116 kDa were analysed and plotted against the 
zinc concentration. These data are displayed in figure 9.8.
Figure 9.8, Densitometric analysis of the 60 - 
116 kDa region. The area under the curve 
(arbitrary units) was background subtracted and 
plotted against zinc concentration. The amount of 
HIS-GLUT1 protein used was 13pmoles. The 
relationship is best described as hyperbolic. The 
Ka equates to the addition of 5.7 pmoles of zinc.
HIS-GLUT1 zinc dependent aggregation appeared to be governed by a 
hyperbolic relationship. The Ka of aggregation was determined to be 142 nM, which is 
equivalent to the binding of 1 zinc ion : 2 HIS-GLUT1 molecules. Maximum 
radioligand binding, as determined by photolabelling, was 1 zinc ion : 1.64 HIS-GLUT1
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Chapter 9 GLUT1 Aggregation
molecules. In conclusion, maximum photolabelling occurred well below the maximum 
level of aggregation.
Section 9.5 
HIS-GLUT 1 Time dependent aggregation
Time dependent aggregation was tested for using the HIS-GLUT 1 protein. Time 
courses were run using HIS-GLUT 1 incubated with stochiometric amounts of zinc to 
promote aggregation throughout the time course. This experiment was again designed to 
mimic the incubation of protein with zinc during photolabelling.
The only visible form of aggregation was a band running above 205 kDa. This 
band became apparent after 10 minutes of incubation with stochiometric quantities of 
zinc. The densitometric analysis of the immunoblot is displayed in figure 9.9.
GLUT1 Time Dependent 
Aggregation
205 66 45 29 kDa
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Figure 9.9, Densitometric analysis of HIS-GLUT1 time dependent aggregation. The plot 
demonstrated how the whole molecular weight range was affected over 60 minutes of the time course. 
The aggregate running above 205 kDa showed the most time dependent variation.
Aggregation was observed to increase in a time dependent manner, but would be 
much slower in the absence of zinc. The incubatory periods during photolabelling were 
reduced accordingly in an attempt to reduce the levels of aggregation.
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Section 9.6 
Discussion
In conclusion, it appears that aggregation is indeed governed by the proposed 
factors listed in the introduction. The largest increases in aggregation were observed by 
varying the concentrations of zinc in both the HIS-GLUT 1 and HIS-C-TERM proteins.
Increases in aggregation on a time dependent basis correlate with the observed 
levels of aggregation seen in photolabelling. Photolabelling experiments performed 
during a shorter time frame resulted in less aggregation.
Aggregation during photolabelling was never completely eliminated because it 
was not possible to control all of the conditions, indeed several experiments actively 
encouraged aggregation. Furthermore, the polyhistidine tag itself appeared to encourage 





Photolabelling experiments were undertaken to investigate the activity of 
expressed recombinant glucose transporters. It was hypothesised that the C-terminal 
glucose transporter constructs would lack any radioligand binding activity, as 
determined by Cope et al, (1994). Experiments were designed using anti C-terminal 
antibodies and zinc. This was done in an attempt to produce functional HIS-C-TERM 
protein capable of radioligand binding. It was theorised that the anti C-terminal 
antibodies may form a surface for the HIS-C-TERM protein to pack against, similar to 
that achieved by Iwata et al., (1995) when crystallising cytochrome C oxidase. Zinc 
ions were introduced in the hope that the polyhistidine tags would bind to the zinc, 
forming a stable, active complex. However, experiments indicated that the 
HIS-C-TERM protein was capable of ligand binding in the absence of other factors. 
Anti C-terminal antibodies had little effect, though the addition of zinc ions to the 
protein had a remarkable effect.
Photolabelling studies were performed according to the method described in the 
Materials and Methods section. Variables have been described for each individual 
experiment. The following photolabels were used: 2-V-4-(l-azi-2,2,2-trifluoroethyl)- 
benzoyl-1,3-[3H]-bis-(D-mannos-4-yloxy)-2-propylamine (ATB-[2-3H]BMPA)
(synthesised by Prof. G. D. Holman) and cytochalasin B. These chemicals bind to the 







Figure 10.1, Binding locations of ATB-BMPA and cytochalasin B. The photolabels ATB-BMPA and 
cytochalasin B bind to external and internal binding sites respectively (but not at the same time).
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The structure of cytochalasin B is displayed in 
figure 10.2. Cytochalasin B has a high affinity towards the
internal binding site of the glucose transporter. By
irradiating the glucose transporter-cytochalasin B complex 
with high energy ultra violet radiation it is possible for 
cytochalasin B to become covalently bound to the glucose 
transporter protein. UV irradiation is thought to
photo-activate tryptophan residues on the glucose
transporter, possibly tryptophan 388 and tryptophan 412. 
These tryptophan residues are thought to be closely 
associated with the internal binding site of the glucose
A fungal toxin which has a high transporter (Inukai et al., 1994). Once activated the
affinity to the internal binding tryptophan residues form a stable covalent bond with the
site of the glucose transporter. . , , .
cytochalasin B molecule. The cytochalasin B molecule
carries a tritium label making detection of the complex
possible using standard radiolabel detection techniques.
The ATB-BMPA (figure 10.3) used was first characterised by Clark and 
Holman, (1990). ATB-BMPA has a high affinity towards the external binding site of the 
glucose transporter. UV irradiation of the ATB-BMPA and glucose transporter complex 
results in the photo-activation of the azi group on ATB-BMPA. The azi group then 
reacts with the glucose transporter to form a covalently bound complex. The ATB- 
BMPA molecule carries a tritium label which can be detected by standard radiolabel 
detection techniques.
Figure 10.3, The photolabel ATB-BMPA.
The photolabel ATB-BMPA is displayed 
with the azi (N=N) group at the top. 
ATB-BMPA was kindly synthesised by 
Professor G.D. Holman, University of Bath.
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Photolabelling was performed as described in the Materials and Methods 
section. The glucose transporter constructs were radiolabelled with the appropriate 
affinity label and UV irradiated to covalently bond the label to the protein. The labelled 
protein was then separated on a polyacrylamide gel. Following electrophoresis the gel 
was cut into sections and the radioactivity in each section counted. A control experiment 
was performed using 2 mg of uninfected Sf9 cells, 2 mg of Sf9 cells expressing 
HIS-GLUT1 and 2 mg of Sf9 cells expressing GLUT1. The Sf9 cells were 
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Figure 10.4, Photolabelling control with ATB-(2-3H]BMPA. Sf9 cells were solubili2«d in 1 ml of
5 mM phosphate buffer containing 2% Thesit and protease inhibitors.
ATB-[2-3H]BMPA binding to uninfected Sf9 cells was observed to be 
non-specific resulting in a background of about 1000 DPM / gel slice. It was noted that 
the background does not act to cause any specific peak height amplifications.
When analysing these data there appeared to be a discrepancy in peak height 
between the photolabelling of the HIS-GLUT 1 and GLUT1 recombinant proteins. 2 mg 
of Sf9 membranes expressing the HIS-GLUT1 protein appear to have produced a much 
higher photolabelling peak than the 2 mg of Sf9 membranes expressing the GLUT1 
protein. However, immunoblot analysis has demonstrated there to be slightly more 
GLUT1 than HIS-GLUT 1 present / mg of protein in these batches of cells (table 7.1).
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Cytochalasin B assays performed in chapter 8 also indicated that the HIS-GLUT 1 
protein has a higher activity when compared with the GLUT1 protein. It is hypothesised 
that the polyhistidine tag, on the HIS-GLUT 1 protein, causes the recombinant protein to 
be expressed more slowly during viral infection. Slower expression could allow for the 
correct folding and insertion of the HIS-GLUT1 protein into the membrane. This may be 
achieved by preventing the saturation of protein processing machinery with non-native 
protein. One reason for the decrease in expression rate of HIS-GLUT 1 may be the high 
requirement for histidine in the expression of this protein, a phenomenon also observed 
by Carlsson et al, (1996) when expressing polyhistidine tagged proteins. In addition, 
the extra protein sequence present at the start of the HIS-GLUT 1 protein may act to 
increase the stability of the protein product. Thus, further decreasing the levels of non­
functional HIS-GLUT 1 present.
Experiments performed by Cope et al., (1994) using insect cells demonstrated 
the C-terminal portion of the glucose transporter to be responsible for binding ligand. 
However, photolabelling was never achieved in the absence of the N-terminal portion. 
The following work was carried out to further the study by Cope et al., (1994).
The following experiment, figure 10.5, showed the result of photolabelling the 
C-terminal portion of the glucose transporter with ATB-BMPA.
Figure 10.5, Photolabelling C-TERM 
with ATB-[2-3H]BMPA. 3 mg of
homogenised Highfive cell membranes 
expressing C-TERM were labelled and 
solubilized in 1 ml of 5 mM phosphate 
buffer containing 2% Thesit and protease 
inhibitors. Samples were electrophoresed 
on a 12% polyacrylamide photolabelling 
gel.
It was difficult to detect any photolabel that had bound to the C-terminal 
monomer due to the poor signal to noise ratio. It was concluded that the C-terminal 
portion bound little, if any photolabel. On many of the C-terminal photolabelling gels a
C-TERM Photolabelling 
with ATB-BMPA
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large peak was observed at a molecular weight of 205 kDa. The association of eight 
C-terminal 26 kDa monomeric units would correspond to a peak at 205 kDa. It is 
suggested that the association of eight monomeric units could form an octamer, two 
monomeric units may form a dimer and three monomeric units may form a trimer.
The ability of the HIS-C-TERM protein to bind radioligand was tested. Sf9 cell 
membranes expressing the HIS-C-TERM protein were photolabelled with the photolabel 
ATB-[2-3H]BMPA, figure 10.6.
Figure 10.6, Photolabelling HIS-C-TERM with 
ATB-[2-3HlBMPA. 3 mg of Highfive cell 
membranes expressing HIS-C-TERM were 
labelled and solubilized in 1 ml of 5 mM 
phosphate buffer containing 2% Thesit and 
protease inhibitors. Samples were electrophoresed 
on a 12% polyacrylamide photolabelling gel.
Photolabelling of the HIS-C-TERM protein resulted in a radiolabelled protein 
running near the 29 kDa marker. This molecular weight corresponds to the monomeric 
form of the glucose transporter. However, glucose displacement studies of 
HIS-C-TERM ATB-BMPA binding were inconclusive, figure 10.7.
Figure 10.7, Glucose
displacement studies, using the 
recombinant protein
HIS-C-TERM. 3 mg of Highfive 
cell membranes expressing 
HIS-C-TERM were labelled and 
solubilized in 1 ml of 5 mM 
phosphate buffer containing 2% 
Thesit and protease inhibitors, with 
or without 0.5 M D-glucose. 




























Glucose displacement photolabelling demonstrated a decrease in total 
photolabelling, however, labelling of individual peaks was not significantly reduced. 
The background labelling may have been reduced due to the glucose molecule 
displacing photolabel which was non-specifically bound to the cell membrane and 
HIS-C-TERM protein. In this experiment there did not appear to be any specific 
labelling of the HIS-C-TERM protein. This may have been due to a loss of activity 
during the experiment as the monomer has not bound as much label as in previous 
experiments.
Electrophoresis was performed using a tricine gel system (as described in the 
Materials and Methods section) to ensure that the labelling observed in figure 10.6 was 
not due to a small, undefined protein running at the end of the gel. Tricine gel analysis 
allowed for a more precise determination of the size of the photolabelled protein, figure 
10.8.
HiS-C-TERM and C-TERM 
Photolabelling with a tricine gel 
system, using ATB-BMPA
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with an unidentified small protein
Figure 10.8, Tricine gel photolabel, of HIS-C-TERM and C-TERM expressed in Sf9 cell 
membranes. 3 mg and 2 mg of Sf9 cell membranes expressing HIS-C-TERM and C-TERM, 
respectively, were labelled and electrophoresed on a 16% tricene photolabelling gel.
Figure 10.8 suggests that there is a specific protein being labelled at 
approximately 26 kDa in Sf9 cell membranes expressing HIS-C-TERM protein. Sf9 cell 
membranes expressing C-TERM protein were observed not to bind any photolabel. The 
immunoprecipitation step has been omitted in an attempt to visualise all of the 
photolabelled proteins. This allowed for the detection of the free radioactivity in the 
photolabelled sample. A smaller protein of approximately 16 kDa was observed which
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produced a large photolabelled peak. This peak was not normally observed when 
immunoprecipitation was included in the protocol.
Photolabelling with the glucose analogue ATB-[2-3H]BMPA was used to 
demonstrate binding to the exofacial binding site of the HIS-C-TERM protein. By using 
this label alone it cannot be determined whether the protein has a functional internal site. 
For example, it may be that the protein is locked into one conformation, capable only of 
binding ligand at its exofacial site. To determine if the HIS-C-TERM construct had a 
functional internal site cytochalasin B photo labelling was performed, figure 10.9.
Figure 10.9, Photolabelling 
HIS-C-TERM with
H3-Cytochalasin B. 600 pg of Sf9 
cell membranes expressing 
HIS-C-TERM were labelled and 
electrophoresed on a 12% 
polyacrylamide photolabelling gel. 
Gel slice 6 did not solubilize and has 
therefore been omitted from the 
results.
Cytochalasin B photolabelling resulted in a labelled peak at approximately 
26 kDa, this would correspond to the expected size of the HIS-C-TERM protein.. The 
low levels of radioactivity in this experiment were due to the smaller amounts of 
radioactive label used.
Photolabelling experiments suggested that both internal and external binding 
sites are intact and capable of binding ligand. However, it was not possible to 
demonstrate glucose displacement of the H3S-C-TERM construct. More work would be 
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The Effect of Zinc on Human Erythrocyte GLUT1
The HIS-C-TERM protein was engineered with a polyhistidine tag on the 
N-terminal end. This provided the recombinant protein with a metal binding site. 
Because the HIS-C-TERM protein was capable of binding to metal ions, the question 
was posed, ‘Is the activity of HIS-C-TERM affected by metal ion concentration?’ To 
answer this question it was first determined whether there were any effects of zinc ions 
on the wild-type form of the protein. For this purpose, human erythrocyte GLUT1 was 
photolabelled with varying concentrations of zinc ions, (zinc ions were derived from the 
compound zinc sulphate in aqueous solution), figures 10.10.
Figure 10.10, Photolabelling
human GLUT1 with varying 
concentrations of zinc. 50 pg
(33 pmoles) of human erythrocyte 
GLUT1 were incubated with varying 
concentrations of zinc, labelled and 
electrophoresed on a 10% 
polyacrylamide photolabelling gel.
The experiment (figure 10.10) demonstrated that there was very little deviation 
in radioligand binding activity between the presence and the absence of low 
concentrations of zinc ions in solution. In both cases, the addition of zinc does not 
significantly increase or decrease photolabel binding. It was therefore concluded that 
low zinc concentrations had no effect on the activity of the human GLUT1 protein.
The following experiment (figure 10.11) demonstrated that high concentrations 
of zinc inhibit ligand binding, possibly by interfering with the electrostatic forces within 
the protein. Disruption of electrostatic forces may result in the alteration of the protein’s 
conformation.
Human GLUT 1 (33 pmoles) 
Photolabelling with ATB-BMPA 
and Zinc
4000-1
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Figure 10.11, High levels 
of zinc inhibit ligand
binding. 500 pg (325 
pmoles of human
erythrocyte GLUT1, were 
incubated with zinc or
D-glucose for 10 minutes. 
Erythrocyte membranes 
were labelled and
electrophoresed on a 10% 
polyacrylamide gel.
It was hypothesised that low concentrations of zinc do not have a significant 
effect on the activity of wild-type human GLUT1 protein, whereas high concentrations 
of zinc do have detrimental effects on the activity of human GLUT1 protein.
Section 10.4 
The Effect of Zinc on HIS-C-TERM Photolabelling with 
ATB-12-3H1BMPA
Figure 10.12 demonstrates the effect of high levels of zinc upon the HIS-C- 
TERM protein. High levels of zinc can be seen to have an inhibitory effect on ligand 
binding.
Figure 10.12, Zinc can have a negative 
effect on ligand binding. 3 mg of
homogenised Highfive cell membranes 
expressing HIS-C-TERM (1305 pmoles) 
were incubated with or without zinc for 
10 minutes. Samples were 
electrophoresed on a 12% polyacrylamide 
photolabelling gel.
HIS-C-TERM Photolabeiling 
with Zinc and ATB-BMPA
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It seems likely that in the presence of large quantities of zinc the tertiary 
structure of the protein is disrupted. This may be due to the disruption of electrostatic 
bonds within the protein. In the case of the polyhistidine tagged proteins, excessive 
amounts of metal ions may result in the polyhistidine tag becoming saturated with metal 
ions, causing steric hindrance to the ligand binding regions of the protein. It was 
hypothesised that in the presence of high concentrations of metal ions both mechanisms 
would occur. Further experiments have indicated that stochiometric concentrations of 
zinc act to enhance the ligand binding activity of the HIS-C-TERM protein, probably 
through metal ion interactions with the polyhistidine tag, figures 10.13 - 10.14.
Quantitative immunoblot assays were used to measure the amount of 
recombinant protein used in each experiment. Both the amount of recombinant protein 
present and the amount of zinc ions present were calculated. From these calculations the 
ratio of components at maximum ligand binding (as determined by photolabeiling) was 
determined.
The amount of Highfive expressed HIS-C-TERM protein was determined by 
immunoblot assay to be 435 pmoles / mg (1305 pmoles / 3 mg) of membrane protein. 
This is equivalent to 435 pmoles of metal binding sites which should, theoretically, be 
capable of metal ion binding.
Figure 10.13, Zinc can 
have a beneficial effect on 
ligand binding. 3 mg of
homogenised Highfive cell 
membranes expressing 
HIS-C-TERM (1305
pmoles) were incubated 
with varying amounts of 
zinc for 15 minutes and 
labelled. Samples were 
electrophoresed on a 12% 
polyacrylamide gel.
The above experiment (figure 10.13) indicated that the addition of small amounts 
of zinc had a beneficial effect on radio-ligand binding. It was observed that the addition 
of 100 pM of zinc had the most effect on photolabeiling. Higher zinc concentrations
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acted to decrease the level of photolabeiling. The trend indicated that there was an 
optimum amount of zinc required for maximum ligand binding.
Because the osmolarity of 5 mM phosphate buffer was very low it was 
hypothesised that the HIS-C-TERM protein was losing activity and that the use of a 
physiological buffer would be more appropriate. The following experiment was 
performed in Kreb-Ringer hepes buffer, in order to test this hypothesis, figure 10.14.
Figure 10.14, Zinc can have a 
beneficial effect on ligand 
binding. 3 mg of homogenised 
Highfive cell membranes, in 
KRH buffer with protease 
inhibitors, expressing
HIS-C-TERM (1305 pmoles) 
were incubated with varying 
amounts of zinc for 35 
minutes. Samples were 
labelled and electrophoresed 
on a 12% polyacrylamide gel.
Incubation in Kreb-Ringer hepes (KRH) buffer appeared to reduce the binding 
capacity of the HIS-C-TERM protein, in the absence of zinc, to negligible amounts. This 
may be due to high levels of metal ions contained within the KRH buffer (1.25 mM 
magnesium, 4.7 mM potassium, 1.25 mM calcium ions) having the same effect as the 
addition of excessive amounts of zinc ions. The addition of small amounts of zinc ions 
to this sample had a beneficial effect, similar to that seen in the previous experiment, 
figure 10.13. It is possible that the zinc ions compete for binding sites with other metal 
ions present. Zinc ions have a greater affinity towards the polyhistidine tag than 
magnesium, calcium or potassium ions. On the addition of 600 nM zinc a large increase
in labelled monomeric units occurred. By plotting the total area beneath the curve
(figure 10.15) against the amount of zinc, a second order polynomial plot can be fitted to 
the points. A theoretical maximal effect would be achieved by the addition of 515 
pmoles of zinc, this would be equal to 2.5 HIS-C-TERM molecules being associated 
with 1 zinc ion.
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Figure 10.15, A polynomial plot between the integral 
area beneath the curve and pmoles of zinc present. The
areas beneath the curve (arbitrary units) were taken from 
figure 10.14. For each individual zinc concentration the area 
below the entire curve was calculated and plotted against 
the zinc concentration for that curve. Zinc has its theoretical 
maximal beneficial effect at 515 pmoles/ .
Section 10.5 
Summary of HIS-C-TERM Photolabeiling
Results presented here suggested that the protein, HIS-C-TERM can be 
photolabelled using the radioactive ligands cytochalasin B and ATB-BMPA. However, 
glucose displacement analysis was inconclusive, so it was not possible to state if the 
binding was specific towards the C-terminal half of the glucose transporter. However, if 
the binding activity exhibited by the HIS-C-TERM construct was found to be specific it 
may provide further evidence for the function of the N-terminal region of the wild-type 
glucose transporter. The addition of the polyhistidine tag at the start of the 
HIS-C-TERM protein may have allowed this construct to take on a stable structure.
Examination of several photolabeiling experiments indicated that the C-terminal 
portion was capable of binding more radio-ligand when in the proposed dimeric or 
octameric form. It was suggested that by forming a dimeric unit the HIS-C-TERM 
protein mimicked the wild-type form of the protein, where both C-terminal sub-units are 
capable of ligand binding. It has been shown that the wild-type glucose transporter is 
capable of associating (Hebert and Carruthers, (1992)) and may function as an complex. 
It is possible that the C-terminal portion of the protein is forming a similar structure 
from dimeric units.
It was demonstrated that zinc had both a positive and negative effect upon the 
HIS-C-TERM protein. At high zinc concentrations, the metal ions have an inhibitory 
effect on radio-ligand binding. This may be due to the disruption of electrostatic bonds
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within the protein, this was also observed during photolabeiling of the human 
erythrocyte GLUT1 protein. Further to this, the metal ions may well act to saturate the 
polyhistidine tag. Saturation of the polyhistidine tag could make the N-terminus too 
‘bulky’, causing steric hindrance. This may disrupt the protein, preventing it from taking 
on the correct conformation for ligand binding.
At low concentrations, free metal ions scavenged by the polyhistidine group may 
provide sites for other HIS-C-TERM units to bind to. This would allow for the 
formation of the proposed dimers, trimers and octamers. However, in the presence of 
high concentrations of zinc, figure 10.12, a depletion of octameric and dimeric units was 
observed. A consequence of saturating the polyhistidine tag appears to be the prevention 
of protein interactions via metal ion binding sites.
Section 10.6 
HIS-GLUT1 Photolabeiling
ATB-BMPA photolabeiling, of the protein HIS-GLUT 1, has already been 
demonstrated in figure 10.4. The experiment, displayed in figure 10.4, showed that the 
HIS-GLUT 1 protein was capable of binding radioligand at the external binding site. 
Cytochalasin B binding to the HIS-GLUT 1 protein is demonstrated in the following 
experiment, figure 10.16.
Figure 10.16, HIS-GLUT1 
Photolabeiling with cytochalasin B.
1.6 mg of homogenised Highfive cell 
membranes, in 5 mM phosphate buffer 
with protease inhibitors, expressing 
HIS-GLUT1. Samples were labelled 
and electrophoresed on a 12% 
polyacrylamide photolabeiling gel.
HIS-GLUT 1 Photolabeiling 
with cytochalasin B





The 50 kDa peak, figure 10.16, represents the proposed monomeric form of the 
HIS-GLUT 1 protein. The peak at 205 kDa represents the proposed tetrameric form of 
the protein. The HIS-GLUT 1 protein appears to be capable of binding radioligand at its 
internal binding site. This indicated that the internal binding site was intact and that the 
protein was likely to have a wild-type conformation Glucose displacement of the
Figure 10.17, HIS-GLUT1 
Photolabeiling, displaying 
D-glucose displacement. 1.6
mg of Highfive cell 
membranes expressing
MS-GLUT1 were
homogenised in 5 mM 
phosphate buffer with 
protease inhibitors,. Samples 
were labelled and 
electrophoresed on a 10% 
polyacrylamide gel.
Glucose displacement studies demonstrated that the HIS-GLUT 1 protein was 
capable of recognising its natural substrate, D-glucose and is likely to be in a wild type 
conformation. High levels of labelling were observed in the proposed tetrameric peak 
region (205 kDa). This may be a result of longer incubation times with the radioligand at 
room temperature. The photolabeiling experiment displayed in figure 10.4 was 
performed on ice and the protein was incubated with ATB-BMPA for less than 4 
minutes.
Section 10.7 
The Effect of Zinc on HIS-GLUT Photolabeiling with 
ATB-[2-3HlBMPA
Zinc has been observed to have both a positive and negative effect on the HIS-C- 
TERM protein. Figure 10.18 displays the effect of incubating 696 pmoles of 
HIS-GLUT 1 with 7 pmoles of zinc. The 45 kDa peak is greatly reduced which is
ATB-BMPA labelling was demonstrated in figure 10.17.
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thought to be due to the disruption of electrostatic bonds within the protein, this in turn 
may disrupt protein conformation. The proposed tetramer, at 205 kDa, was completely 
eliminated.
Figure 10.18, HIS-GLUT1 
photolabeiling, exhibiting 
the negative effect of zinc on 
ligand binding. 1.6 mg of
homogenised Highfive cell 
membranes expressing
HIS-GLUT1 (696 pmoles
HIS-GLUT 1) were incubated 
with or without zinc for 10 
minutes. Samples were 
labelled and electrophoresed 
on a 12% polyacrylamide gel.
Radioligand binding appeared to be greatly reduced by the addition of large 
amounts of zinc. The following 3 experiments display the effects of small amounts of 
zinc upon the HIS-GLUT1 protein, figures 10.19 - 10.22.
Figure 10.19, HIS-GLUT1 
Photolabeiling, exhibiting the 
effect of zinc on ligand 
binding. 2 mg of homogenised 
Highfive cell membranes 
expressing HIS-GLUT 1 were 
incubated with or without zinc 
in 5 mM phosphate buffer for 5 
minutes. Samples were labelled 
and electrophoresed on a 10% 
polyacrylamide photolabeiling 
gel.
The experiment displayed in figure 10.19, showed a significant increase in 
photolabel binding in the presence of small amounts of zinc. The levels of aggregation 
were also reduced in this experiment, which was attributed to the short incubation times 
(10 minutes) with zinc and ATB-BMPA. It was though that the longer incubation times
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were responsible for increasing the level of aggregation observed. The experiment was 
repeated with a longer incubation time, the results are displayed in figure 10.20.
Figure 10.20, HIS-GLUT1 
Photolabeiling, exhibiting the 
effect of zinc on ligand binding. 2
mg of homogenised Highfive cell 
membranes expressing HIS-GLUT 1 
were incubated with or without zinc 
for 35 minutes. Samples were 
labelled and electrophoresed on a 
10% polyacrylamide photolabeiling 
gel.
The above experiment, figure 10.20, again demonstrated an increase in bound 
photolabel on the addition of small amounts of zinc. Data from this experiment was used 
to plot the area beneath the curve against the amount of zinc added, figure 10.21, and 
was found to fit a polynomial relationship. A maximum theoretical response was 
predicted at 530 pmoles zinc. The areas calculated include the aggregation peaks. At
maximum radioligand binding a ratio of protein : metal ions of 1.64 HIS-GLUT 1 : 1
zinc ion was observed.
Figure 10.21, A polynomial plot between the integral area 
beneath the curve and pmoles of zinc present. The areas 
beneath the curve (arbitrary units) were taken from figure 
10.20. For each individual zinc concentration the area below 
the entire curve was calculated and plotted against the zinc 
concentration for that curve. Zinc has its theoretical maximal 
beneficial effect at 530 pmoles/ 3 v ru ^ ro V ^ \ri.
Because of the low osmolarity of 5 mM phosphate buffer a physiological buffer 
was tested to ensure that the HIS-GLUT1 protein was not taking on a novel
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conformation in the low osmolar buffer. KRH buffer was used as the physiological 
buffer. The results of this experiment are displayed below in figure 10.22.
Figure 10.22, HIS-GLUT1 
photolabeiling, exhibiting the 
effect of zinc on ligand binding.
3 mg of homogenised Highfive 
cell membranes expressing 
HIS-GLUT 1 (1305 pmoles
HIS-GLUT 1) were incubated 
with or without zinc for 5 
minutes in KRH buffer with 
protease inhibitors. Samples were 
labelled and electrophoresed on a 
10% polyacrylamide gel.
In the above experiment, figure 10.22, Highfive cells expressing the 
HIS-GLUT 1 protein construct were homogenised in KRH buffer. Very few aggregates 
were observed, probably due to the short incubation times and high concentrations of 
metal ions present in the KRH buffer. Incubation with KRH buffer also appeared to 
eliminate any response from the addition of small amounts of zinc. This may have been
because the HIS-GLUT 1 protein had already been stimulated to bind the maximum
amount of radioligand by the metal ions present in the KRH buffer, saturating the 
polyhistidine tags with metal ions.
When resuspended in KRH buffer, the result of adding zinc to the HIS-GLUT1 
protein was different to the result obtained from adding zinc to the HIS-C-TERM 
protein. The HIS-GLUT 1 protein, unlike the HIS-C-TERM protein, appeared to be fully 
functional as a metal ion saturated monomer. This may be because the N-terminal 
portion of the protein acts to ‘shield’ the binding site from any effect that the metal ion 
saturated polyhistidine site may have on the protein structure.
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Summary of HIS-GLUT1 Photolabeiling
It has been demonstrated that the HIS-GLUT 1 protein has affinity for the 
radioligands cytochalasin B and ATB-BMPA. This demonstrated that both the internal 
and external binding sites of the HIS-GLUT 1 protein have a conformation similar to that 
of the wild-type protein. Furthermore, it was shown that binding of the ligand 
ATB-[2-3H]BMPA was D-glucose displaceable, indicating that the external binding site 
has retained its affinity for its natural substrate, glucose. These data, together with 
cytochalasin B assay results, indicate that the recombinant protein HIS-GLUT 1 still 
recognises its natural substrate at both the external and internal sites. Unfortunately, it 
was not possible to measure D-glucose transport across the membrane of infected insect 
cells due to the cell membranes becoming ‘leaky’ following viral infection. However, 
experiments carried out by Dr Annette Schiirmann (Institute for Pharmacology and 
Toxicology, Aachen, Germany) on reconstituted HIS-GLUT1 from Sf9 cells (University 
of Bath) demonstrated that an increased level of D-glucose transport was obtained from 
HIS-GLUT1 transfected Sf9 cells (unpublished data) in comparison with uninfected Sf9 
cells.
Under certain reaction conditions the addition of zinc had a beneficial effect on 
the binding of radioligand. It was possible that the zinc ions caused an association of 
glucose transporters that was beneficial to ligand binding. Alternatively, the bound zinc 
ions may have conferred a slightly different protein structure which allowed more 
photolabel to bind.
10.9 Discussion
Experiments suggested that the HIS-C-TERM protein was capable of binding 
glucose analogues. Unfortunately, in the absence of glucose displacement data this 
cannot be confirmed. However, if the HIS-C-TERM construct is capable of functioning 
as a single unit, then this rules out the possibility of the N-terminal portion being 
involved in the external glucose binding site. It is therefore more likely that the 
glutamine 161 mutation, generated by Mueckler et al, (1994) causes a massive
Page 156
Chapter 10 Photolabeiling
structural change transmitted through the protein structure, rather than being involved 
directly in the binding site itself. Both the HIS-C-TERM and C-TERM proteins were 
shown to be expressed at similar levels in the Sf9 cell (by immunoblotting), 
demonstrating that any differences observed were not simply due to different levels of 
expression.
It was hypothesised that the C-TERM protein may represent the original 
ancestral protein, which existed before the proposed gene duplication event (Szkutnicka 
et al, (1989). The ancestral protein may have had a veiy low capacity for transporting 
glucose. Glucose transport across the membrane would therefore have been very slow. 
Evolutionary pressures may have then acted to select a mutated form of the glucose 
transporter. A form which was generated from a gene duplication event. The gene 
duplication event may have produced a glucose transporter which had a higher capacity 
for transporting glucose.
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11.0 Purification of Polvhistidine Tagged GLUT1 
Section 11.1 Introduction
The recombinant proteins HIS-GLUT 1 and HIS-C-TERM were N-terminally 
polyhistidine tagged to aid purification while using a chelating nickel Sepharose 
column. This technique can result in a pure protein. If large quantities of purified 
HIS-GLUT1 and HIS-C-TERM protein were obtained it would be possible to start 
crystallisation trials on the proteins. This could result in 3-dimensional X-ray 
crystallographic analysis or 2-dimensional electron diffraction analysis being performed. 
This structural information would confirm or disprove the proposed 3-dimensional 
theoretical structures for the glucose transporter protein.
It was hypothesised that the HIS-C-TERM construct would have a higher 
affinity towards the matrix and would prove simpler to purify. It was further 
hypothesised that its compact, simpler structure would prove easier to crystallise and 
analyse by X-ray ciystallographic analysis.
Section 11.2 Cell Fractionation
Sf9 cells expressing the HIS-GLUT1 protein were homogenised and fractionated 
at an appropriate speed for 15 minutes using a Beckman ultracentrifuge, table 11.1. The 
HIS-GLUT1 protein was found to be present in three of the four fractions by 
immunoblot analysis. The HIS-GLUT1 protein was not fully recovered by 
centrifugation for 15 minutes at 22,000 g. This suggested that the HIS-GLUT1 protein 
was associated with internal membranes and structures, other than the plasma 
membrane. This data was consistent with confocal microscopy studies that suggested 
some of the HIS-GLUT1 protein was mis-targeted to internal cellular structures. The 
presence of HIS-GLUT1 in the 22,000-541,000 g fraction is shown on the 
immunoblot, figure 11.1. The immunoblot was densitometrically analysed and the 
results are displayed in figure 11.2 and table 11.2.
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Fraction Fraction contents
0 - 350 g Whole cells, large membrane fragments
350 - 22,000 g Membrane fragments
22,000-541,000 g Microsomal fraction, very small membrane fragments
Supernatant Soluble cytoplasmic proteins |
Table 11.1, Fractionation of Sf9 cells expressing HIS-GLUT1.. HIS-GLUT1 was found to be present 
in the first 3 fractions but not in the 541,000 g supernatant.
Figure 11.1, Immunoblot assay 
to determine the composition of 
membrane fractions. Sf9 cells 
were homogenised and the 
membranes pelleted in a
Beckman ultracentrifuge. 20 pg 
of protein was loaded on a 10% 
polyacrylamide gel as follows: 
Lane 1: 20 pg of fraction A 
supernatant (supernatant from an 
15 minute centrifugation of
homogenised Sf9 cells at 22,000 
g); lane 2: 20 pg of fraction A 
pellet (Sample A, 0 - 22,000 g for 15 minutes); lane 3: 20 pg of fraction B pellet (fraction B: Fraction A, 
pelleted at 541,000 g for 15 minutes); lane 4: 20 pg of fraction C, from fraction B supernatant (fraction C: 
Fraction B, 541,000 g supernatant); lane 5: 20 pg of Sf9 cells expressing HIS-GLUT1; lane 6: 20 pg 
non-transfected Sf9 cells; lane 7: human GLUT1 standard, 10 ng; lane 8: human GLUT1 standard, 25 ng; 
lane 9: human GLUT1 standard, 50 ng; lane 10: human GLUT1 standard, 75 ng; lane 11: human GLUT1 
standard, 100 ng.
Centrifugation for 15 minutes at 541,000 g was observed to pellet all of the 
membranes with associated HIS-GLUT1 protein. The immunoblot was analysed using a 
BioRad scanner with molecular analyst software for the PC. A standard curve was
generated from the human GLUT1 standard and is displayed below in figure 11.2. The




MeanOD 0.53 1.15 0.44 0.18 0.69 0.23 0.24 0.29 0.45 0.58 0.82
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Figure 11.2, Immunoblotting calibration curve to 
determine the composition of membrane fractions 
(cf. figure 11.1). Figure 11.1 was densitometrically 
analysed and the data generated from the standards 
plotted. From this standard curve the amount of 
unknown HIS-GLUT1 was calculated, table 11.2.
Lane Total Amount of HIS-GLUT1 in pg / 
150 ml culture
Lane 5: Starting material ! 252 ng
Lane 2: 22,000 g pellet i.............................. 96 HB..............................
Lane 1: 22,000 g supernatant 1..............................146 gg............................ 1
Lane 3: 541,000 g pellet | 122 gg
1 Lane 4: 541,000 g supernatant i_______________ im-----„ ---1
Table 11.2, The table displays the calculated distribution of fractionated HIS-GLUT1 protein.
The immunoblot displayed in figure 11.1 demonstrated that the HIS-GLUT1 
protein was associated with the three fractions between 0 - 541,000 g. The HIS-GLUT1 
protein was not found in the 541,000 g supernatant, demonstrating it to be insoluble and 
entirely associated with cellular membranes. It was observed from the densitometry data 
(table 11.2) that 58% of the protein was lost by centrifugation at 22,000 g for 15 minutes 
(146 pg were lost and only 96 pg were recovered). Centrifugation of the 22,000 g 
supernatant at 541,000 g for 15 minutes resulted in the recovery of 122 pg of 
recombinant protein, which constituted most of the lost protein. To ensure total recovery 
of the HIS-GLUT1 protein, cell homogenates were routinely centrifuged at 541,000 g 
for 15 minutes.
Further analysis of the cell wash supernatant demonstrated a significant amount 
of soluble protein with an apparent molecular weight of 66 kDa, figure 11.3.
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Figure 11.3,
Coomassie stained gel 
demonstrating the 
presence of a soluble 
protein at 66 kDa. Sf9 
cells expressing
fflS-GLUTl were 
washed in a 1 ml 
volume of 5 mM 
phosphate buffer and 
40 pi aliquots were
taken and loaded on a 10% polyacrylamide gel as follows: Lane 1: 40 pi of 1st supernatant; lane 2: 40 pi 
of 2nd supernatant; lane 3: 40 pi of 3rd supernatant; lane 4: 40 pi of 4th supernatant; lane 5: 40 pi of 5th 
supernatant.
The large protein band running at 66 kDa was thought to be bovine serum 
albumin (BSA), derived from the foetal calf serum that the cells were incubated in 
during growth. The BSA may either be adhering to the cell membranes or it may be 
taken up and retained within the cell. The above experiment indicated that most of the 
BSA was removed after about three washes with buffer. However, it would be possible 
to completely eliminate BSA from the system by adapting the insect cells to grow in a 
serum free medium. In order to routinely remove the BSA, cells were homogenised and 
washed 3 times using 5 mM phosphate buffer containing protease inhibitors.
Section 11.3 
Detergent Analysis
Four detergents were selected for screening (based on economy, availability and 
physical properties) these were: Thesit, SB 12 (Zwittergent® 3-12), Octyl glucoside and 
Triton X-100. Detergents were tested for their ability to solubilize homogenised insect 
cells. Following solubilization samples were centrifuged to remove unsolubilized 
material. Equal amounts of protein were taken from the solubilized supernatant and 
unsolubilized pellet for analysis by immunoblot assay. All four detergents appeared to 
solubilize HIS-GLUT1 and HIS-C-TERM at room temperature, but at 4°C triton X-100
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did not solubilize either protein construct efficiently. For this reason triton X-100 was 
not selected for further testing. None of the detergents used were capable of completely 
solubilizing the HIS-GLUT1 or the HIS-C-TERM proteins. Thesit, SB 12 (Zwittergent® 
3-12) and Octyl glucoside were tested for use on a Pharmacia Biotech HiTrap™ affinity 
column.
Section 11.4 FPLC Analysis 
Detergent - Thesit
Cells were prepared and solubilized in 5 mM phosphate buffer containing 1% 
Thesit with protease inhibitors. Protein was solubilized at a ratio of 2 mg of protein to 
1 ml of detergent. The insoluble material was pelleted at 164,000 g in a Beckman 
ultracentrifuge for 15 minutes and was loaded onto a 5 ml (bed volume) Pharmacia 
Biotech metal chelating column, previously charged with 15 ml of 0.1 M nickel 
sulphate. The column was washed using 25 ml of IMAC buffer containing 1% Thesit, 
protease inhibitors and no imidazole. Elution was over a 25 ml gradient ending in IMAC 
200 buffer containing 1% Thesit, protease inhibitors and 200 mM imidazole (ie., 
forming a gradient between 0 and 200 mM imidazole) on a Pharmacia FPLC unit. The 
column was run three times, once with no protein as a control, once with HIS-GLUT1
Figure 11.4, FPLC 
control using a nickel 
column. A Pharmacia 
Biotech HiTrap column 
(charged with nickel) 
was run with no protein 
using 5 mM phosphate 
buffer containing 1% 
Thesit. The red line 
represents the imidazole 
gradient and the blue 
line the increase in 
absorption at 280 nm. 
The column had been
previously used for histidine tagged protein purification which explains the minor peak in the elution line.
and once with HIS-C-TERM, figures 11.4 - 11.6.
1AU 1AU 1AU 1 AU
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Figure 11.5, FPLC elution of HIS-GLUT1 using a nickel column. A Pharmacia Biotech HiTrap 
column (charged with nickel) was loaded with HIS-GLUT1 protein. The red line represents the imidazole 
gradient and the blue line the increase in absorption at 280 nm. The wash was monitored at a sensitivity of 
2 AU and the elution at a sensitivity of 1 AU.
2 AU 1 AU 1 AU2 AU
Time
Figure 11.6, FPLC elution of HIS-C-TERM using a nickel column. A Pharmacia Biotech HiTrap 
column (charged with nickel) was loaded with HIS-C-TERM protein. The red line represents the 
imidazole gradient and the blue line the increase in absorption at 280 nm. The wash was monitored at a 
sensitivity of 2 AU and the elution at a sensitivity of 1 AU.
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Protein elution was observed to occur at 35% of the total imidazole gradient, (70 
mM imidazole). In both FPLC plots, figures 11.5 and 11.6, the elution peak forms a 
twin peak, the first indication that the HIS-GLUT1 and HIS-C-TERM proteins have not 
been eluted as pure proteins. Column fractions were analysed by SDS-PAGE followed 
by Coomassie Blue staining and by immunoblot analysis. Immunoblotting revealed that 
the HIS-GLUT1 protein had been specifically eluted in the peak fractions 13, 14 and 15. 
However, Coomassie staining revealed that there were many impurities present in the 
peak fractions. It was observed that the imidazole content of the fractions interfered with 
the protein assay system used, therefore constant volumes were loaded on the gel to 
visualise eluted proteins.
Figure 11.7, Immunoblot 
analysis of Thesit 
solubilized HIS-GLUT1 
eluted from a HiTrap 
nickel column. Solubilized 
Sf9 cells were eluted from 
a Pharmacia Biotech 
HiTrap nickel column and 
electrophoresed on a 12% 
polyacrylamide gel as 
follows: Lane 1: 40 pi of 
sample loaded on column; 
lane 2: 40 pi of column 
wash; lane 3: 40 pi of fraction 8; lane 4: 40 pi of fraction 9; lane 5: 40 pi of fraction 10; lane 6: 40 pi of 
fraction 11; lane 7: 40 pi of fraction 12; lane 8: 40 pi of fraction 13; lane 9: 40 pi of fraction 14; lane 10: 
40 pi of fraction 15; lane 11: 40 pi of fraction 16; lane 12: 40 pi of fraction 17.
SDS-PAGE analysis was repeated for the HIS-C-TERM protein. Coomassie 
staining revealed many impurities in the peak fractions. However, immunoblot analysis 
demonstrated that very little HIS-C-TERM protein was detectable in the peak fractions, 
figure 11.8.
Modifications were made to the purification protocol using the Thesit detergent 
system, but had no effect on the results. Modifications included increasing the detergent 
concentration to 2% Thesit in order to achieve better solubilization and the inclusion of 
20 mM imidazole in the wash buffer to reduce non-specific binding to the column.
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The use of Thesit was discontinued following the attempted purification of 
recombinant protein. There were also further concerns that the peroxide and aldehyde 
impurities of Thesit may well be damaging the recombinant protein.
Figure 11.8, Immunoblot analysis 
of Thesit solubilized
HIS-C-TERM eluted from a 
HiTrap nickel column. Solubilized 
Sf9 cells were collected from a 
Pharmacia Biotech HiTrap nickel 
column using a Pharmacia Biotech 
FPLC unit and electrophoresed on a 
12% polyacrylamide gel as follows: 
Lane 1: 40 pi of sample loaded on 
column; lane 2: 40 pi of column 
wash; lane 3: 40 pi of fraction 7; 
lane 4: 40 pi of fraction 8; lane 5: 40 pi of fraction 9; lane 6: 40 pi of fraction 10; lane 7: 40 pi of fraction
11; lane 8: 40 pi of fraction 12; lane 9: 40 pi of fraction 13; lane 10: 40 pi of fraction 14.
Detergent - SB 12
SB 12 derivatives were reported by Pourcher et al., (1995) to be suitable detergents 
for solubilizing the polyhistidine tagged melibiose permease. SB 12 was tested as a possible 
detergent system for solubilizing the HIS-GLUT1 protein. The HIS-GLUT1 protein was 
solubilized in 5 mM phosphate buffer containing 2% SB 12 with protease inhibitors (2 mg 
protein : 1 ml detergent). The column was washed with 25 ml of IMAC 20 buffer and then 
eluted over a 25 ml gradient up to a final concentration of 200 mM imidazole, using IMAC 
200 buffer. The FPLC plot is displayed in figure 11.9.
There were no specific elution peaks visible throughout the graduated increase in 
imidazole concentration. Furthermore, it was apparent that the detergent SB 12 altered 
the oxidation state of the immobilised metal ions. The application of SB 12 (with or 
without solubilized protein) to either a nickel column or copper column turned the 
column a brown colour or yellow colour, respectively. The coloration could only be 
removed by washing the column using 7 M hydrochloric acid.
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Figure 11.9, FPLC elution of HIS-GLUT1 using a nickel column. A Pharmacia Biotech HiTrap 
column (charged with nickel) was loaded with HIS-GLUT1 protein solubilized in 5 mM phosphate buffer 
containing 2% SB 12 with protease inhibitors. The red line represents the imidazole gradient and the blue 
line the increase in absorption at 280 nm. The FPLC was monitored at a sensitivity of 1 AU.
The chemical alteration of the column, by the detergent SB 12, clearly destroyed 
any affinity towards the histidine tagged protein. Thus the detergent was eliminated 
from further screening.
Detergent - Octyl Glucoside
The detergent Octyl Glucoside is less economical, but has been the detergent of 
choice for solubilizing erythrocyte GLUT1 for many years. Test columns were run using 
octyl glucoside.
A Pharmacia Biotech HiTrap column was charged with 0.1 M nickel sulphate 
and loaded with 10 mg of protein solubilized in 5 ml of 5 mM phosphate buffer 
containing 1.35% octyl glucoside with protease inhibitors. The protein was loaded on to 
the column and eluted using a Pharmacia FPLC unit. The column was washed with 
25 ml of IMAC 20 buffer containing 100 mM sodium chloride, 20 mM imidazole and 
0.75% octyl glucoside. The column was eluted over a 25 ml gradient. The 100% final
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elution buffer was composed of IMAC 200 buffer containing 100 mM sodium chloride, 
200 mM imidazole and 0.75% octyl glucoside.
The column run was repeated with the same buffers, using a 20 ml wash and a 7 
ml elution gradient. For comparison, the column was run using copper as the 
immobilised metal ion. The same buffer conditions were used on the copper column as 
described above. A 20 ml wash and a 15 ml elution gradient were used during the run.
The FPLC plots of the HIS-GLUT1 protein on both nickel and copper columns 
are displayed on the following pages, figures 11.10, 11.11 and 11.12. Ail column runs 
resulted in sharp elution peaks. Fractions were analysed on polyacrylamide gels using 
Coomassie staining and immunoblot analysis.






Figure 11.10, FPLC elution of HIS-GLUT1 using a nickel column. A Pharmacia Biotech HiTrap 
column (charged with nickel) was loaded with HIS-GLUT1 protein. The red line represents the imidazole 
gradient and the blue line the increase in absorption at 280 nm. The FPLC was monitored at a sensitivity 
of 0.2 AU.
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Figure 11.11, FPLC elution of HIS-GLUT1 using a nickel column. A Pharmacia Biotech HiTrap 
column (charged with nickel) was loaded with HIS-GLUT1 protein. The column was washed with 20 ml 
of wash buffer and eluted over a 7 ml gradient. The red line represents the imidazole gradient and the 




Figure 11.12, FPLC elution of HIS-GLUT1 using a copper column. A Pharmacia Biotech HiTrap 
column (charged with copper) was loaded with HIS-GLUT1 protein. The red line represents the imidazole 
gradient and the blue line the increase in absorption at 280 nm.
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FPLC samples from the nickel Sepharose column (figure 11.10) were analysed 
by immunoblot assay and by Coomassie staining, figure 11.13 and figure 11.14, 
respectively. The FPLC plot displayed in figure 11.10 indicated that the major protein 
band was eluted at about 30% of 200 mM imidazole (60 mM imidazole), and was 
contained within fraction 14 (peak fraction). The FPLC plot displayed in figure 11.11 
demonstrated that the wash and the elution of the HIS-GLUT1 protein can be performed 
using much smaller volumes of buffer. Thus making the process more economical.
Figure 11.13, Immunoblot 
analysis of octyl glucoside 
solubilized HIS-GLUT1 eluted 
from a nickel column (cf. figure
11.10). Solubilized Sf9 cells were 
loaded on to a Pharmacia Biotech 
HiTrap column charged with nickel 
ions and electrophoresed on a 12% 
polyacrylamide gel as follows: Lane 
1: 40 pi taken from insoluble cell 
debris following octyl glucoside 
solubilization; lane 2: 40 pi taken from 5 ml of solubilized Sf9 cells expressing HIS-GLUT1; lane 3: 40 
pi of column wash; lane 4: 40 pi of fraction 11; lane 5: 40 pi of fraction 12; lane 6: 40 pi of fraction 13; 
lane 7: 40 pi of fraction 14; lane 8: 40 pi of fraction 15; lane 9: 40 pi of fraction 16; lane 10: 40 pi of 
fraction 24; lane 11: 40 pi of fraction 25; lane 12: 40 pi of fraction 26; lane 13: 40 pi of fraction 27.
Immunoblot analysis has demonstrated that fraction 14 was the peak fraction. 
This corresponded to the peak fraction observed by FPLC absorption analysis. Smaller 
amounts of HIS-GLUT1 were eluted in the fractions following fraction 14. After 
solubilization an insoluble pellet of cell debris remained. This was resuspended in 1 ml 
of buffer, of which 40 pi was loaded in lane 1. This allowed for comparison with the 
40 pi sample of solubilized HIS-GLUT1 contained in 5 ml of buffer, lane 2 (figure 
11.13 and 11.14). It was observed that the majority (about 90%) of the HIS-GLUT1 
protein had been solubilized by octyl glucoside.
Comparison of the immunoblot (figure 11.13) with a Coomassie stained
polyacrylamide gel (figure 11.14) loaded with the same fractions revealed that fraction
14 was not a pure fraction.
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Figure 11.14,
Coomassie stained 
polyacrylamide gel of 
purified HIS-GLUT1 
eluted from a nickel 
column (cf. figure
11.10). Solubilized Sf9 
cells were loaded on to 
a Pharmacia Biotech 
HiTrap column charged 
with nickel ions and
electrophoresed on a 12% polyacrylamide gel as follows: Lane 1: 40 pi taken from insoluble cell debris 
following octyl glucoside solubilization; lane 2: 40 pi taken from 5 ml of solubilized Sf9 cells expressing 
HIS-GLUT1; lane 3: 40 pi of column wash; lane 4: 40 pi of fraction 11; lane 5: 40 pi of fraction 12; lane 
6: 40 pi of fraction 13; lane 7: 40 pi of fraction 14; lane 8: 40 pi of fraction 15; lane 9: 40 pi of fraction 
16; lane 10: 40 pi of fraction 24; lane 11: 40 pi of fraction 25; lane 12: 40 pi of fraction 26; lane 13: 40 pi 
of fraction 27.
Coomassie staining indicated that fraction 14 contained an impurity which had 
an apparent molecular weight of 66 kDa. In an attempt to alter the binding 
characteristics of the column, the column was run using copper as the metal ion. It was 
hypothesised that copper ions may change the binding affinity of either HIS-GLUT1, or 
the contaminants, or both.
Sf9 cells expressing HIS-GLUT1 were solubilized and loaded on a column 
charged with 0.1 M copper sulphate. Figure 11.12 displays the FPLC elution profile of 
HIS-GLUT1 protein using an immobilised copper column. A protein fraction containing 
HIS-GLUT1 was eluted at approximately 50% of 200 mM imidazole (100 mM 
imidazole) demonstrating that the retained proteins had a higher affinity towards the 
copper ions. Unfortunately the affinity of the column towards contaminating proteins 
was also increased.
kDa 1 2 3 4 5 6 7 8 9 10 11 12 13
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Figure 11.15, Immunoblot analysis of 
HIS-GLUT1 eluted from a copper 
column. Solubilized Sf9 cells were 
loaded on to a Pharmacia Biotech HiTrap 
column charged with copper ions and 
electrophoresed on a 12% polyacrylamide 
gel as follows: Lane 1: 40 pi of fraction 9; 
lane 2: 40 pi of fraction 10; lane 3: 40 pi 
of fraction 11; lane 4: 40 pi of fraction 12; 
lane 5: 40 pi of fraction 13; lane 6: 40 pi 
of fraction 14; lane 7: 40 pi of fraction 15; 
lane 8: 40 pi of fraction 16; lane 9: 40 pi of fraction 17; lane 10: 40 pi of fraction 18. Fractions 12 and 13 
were observed to contain the peak fractions of HIS-GLUT1 and corresponded to the observed peak on the 
FPLC plot.
The bands appearing at 29 kDa on the immunoblot may be due to degradation of 
the HIS-GLUT1 protein. The above immunoblot was compared with the corresponding 
Coomassie stained polyacrylamide gel, figure 11.16.
Figure 11.16, Coomassie stained
polyacrylamide gel analysis of 
HIS-GLUT1 eluted from a copper 
column. Solubilized Sf9 cells were 
loaded on to a Pharmacia Biotech 
HiTrap column charged with copper 
ions and electrophoresed on a 12% 
polyacrylamide gel as follows: Lane 
1: 40 pi of fraction 9; lane 2: 40 pi 
of fraction 10; lane 3: 40 pi of 
fraction 11; lane 4: 40 pi of fraction 
12; lane 5: 40 pi of fraction 13; lane 
6: 40 pi of fraction 14; lane 7: 40 pi of fraction 15; lane 8: 40 pi of fraction 16; lane 9: 40 pi of fraction 
17; lane 10: 40 pi of fraction 18.
Coomassie staining revealed that many contaminating proteins were co-eluted 
with the HIS-GLUT1 protein. Major contaminating bands appeared at 25 and 66 kDa. 
Because the affinity of the contaminating proteins also appeared to have been increased,
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studies using copper ions were discontinued and experiments continued using nickel 
ions.
These initial experiments have demonstrated that the recombinant protein, 
HIS-GLUT1, has an appreciable affinity towards immobilised metal ions on a Sepharose 
column. This suggests that:
a) The histidine tag is being expressed and is present on the protein
b) The histidine tag protrudes far enough out of the protein structure to allow for
specific binding of immobilised metal ions to occur.
Because the HIS-GLUT1 protein was eluted in one main elution peak, as 
observed by FPLC analysis, it was possible to elute the HIS-GLUT1 protein using a step 
gradient. Following the application of the IMAC 20 (20 mM imidazole buffer) wash 
buffer, IMAC 200 (200 mM imidazole buffer) elution buffer was applied. Further 
analysis was performed using octyl glucoside on a nickel column.
Section 11.5 
Ion Exchange Column - Anion Exchange using PEAE Cellulose
In order to eliminate contaminating proteins, the possibility of including a 
second column was investigated. A DEAE (diethyl amino ethyl) cellulose column was 
selected for testing. This column was chosen because it had been previously successful 
in the purification of human GLUT1 from erythrocytes (Baldwin and Lienhard, (1989)).
As a control erythrocyte GLUT1 was purified using a DEAE cellulose column. 
Erythrocyte ghosts were solubilized in 5 mM phosphate buffer containing 1.35% octyl 
glucoside with protease inhibitors at pH 7.4. The column was eluted using a step 
gradient containing increasing concentrations of sodium chloride (50 - 500 mM). The 
fractions were analysed by immunoblot analysis and the results displayed in figure 11.17 
below.
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Figure 11.17, Immunoblot analysis of 
erythrocyte GLUT1 eluted from a DEAE 
cellulose column. Human erythrocyte ghosts 
were solubilized run on a DEAE cellulose 
column. 4 ml fractions were collected and 20 
pi aliquots were taken and electrophoresed 
on a 10% polyacrylamide gel as follows: 
Lane 1: 20 pi of solubilized membranes; 
lane 2: 20 pi of 3 ml column load; lane 3: 20 
pi of 50 mM NaCl; lane 4: 20 pi of 50 mM NaCl; lane 5: 20 pi of 100 mM NaCl; lane 6: 20 pi of 100 
mM NaCl; lane 7: 20 pi of 200 mM NaCl; lane 8: 20 pi of 200 mM NaCl; lane 9: 20 pi of 300 mM NaCl; 
lane 10: 20 pi of 400 mM NaCl; lane 11: 20 pi of 500 mM NaCl; lane 12: 20 pi of 1 M NaCl.
Erythrocyte GLUT1 was observed to be eluted at a concentration of only 50 mM 
NaCl, indicating that erythrocyte GLUT1 had little or no affinity towards the DEAE 
cellulose column. A small amount of erythrocyte GLUT1 appeared to be retained on the 
column. This retention was probably due to protein being caught in the matrix of the 
column and would be completely removed by the 50 mM sodium chloride wash if 
continued.
Sf9 Expressed HIS-GLUT1
Sf9 cell membranes expressing HIS-GLUT1 were homogenised and solubilized 
in 5 mM phosphate buffer containing 1.35% octyl glucoside. A DEAE cellulose column 
was prepared (bed volume, 8 ml) and the solubilized cell protein loaded on to the 
column. The column was eluted using a step gradient. The step gradient consisted of 4 
ml volumes of elution buffer containing 5 mM phosphate buffer with protease 
inhibitors, 0.75% octyl glucoside and increasing concentrations of sodium
chloride (50 - 500 mM). 4 ml fractions were collected from the column and 40 pi 
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Figure 11.18, Immunoblot analysis of 
HIS-GLUT1 protein eluted from a DEAE 
cellulose column. Sf9 cells were solubilized 
loaded on to a DEAE cellulose column. 4 ml 
fractions were collected and 40 pi aliquots 
were taken and electrophoresed on a 12% 
polyacrylamide gel as follows: Lane 1: 40 pi 
of solubilized membrane; lane 2: 40 pi of 50 
mM NaCl; lane 3: 40 pi of 50 mM NaCl; lane 
4: 40 pi of 50 mM NaCl; lane 5: 40 pi of 100
mM NaCl; lane 6: 40 pi of 100 mM NaCl;
lane 7: 40 pi of 200 mM NaCl; lane 8: 40 pi of 200 mM NaCl; lane 9: 40 pi of 300 mM NaCl; lane 10: 40
pi of 400 mM NaCl; lane 11: 40 pi of 500 mM NaCl; lane 12: 40 pi of 500 mM NaCl.
Comparison of the immunoblot with the Coomassie stained polyacrylamide gel, 
figure 11.19, indicated that the majority of contaminants were not retained on the 
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Several contaminating proteins were observed to be eluted from the DEAE 
cellulose column on the application of 50 mM sodium chloride elution buffer. However, 
the HIS-GLUT1 protein was retained and only eluted on the application of 200 mM 
sodium chloride. The affinity displayed by the HIS-GLUT1 protein towards the DEAE 
cellulose column was not as predicted. It was proposed that the increase in HIS-GLUT1 
affinity was as a direct result of the addition of the enterokinase site before the 
N-terminal polyhistidine tag. The addition of several aspartic acid residues, which at 
pH 7.4 would be negatively charged, appeared to have resulted in an increased negative 
charge on the surface of the protein. This provided further evidence to suggest that the 
polyhistidine tag and preceding amino acids were protruding from the surface of the 
protein and were accessible to metal ions.
The use of the DEAE cellulose column, in combination with the nickel column, 
carries disadvantages as well as advantages. The inclusion of this column in the protocol 
serves to increase the amount of time that the HIS-GLUT1 protein is incubated with the 
detergent octyl glucoside. This is important as erythrocyte GLUT1 has been reported, by 
Baldwin and Lienhard, (1989), to undergo degradation and loss of activity with long 
periods of incubation in the detergent octyl glucoside. Inclusion of the DEAE cellulose 
column also leads to a greater loss of HIS-GLUT1 protein throughout the purification 
protocol. For these reasons the DEAE cellulose column was not included as part of the 
purification strategy.
Section 11.6 
Isolation of Egg Yolk Lipids for Reconstitution of the Glucose 
Transporter
Following column chromatography it was necessary to reconstitute the 
HIS-GLUT1 protein into lipid vesicles. Two types of phospholipid were used: type II-S 
soybean phospholipids (Sigma) and egg yolk phospholipids. Egg yolk phospholipids 
were isolated from egg yolks and purified according to the protocol described in the 
Materials and Methods section. Lipid fractions were collected and analysed by thin layer 
chromatography (TLC), figure 11.20.
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Figure 11.20, TLC analysis 
of egg yolk lipids separated 
on a silica column. Fractions 
4, 5 and 10 were combined to 





TLC analysis demonstrated the egg yolk lipids to be rich in 
phosphatidylethanolamine. In order to obtain a lipid mixture with equal amounts of 
phosphatidylethanolamine and phosphatidylcholine fractions 4, 5 and 10 were taken, 
combined and termed as fraction B. Fractions were combined because too much 
phosphatidylethanolamine could lead to the disruption of membrane vesicles. Fractions 
1 and 2 contained only neutral lipids and were discarded. The remaining fractions were 
combined and termed as fraction A. The samples generated were then re-tested by TLC 
analysis, displayed in figure 20.21.
Figure 11.21, TLC analysis of combined egg yolk lipids 
(cf. figure 11.20). Fraction B was considered to contain 
approximately equal amounts of phosphatidylcholine and 
phosphatidylethanolamine.
Fraction B contained 610 mg of lipid with a density of 0.828 g / cm3 and was 
used for the reconstitution of the glucose transporter.
Both egg yolk lipids and soybean lipids produced good results on reconstitution 
of the HIS-GLUT1 and HIS-C-TERM proteins. However most of the experiments 
performed in this thesis used soybean lipids. This was because the soybean lipids proved 
to be more soluble in the detergent octyl glucoside than the egg yolk lipids.
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Section 11.7 Protein Stability in Octyl Glucoside
Baldwin and Leinhard, (1989) have reported that human erythrocyte GLUT1 is 
unstable in the detergent octyl glucoside. Incubation in octyl glucoside was reported to 
result in the loss of glucose binding activity on a time dependent basis. The stability of 
the recombinant constructs GLUT1, HIS-GLUT1 and HIS-C-TERM were also 
questioned and tested by incubating the proteins with octyl glucoside for varying 
amounts of time. The amount and activity of the recombinant protein following 
incubation was detected by immunoblot and cytochalasin B assay.
Immunoblot Analysis
Samples of homogenised Sf9 cell membranes expressing HIS-GLUT1, HIS-C- 
TERM and GLUT1 were incubated in 5 mM phosphate buffer containing 1.5% octyl 
glucoside with protease inhibitors. Aliquots were taken over a time course of 6 Y2 h and 
analysed by immunoblotting, the results are displayed in figures 11.22 - 11.24.
Figure 11.22, HIS- 
C-TERM incubated 
with octyl glucoside.
Sf9 cells expressing 
HIS-C-TERM were 
incubated with 1.5% 
octyl glucoside and 
loaded onto a 12% 
polyacrylamide gel as 
follows: Lane 1: 0 
minutes; lane 2: 30 
minutes; lane 3: 1 h; 
lane 4: VA h; lane 5: 
2 h; lane 6: 2lA h; 
lane 7: 3 h; lane 8: 4
kDa 1 2 3 4 5 6  7 8  9 10 11
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The HIS-C-TERM immuno reactive protein band does not show a significant 
decrease in intensity throughout the time course, as determined from optical density 
measurements. These results were mirrored by the HIS-GLUT1 and GLUT1 proteins 
displayed in figures 11.23 and 11.24. The mean optical density data is displayed on the 
immunoblots.
Figure 11.23, HIS-GLUT1 
incubated with octyl glucoside. Sf9
cells expressing HIS-GLUT1 were 
incubated with 1.5% octyl glucoside 
and loaded onto a 10% 
polyacrylamide gel as follows: Lane 
1: 0 minutes; lane 2: 30 minutes; lane 
3: 1 h; lane 4: VA h; lane 5: 2 h; lane 
6: 2lA h; lane 7: 3 h; lane 8: 4 h; lane 
9: 5 h.
Figure 11.24, GLUT1 incubated 
with octyl glucoside. Sf9 cells 
expressing GLUT1 were incubated 
with 1.5% octyl glucoside and loaded 
onto a 10% polyacrylamide gel as 
follows: Lane 1: 0 minutes; lane 2: 30 
minutes; lane 3: 1 h; lane 4: VA h; 
lane 5: 2 h; lane 6: 2lA h; lane 7: 3 h; 
lane 8: 4 h; lane 9: 5 h.
Immunoblot analysis has demonstrated that there was no significant degradation 
of Sf9 expressed HIS-C-TERM, HIS-GLUT1 or GLUT1 during incubation with octyl 
glucoside. Variation is thought to be due to transfer inefficiency. The HIS-GLUT1 
protein was taken for further analysis by cytochalasin B assay.
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Cvtochalasin B Assay - HIS-GLUT1 Activity in Octvl Glucoside
Homogenised Sf9 cell membranes, expressing HIS-GLUT1, were incubated for 
up to 7 h in 5 mM phosphate buffer containing 1.5% octyl glucoside with protease 
inhibitors. 1 mg samples were taken throughout the time course and dialysed; 
reconstitution was in soybean type II-S lipids. Samples were assayed using a standard 
cytochalasin B assay as described in the Materials and Methods section. The total 
amount of free and bound ligand at each time point was calculated and the Bmax 
plotted, figure 11.25
Figure 11.25, Time course of 
activity of HIS-GLUT1 in the 
presence of octyl glucoside. HIS- 
GLUT1 was exposed to octyl 
glucoside over a period of 7 h. The 
Bmax values from cytochalasin B 
assays were calculated and plotted. 
The line was found not to deviate 
significantly from the horizontal 
(P=0.67).
Throughout the time course there was very little decrease in HIS-GLUT1 affinity 
towards the radioligand, cytochalasin B. The line of best fit was not found to deviate 
significantly from the horizontal (P=0.67). It was concluded that over the time period 
tested there was very little deterioration of HIS-GLUT1 activity.
HIS-GLUT1 Activity in Octvl Glucoside with Substrate Protection
It was theorised that octyl glucoside could be recognised by the GLUT1 protein 
as a substrate mimic. Octyl glucoside could bind to the GLUT1 substrate binding site 
and reduce the activity of the transporter, by either blocking the site, or by denaturing 
the protein. The detergent octyl glucoside appeared to have had very little effect on the
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activity of the HIS-GLUT 1 protein in the absence of glucose. Nevertheless, the time 
course was also performed in the presence of 0.5 M D-glucose, in an attempt to protect 
the binding site from octyl glucoside. The results of this are displayed in figure 11.26.
Figure 11.26, Time course of activity of 
HIS-GLUT1 in the presence of octyl 
glucoside and 0.5 M D-glucose. HIS- 
GLUT 1 was exposed to octyl glucoside and 
0.5 M D-glucose over a period of 7 h. The 
Bmax values from cytochalasin B assays 
were calculated and plotted. The line was 
found not to deviate significantly from the 
horizontal (P=0.92).
The addition of 0.5 M D-glucose appeared to have very little effect on the HIS- 
GLUT 1 protein activity. In both time courses there were no significant losses of activity 
over the 7 h time period. Immunoblotting also demonstrated very little observable 
deterioration in the HIS-GLUT 1 protein and it was concluded that octyl glucoside had 
little effect on the Sf9 expressed proteins over the 7 h time period observed. It is 
possible that the HIS-GLUT 1 protein would be affected by incubation with octyl 
glucoside over longer time periods, but since the solubilization and chromatographic 
stages of purification were accomplished within 3 h, this was not tested.
Section 11.8 
GLUT1 Control Column
To determine that the GLUT1 protein does not have an intrinsic affinity towards 
the nickel column the following experiment was performed. A 1 ml Sepharose chelating 
column was charged with 0.1 M nickel sulphate and pre-equilibrated with the wash 
buffer. 4 mg of homogenised Sf9 cells expressing GLUT1 were solubilized and loaded 
on the column. The column was washed with 10 ml of wash buffer and eluted with 5 ml
HIS-GLUT1 Activity time course  
in octyl glucoside with 0.5 M 
glucose
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of elution buffer, 2 ml fractions were collected and analysed by immunoblot assay, 
displayed in figure 11.27.
Figure 11.27, Immunoblot of Sf9 expressed 
GLUT1 protein eluted from a nickel column.
4 mg of Sf9 cells expressing GLUT1 were 
solubilized and loaded onto a 1 ml nickel 
chelating Sepharose column charged with 0.1 M 
nickel sulphate. 40 pi aliquots from each fraction 
were loaded on a 10% polyacrylamide gel as 
follows: lane 1: fraction 1; lane 2: fraction 2; 
lane 3: fraction 3; lane 4: fraction 4; lane 5: 
fraction 5; lane 6: fraction 6; lane 7: fraction 7; 
lane 8: fraction 8; lane 9: fraction 9; lane 10: fraction 10. Fractions 1 represents the load, fractions 2 - 6  
represent the wash and fractions 7 - 1 0  represent the elution.
GLUT1 was seen to elute from the column in the wash buffer. None of the 
GLUT1 protein was retained upon the column following the wash, this suggested that 
the addition of the polyhistidine tag confers nickel ion affinity up on the GLUT1 
protein.
Sf9 Control Column
An Sf9 control column was run to determine whether any Sf9 proteins have an 
affinity towards the nickel column. A 1 ml nickel chelating Sepharose column was 
charged with 0.1 M nickel sulphate and pre-equilibrated with wash buffer. 4 mg of 
uninfected Sf9 cells were homogenised, solubilized and loaded on to the column. The 
column was washed using 10 ml of wash buffer and eluted using 5 ml of elution buffer.
1.9 ml fractions were collected from the column. 40 pi samples were taken from the 
collected fractions and analysed by immunoblotting, no immunospecific bands were 
revealed by immunoblot analysis. In order to clearly visualise the contaminating Sf9 cell 
proteins with an affinity towards the nickel column larger amounts of dialysed protein 
were loaded onto a polyacrylamide gel for analysis. Dialysed protein samples were 
concentrated by chloroform / methanol precipitation and visualised by silver staining.
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The gel compares the protein content of the wash, fraction 1, with the elution, fraction 9. 
The results are displayed in figure 11.28.
Figure 11.28, Silver stained 
polyacrylamide gel of Sf9 
cell proteins eluted from a 
nickel coiumn. Samples from 
dialysed fractions were loaded 
in two different amounts on a 
10% polyacrylamide gel as 
follows: Lane 1: 35 pi of 
fraction 1; lane 2: 71 pi of 
fraction 1; lane 3: 612 pi of 
fraction 9; lane 4: 1020 pi of 
fraction 9; lane 5: 2 pg human 
GLUT1 standard.
Several protein bands were observed in the column wash, fraction 1, which have 
no affinity towards the column. However, in fraction 9 there appeared to be at least two 
contaminating Sf9 proteins with a high affinity towards the column. These proteins are 
present at 66 and 45 kDa and are only eluted with high concentrations of imidazole. The 
protein at 66 kDa is thought to be BSA, used during Sf9 cell incubation. This could be 
eliminated by adapting the cells to grow in serum free medium. The origin on the 45 
kDa band is unknown, but previous results suggest that it could be removed by the use 
of a DEAE cellulose column.
Section 11.9 
Purification of HIS-GLUT1 Expressed in Sf9 Cells
A 1 ml HiTrap™ column was charged with 0.1 M nickel sulphate and 
pre-equilibrated with 3 ml of wash buffer. 4 mg of Sf9 cells expressing HIS-GLUT 1 
were homogenised, solubilized and loaded on to the column. 1.9 ml fractions were 
collected and 40 pi aliquots were taken from each fraction. The aliquots were analysed
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by immunoblot assay, figure 11.30, and by PAGE followed by Coomassie blue staining. 
Fractions were then dialysed against GLUT1 dialysis buffer for further analysis.
Figure 11.30, Immunoblot of 
Sf9 expressed HIS-GLUT1 
protein eluted from a nickel 
column. 40 pi from each 
column fraction were loaded 
on to a 10% polyacrylamide 
gel as follows: lane 1: fraction 
1; lane 2: fraction 2; lane 3: 
fraction 3; lane 4: fraction 4; 
lane 5: fraction 5; lane 6:
fraction 6; lane 7: fraction 7; 
lane 8: fraction 8; lane 9:
fraction 9; lane 10: fraction 10. 
Fraction 1 represents the load, 
fractions 2 - 6  represent the wash and fractions 7 -1 0  represent the elution.
PAGE followed by Coomassie staining revealed that there was very little protein 
present in any of the fractions, other than fractions 2 and 3. However, immunoblotting 
demonstrated that HIS-GLUT1 protein was retained and specifically eluted in fractions 
8 and 9. A high level of HIS-GLUT1 flow through was observed in fractions 2 and 3
(more than 50%) and will be discussed later (figures 11.32 and 11.33).
In order to determine how many contaminating proteins were present, dialysed 
fractions 2 and 9 were taken and concentrated by chloroform / methanol precipitation. 
Samples were loaded onto a 10% polyacrylamide gel and visualised using the BioRad 
silver stain plus system, figure 11.31.
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Figure 11.31, Silver stained polyacrylamide gel of Sf9 expressed HIS-GLUT1 protein eluted from 
a nickel column. Samples from dialysed fractions 2 and 9 were taken and loaded in two different 
amounts on a 10% polyacrylamide gel as follows: Lane M: high molecular weight marker; lane 1: 2 fig 
of Sf9 membranes expressing HIS-GLUT1; lane 2: 10 pg (40 pi) of fraction 2; lane 3: 20 pg (79 pi) of 
fraction 2; lane 4: 150 pg (557 pi) of fraction 9; lane 5: 250 pg (929 pi) of fraction 9; lane 6: 2 pg of 
human GLUT1 standard.
Following dialysis residual amounts of imidazole appeared to have remained in 
the sample and have made the protein assay results unreliable. From comparison with 
the Sf9 standard it was estimated that there were between 2 - 3 pg of protein in lane 5.
The 66 kDa band, assumed to be BSA, was observed in both fractions 2 and 9, its 
presence was also observed in uninfected Sf9 cells. The 66 kDa protein (BSA) is clearly 
the major contaminating protein co-eluting with the HIS-GLUT1 protein. Other visible 
contaminating proteins were present at approximately 30 and 90 kDa. Although it was 
difficult to determine the origin of these proteins, wild-type viral coat protein 
(polyhedrin) and degraded HIS-GLUT1 protein are both possibilities that have been 
eliminated. Polyhedrin protein was discounted because it has a slightly different 
apparent molecular weight. Degraded HIS-GLUT1 protein was discounted because the 
band had no immunoreactivity, protease inhibitors were present and low temperatures
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(<4°C) were maintained throughout the experiment. Samples were analysed by 
quantitative immunoblotting to determine the amount of HIS-GLUT1 protein contained 
within each fraction, figure 11.32 and 11.33.
Figure 11.32, Immunoblot of 
Sf9 expressed HIS-GLUT1 
protein eluted from a nickel 
column. Concentrated samples 
were loaded on to a 10% 
polyacrylamide gel as follows: 
lane 1: 20 pg Sf9 cells 
expressing HIS-GLUT1; lane 
2: 65 pi of fraction 1; lane 3: 
75 pi fraction 2; lane 4: 97 pi 
of fraction 3; lane 5: 129 pi of 
fraction 4; lane 6: 121 pi of fraction 5; lane 7: 200 ng human GLUT1 standard; lane 8: 400 ng human 
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Table 11.3, Densitometric analysis of figure 11.32. The above table demonstrates the amount of HIS- 
GLUT1 found in fractions 1 - 5 in pg / ml.
Mean OD j amount in ng j P.moles / mg
....................... |.................................... !............pg./ml........
0.397 428 ng / 20 pg /
0.050 | 0 ng / 65 pi j O pg / ml
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Figure 11.33, Immunoblot of 
Sf9 expressed HIS-GLUT1 
protein eluted from a nickel 
column. Concentrated samples 
were loaded on to a 10% 
polyacrylamide gel as follows: 
lane 1: 20 pg Sf9 cells
expressing HIS-GLUT1; lane 2: 
119 pi of fraction 6; lane 3: 123 
pi fraction 7; lane 4: 160 pi of 
fraction 8; lane 5: 75 pi of 
fraction 9; lane 6: 127 pi of 
fraction 10; lane 7: 200 ng human GLUT1 standard; lane 8: 400 ng human GLUT1 standard; lane 9: 500 
ng human GLUT1 standard; lane 10: 600 ng human GLUT1 standard.
Fraction Mean OD amount in ng pmoles / mg
pg / ml
Sf9 cell control 0.286 507 ng / 20 pg 551 pmoles / mg
6 0 ng / 119 pi 0 pg / ml
7 0 ng / 123 pi 0 pg / ml
8 0 ng / 160 pi 0 pg / ml
9 0.071 170 ng / 75 pi 2.3 pg / ml
10 0 ng / 127 pi 0 pg / ml
Table 11.4, Densitometric analysis of figure 11.32. The above table demonstrates the amount of HIS- 
GLUT1 found in fractions 6 -10, in pg / ml.
HIS-GLUT1 Yield
The column yield for HIS-GLUT1 protein has been calculated for a 500 ml culture 
of Sf9 cells. The calculations are as follows: 33 mg of washed membranes were 
obtained from a 500 ml Sf9 cell culture. The Sf9 cells in this experiment expressed HIS- 
GLUT1 at 507pmoles/mg of membrane protein (mean of densitometric data, tables 
11.3 and 11.4). Therefore, 507 pmoles x 33 mg = 16.7 nmoles of HIS-GLUT1 were 
expressed / 500 ml culture, which is equal to 770 pg of HIS-GLUT1 expressed / 500 ml 
culture.
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4 mg of Sf9 cell membranes expressing HIS-GLUT1 were purified on an 
immobilised nickel column. The 4 mg of membranes contained 93.3 pg of HIS-GLUT1. 
Following purification, the retained HIS-GLUTl protein was completely eluted in 
fraction 9 and was calculated by immunoblot analysis to contain 2.3 pg / ml of HIS- 
GLUT1. The fraction size was 1.9 ml and therefore the fraction contained 4.3 pg of 
purified HIS-GLUTl.
Therefore, the total yield from a 500 ml Sf9 cell culture expressing HIS-GLUTl 
was 36 pg of purified HIS-GLUTl. From the original culture only 5% of the 
HIS-GLUTl was recovered.
The amount of HIS-GLUTl protein lost in the wash fractions is shown as follows: 
Fractions 2 and 3 contain 2.1 and 0.9 pg / ml of HIS-GLUTl, respectively. This 
represents a total of 5.6 pg of HIS-GLUTl. The HIS-GLUTl protein lost in the wash 
step for a 500 ml culture was therefore 45.8 pg of HIS-GLUTl, this represents 6% of 
the HIS-GLUTl from the original culture. This suggests that 89% of the HIS-GLUTl 
protein has been lost from the 500 ml culture. This protein may have been lost during 
solubilization of the membranes, running the column and by experimental error. It was 
previously observed that not all of the HIS-GLUTl protein was solubilized by detergent, 
some of the HIS-GLUTl protein remained in the unsolubilized cell pellet.
From the yield calculations it can be seen that 46% of the HIS-GLUTl protein 
was retained on the column and that 54% is eluted off in the wash buffer. This ratio of 
approximately 1 : 1 was maintained throughout all of the purification experiments. This 
was probably a result of the HIS-GLUTl protein having a low affinity towards the 
nickel column, possibly due to the polyhistidine tag being masked by amino acid tertiary 
structure or by being partially buried in the detergent micelle / lipid bilayer. It was 
thought that the yield could be improved by increasing the affinity of the polyhistidine 
tag towards the nickel column, this could be achieved by placing the tag on the 
hydrophilic C-terminal end of the protein. A substantial amount of protein has been lost 
during the solubilization step, this could be improved by selecting a more efficient 
detergent system.
The HIS-GLUTl protein was not clearly visible with silver stain analysis (figure
11.31). It is known that certain types of protein are detected by the silver stain system 
with a lower sensitivity. These proteins include glycosylated proteins such as the
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GLUT1 and HIS-GLUTl proteins. A low sensitivity of detection was supported by the 
human GLUT1 2 pg standard, which was barely visible and was known to be pure, 
having no other contaminating proteins to mask its presence.
In conclusion, the total yield from a 500 ml Sf9 cell culture expressing 
HIS-GLUTl was 36 pg of purified HIS-GLUTl, the original culture having contained 
770 pg HIS-GLUTl. However, it was clear that the final product was not completely 
pure and there are still contaminating bands within it.
Section 11.10 
Purification of HIS-GLUTl Expressed in Highfive Ceils
4 mg of Highfive cells expressing HIS-GLUTl were purified on a 1 ml nickel 
chelating Sepharose column. The column was run as in section 11.8, except that it was 
washed using only 8 ml of wash buffer. 40 pi samples were taken from each fraction 
and analysed by immunoblot assay and by PAGE with Coomassie protein staining. 
Fractions 2 and 3 were the only fractions which contained enough protein to allow for 
visualisation using Coomassie staining. Immunoblotting indicated which fractions 





eluted from a nickel 
column. 40 pi from 
each fraction were 
loaded on a 10% 
polyacrylamide gel as 
follows: lane 1:
fraction 1; lane 2: 
fraction 2; lane 3:
fraction 3; lane 4: fraction 4; lane 5: fraction 5; lane 6: fraction 6; lane 7: fraction 7; lane 8: fraction 8; 
lane 9: fraction 9; lane 10: fraction 10. Fraction 1 represents the load, fractions 2 - 6  represent the wash 
and fractions 7 - 1 0  represent the elution. The letter B marks the position of visible banding observed on 
the nitrocellulose, following Ponceau S staining.
kDa 1 2 3 4 5 6 7 8 9  10
• •  - B
29 —
MeanOD 1.18 1.06 0.39 0.17 0.11 0.12 1.15 1.02 0.11
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Densitometric analysis showed that approximately 50% of the HIS-GLUTl 
protein was eluted from the column during the column wash. The same pattern was 
maintained even when only half the amount of protein was loaded on the column, it is 
therefore unlikely to be a result of column saturation as the ratio of retained protein 
would fluctuate. In order to determine the amount of HIS-GLUTl protein present in 
fractions 3 and 9, figure 11.34, the fractions were assessed by quantitative 
immunoblotting, figure 11.35.
Figure 11.35, Quantitative 
immunoblot of Highfive expressed 
HIS-GLUTl. Concentrated
samples were taken from fractions 3 
and 9 and loaded onto a 10% 
polyacrylamide gel as follows: Lane 
1: 30 |ig uninfected Sf9 cell 
membranes; Lane 2: 30 pg of 
Highfive cell membranes expressing 
HIS-GLUTl; Lane 3: 20 pg of 
Highfive cell membranes expressing 
HIS-GLUTl; Lane 4: 10 pg of Highfive cell membranes expressing HIS-GLUTl; Lane 5: 25 pi of 
fraction 3; lane 6: 25 pi of fraction 9; lane 7: 200 ng of human GLUT1 standard; lane 8: 400 ng of human 
GLUT1 standard; lane 9: 500 ng of human GLUT1 standard; lane 10: 600 ng of human GLUT1 standard.
Fraction Mean OD amount in ng / pi pg / ml
2 338 ng /20  pi 16.9 pg / ml
3 0.239 359 ng / 25 pi 14.3 pg / ml
8 398 ng / 25 pi 19.9 pg/ml
9 0.230 333 ng / 25 pi 13.3 pg/ml
Mean Highfive expression values 80 pg / mg 1.7 nmoles / mg
Table 11.5, Densitometric analysis of figure 11.36. The above table demonstrates the amount of HIS- 
GLUTl found in fractions 2, 3, 8 and 9, in pg / ml. Fractions 2 and 8 were analysed from a separate blot, 
which is not shown.
Both the wash fractions and the elution fractions were observed to contain similar 
amounts of HIS-GLUTl. It was calculated from immunoblot analysis that fractions 2 
and 3 and fractions 8 and 9, contained 31 and 33 pg / ml, respectively. Experimental
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evidence again demonstrated a 1 : 1 ratio between the HIS-GLUTl eluted in the wash 
fraction and the HIS-GLUTl eluted in the elution fraction. This suggested the presence 
of two distinct sub groups of HIS-GLUTl protein. One subgroup has a high affinity 
towards the column and the other has a low affinity towards the column. Dialysed 
fractions were concentrated in a Beckman ultracentrifuge at 541,000 g for 30 minutes. 
Samples were analysed on a 10% polyacrylamide gel and the proteins visualised using 
the BioRad silver stain plus system, figure 11.36.
kDa M 1 2 3 4 5
Figure 11.36, Silver stained analysis of column purified HIS-GLUTl. Fractions 3 and 9 were 
concentrated and loaded onto a 10% polyacrylamide gel as follows: Lane M: high molecular weight 
marker; lane 1: 500 pi of fraction 3; lane 2: 750 pi of fraction 3; lane 3: 500 pi of fraction 9; lane 4: 750 
pi of fraction 9; lane 5: 2 pg of human GLUT1 standard. The GLUT1 and HIS-GLUTl bands are 
indicated with a G and the 66 and 95 kDa contaminating bands are indicated with the figures 66 and 95.
Fraction 3 (the wash fraction) was observed to contain many bands and the HIS- 
GLUTl protein can not be seen at all. However, in fraction 9 (the elution fraction) the 
HIS-GLUTl protein is clearly visible as a diffuse band running at 45 kDa. The HIS- 
GLUTl protein band is less diffuse than the human GLUT1 standard because of the 
reduced level of glycosylation in insect cells. Immunoblot analysis suggested that there
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should be 10 pg of HIS-GLUTl present in 750 pi of fraction 9, these data suggested 
that silver staining has a decreased sensitivity with respect to the HIS-GLUTl protein. 
Two contaminating bands were observed, as characterised previously, 66 kDa BSA 
band and the 95 kDa band. Analysis of fractions 2 and 8 from the same column run gave 
similar results.
In an attempt to obtain pure HIS-GLUTl protein, a column was taken and 
over-loaded with HIS-GLUTl. It was hypothesised that an excess of HIS-GLUTl 
protein may compete off the contaminating proteins. A 1 ml chelating Sepharose 
column, charged with nickel, was over loaded with 40 mg of octyl glucoside solubilized 
Sf9 cell membranes expressing HIS-GLUTl. Following analysis on a 10% 
polyaciylamide gel stained with Coomassie blue, the 95 kDa band and other fainter 
contaminating bands were still evident. It was concluded that the excessive over loading 
of HIS-GLUTl protein on the nickel column had no beneficial effect upon HIS-GLUTl 
protein purification.
HIS-GLUTl Yield
The column yield of HIS-GLUTl protein has been calculated for a 500 ml culture 
of Highfive cells. The calculations are as follows: 24 mg of washed membranes were 
obtained from 500 ml of Highfive cell culture. The Highfive cells in this experiment 
expressed HIS-GLUTl protein at 1.7 nmoles HIS-GLUTl /m g of membrane protein 
(mean of densitometric data, table 11.5). Therefore, 1.7 nmoles x 24 mg = 41.8 nmoles 
of HIS-GLUTl were expressed / 500 ml culture, which was equal to 1.9 mg of HIS- 
GLUTl expressed / 500 ml culture.
4 mg of Highfive cell membranes expressing HIS-GLUTl were purified on an 
immobilised nickel column. The 4 mg of membranes contained 321 pg of HIS-GLUTl 
protein. Following purification, the retained HIS-GLUTl protein was eluted in fractions 
8 and 9 and was calculated by immunoblot assay to contain 19.9 and 13.3 p g / m l  of 
HIS-GLUTl, respectively. The fraction size was 1.9 ml and therefore fractions 8 and 9 
contained 63.1 pg / 3.8 ml of purified HIS-GLUTl protein. The total yield from a 
500 ml Highfive cell culture expressing HIS-GLUTl was 378.5 pg of purified HIS- 
GLUTl. From the original culture 20% of the HIS-GLUTl protein was recovered.
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The HIS-GLUTl protein lost in the wash fractions is shown as follows: Fractions 
2 and 3 contain 16.9 and 14.3 pg / ml of HIS-GLUTl, respectively. This represents a 
total of 59.4 pg of HIS-GLUTl. The HIS-GLUTl protein lost in the wash step for a 
500 ml culture was therefore 356.3 pg of HIS-GLUTl protein, this represents 19% of 
the HIS-GLUTl from the original culture.
From the yield calculations it can be seen that 51% of the HIS-GLUTl protein 
was retained on the column and that 49% was eluted in the wash buffer. This is probably 
a result of the HIS-GLUTl protein having a low affinity towards the nickel column, by 
the polyhistidine tag being masked by amino acid tertiary structure or by being partially 
buried in the detergent micelle / lipid bilayer. 61% of the HIS-GLUTl from the 500 ml 
culture was lost during solubilization (some HIS-GLUT protein remained in the 
unsolubilized cell pellet), running the column and as experimental error. This was 
considerably less than that lost during HIS-GLUTl protein purification from Sf9 cells. 
This may have been partly due to the Highfive cell membrane being more effectively 
solubilized by the detergent system used. The yield could be improved by increasing the 
affinity of the polyhistidine tagged protein towards the nickel column. This could be 
accomplished by placing the tag on the hydrophilic C-terminal end of the glucose 
transporter.
Section 11.11 
Purification of the HIS-C-TERM Protein Expressed in Sf9 Cells
The HIS-C-TERM protein was expressed with an N-terminal polyhistidine tag to 
allow for purification of the protein by immobilised metal ion liquid chromatography. 
2 mg of homogenised Sf9 cells expressing the HIS-C-TERM protein were solubilized 
and loaded on to a chelating Sepharose nickel column. The column was washed with 9 
ml of wash buffer and eluted with 5 ml of elution buffer. 1.5 ml fractions were collected 
and 40 pi aliquots were taken from each fraction. The aliquots were analysed by 
immunoblot assay, figure 11.37 and on a 12% polyacrylamide gel followed by 
Coomassie blue staining, results not shown. The only detectable protein present, by 
Coomassie staining was in fraction 2. There were no other proteins detectable on the 
gel. The immunoblot assay is displayed in figure 11.37.
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Figure 11.37, Immunoblot of Sf9 expressed 
HIS-C-TERM protein eluted from a nickel 
column. 40 |il aliquots were taken from each 
column fraction and loaded onto a 12% 
polyacrylamide gel as follows: lane 1: fraction 1; 
lane 2: fraction 2; lane 3: fraction 3; lane 4: 
fraction 4; lane 5: fraction 5; lane 6: fraction 6; 
lane 7: fraction 7; lane 8: fraction 8; lane 9: 
fraction 9; lane 10: fraction 10.
The HIS-C-TERM protein appeared to have little or no affinity towards the 
column. The majority of the HIS-C-TERM protein appeared to have been eluted off 
during the column wash. Only a very small fraction of the protein was observed to have 
been retained by the column. The retained protein was eluted from the column in 
fraction 8, resulting in a very faint monomer and dimer band at approximately 27 and 
50 kDa, respectively.
Section 11.12 Protein Purification Discussion
Table 11.6 summarises the data obtained from purification trials carried out on the 
HIS-GLUTl protein expressed in Sf9 and Highfive insect cells.
Sf9 Expressed HIS-GLUTl
Before Purification After Purification
Yield 770 pg of HIS-GLUTl / 
500 ml of culture
36 pg of HIS-GLUTl / 500 ml of 
culture (6% recovery)
Highfive Expressed HIS-GLUTl
Yield 1.92 mg of HIS-GLUTl / 
500 ml of culture
379 pg of HIS-GLUTl / 500 ml of 
culture (20% recovery)
Purity 8% Pure Approximately 40 % Pure
Table 11.6, Summary of data. The above table summarises the data obtained from purification trials on 
HIS-GLUTl protein expressed in Sf9 and Highfive cells.
During purification a 5 fold increase in purity was achieved. It was estimated that 
the resulting HIS-GLUTl protein was 40 % pure. Further purification of the constructs 
proved difficult without fundamental modifications to the procedure. Modifications may 
include the elimination of the 66 kDa BSA band, by incubating and infecting the insect
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cells in a serum free environment. It could take several weeks to adapt the cells to such a 
system but may well be worth the effort so as to eliminate the contaminating proteins. 
Throughout the procedure the 66 kDa band, thought to be BSA, proved to be a very 
persistent contaminant. The unidentified protein, running at 97 kDa, could be removed 
by including a DEAE cellulose column within the purification protocol. Initial studies 
suggested that a DEAE cellulose column would act as a useful primary column, 
providing an initial sample clean up. The sample could then be refined upon a nickel 
column. One disadvantage however would be the increased loss of HIS-GLUTl protein 
due to an increased number of purification steps.
The HIS-GLUTl protein appeared to have a low affinity towards the nickel 
column and the HIS-C-TERM protein appeared to have no affinity towards the nickel 
column. It was hypothesised that the affinity of the HIS-GLUTl protein towards the 
nickel column may in some way be affected by the conformation of the protein. The 
polyhistidine tag may not be completely free of the protein structure. The polyhistidine 
tag may well be ‘shielded’ by other residues present in the N-terminal sequence or be 
buried in the detergent micelle / lipid bilayer. By random chance about 50% of the 
polyhistidine tags would be free of this structure and capable of binding immobilised 
nickel ions with a certain degree of affinity; the other polyhistidine tags would be buried 
within the protein structure. By separating the polyhistidine tag further from the protein, 
with a longer hydrophilic ‘spacer’, or by placing it at the end of the hydrophilic 
C-terminus, it may be possible to increase the affinity of the HIS-GLUTl protein 
towards the nickel column. This may result in the HIS-GLUTl protein competing off 
the contaminating Sf9 cell proteins, resulting in a purified polyhistidine tagged protein 
product. In the case of the HIS-C-TERM protein the polyhistidine tag may have been 
completely obscured by the detergent micelle.
Weinglass and Baldwin, (1996) have demonstrated a 90% level of purification of 
the glucose transporter protein, based on the use of a C-terminally placed polyhistidine 
tag. The final 39 amino acids of the GLUT1 protein are predicted to be free of the 
membrane and may even be involved in the kinetic control of the transporter. The C- 
terminal end of the GLUT1 protein is already known to be accessible to cytoplasmic 
proteins, and provides the necessary distance required between the GLUT1 protein and 
affinity matrix, making the polyhistidine tag accessible to the immobilised nickel ions.
Page 194
0? itta t ^t&cuddaxtt
Chapter 12 Final Discussion
12.0 Final Discussion
Studies involving point mutation analysis of the human GLUT1 C-terminal tail in CHO 
cells revealed that although there was a significant perturbation of transporter activity by the 
R468L mutation the kinetics of the GLUT2 protein were not conferred upon the GLUT1 
protein. It was concluded that the kinetic function of the glucose transporter was controlled by 
the overall conformation of a much larger region (possibly the whole of the cytoplasmic C- 
terminal tail) and that no one amino acid appeared to be critical for this function. This 
conclusion is consistent with results obtained from C-terminal deletion analysis and chimeric 
protein studies.
Confocal microscopy demonstrated that the full length glucose transporter constructs, 
with or without a polyhistidine tag, were targeted to the plasma membrane. However, plasma 
membrane targeting was perturbed in both C-terminal constructs. The C-terminal constructs 
were not exclusively targeted to the plasma membrane, instead only a small proportion of the 
protein ended up there. Protein mis-folding cannot explain the amount of recombinant protein 
targeted to cytoplasmic membranes other than the endoplasmic reticulum. Mis-folded protein 
should be exclusively retained in the endoplasmic reticulum and protein released into the Golgi 
apparatus should be targeted immediately to the plasma membrane. It is possible that there is a 
specific intracellular targeting motif contained within the C-terminal portion of the glucose 
transporter recognised by Sf9 cells. However, more research would be required to prove or 
disprove this theory. The polyhistidine tag and linking amino acids were observed to have no 
effect on the localisation of any of the constructs. This demonstrated that the polyhistidine tag 
does not disrupt or aid in the targeting of the protein.
Photolabelling of the C-terminal glucose transporter construct (C-TERM) did not result 
in any significant level of photolabelling. Photolabelling of the polyhistidine tagged C-terminal 
glucose transporter construct (HIS-C-TERM) was inconclusive due to poor glucose 
displacement data. It was not possible to prove that the polyhistidine tagged C-terminal half was 
capable of glucose transport due to the insect cells becoming permeable on viral infection.
If the polyhistidine tagged C-terminal construct was capable of transporting substrate 
across the membrane this would provide further evidence to support the glucose transporter 
theory of origin to have been by a gene duplication event (Szkutnicka et ah, (1989)). Indeed, 
the C-terminal construct may have been the original ancestral glucose transporter. Wu et ah, 
(1996) have found that the C-terminal portion of the lactose transporter was capable of lactose 
transport in the absence of the N-terminal half. However, the C-terminal portion was only
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capable of this when modified by the addition of 5 amino acids on the N-terminal end of the 
C-terminal construct.
The present study has shown that a genetically modified form of the rabbit glucose 
transporter protein, expressing a polyhistidine tag on the N-terminal end, does not result in the 
purification of that protein to homogeneity upon a Pharmacia Biotech HiTrap™ nickel column. 
Neither is the column successful in the purification of a genetically truncated glucose 
transporter construct (HIS-C-TERM), with a polyhistidine tag attached to the N-terminal end. 
In both cases it is hypothesised that this is due to the polyhistidine tag either being ‘shielded’ by 
the protein structure or by being partially buried in the detergent micelle when in solution.
It is possible that the binding affinity of the polyhistidine tagged constructs could have 
been improved by either extending the amino acid spacer region (the region between the 
polyhistidine tag and the protein), increasing the number of histidine residues forming the tag or 
by placing the tag on the C-terminal end of the transporter. The C-terminal tail was predicted to 
be highly hydrophilic by hydropathy plot analysis (figure 1.1) and appears to be accessible to 
soluble components within the cytoplasm. A structure that is readily accessible to soluble 
cellular components should theoretically provide an ideal site for the positioning of a 
polyhistidine tag and allow for complete access to the tag by immobilised metal ions. Placing 
the polyhistidine tag at the end of the protein would also provide a secondary benefit, it would 
result in the complete elimination of partially expressed products from the final purified product 
(partially expressed products will not possess a polyhistidine tag and will therefore not be 
bound by the nickel column). The purification experiments performed in this study may indicate 
that the N-terminal end of the glucose transporter is closely associated with the lipid bilayer, 
and may be barely free of the membrane. Davies et al., (1987a&b) have observed that anti 
N-terminal antibodies displayed little affinity towards the glucose transporter protein. This also 
indicated that in the native state the N-terminal tail may be partially buried within the 
membrane.
Weinglass and Baldwin, (1996) have reported on the expression of a C-terminal 
polyhistidine tagged glucose transporter construct in insect cells. Following solubilization in the 
detergent octyl glucoside they reported a 90% level of purification. Weinglass and Baldwin, 
(1996) did not report which proteins were causing contamination of their polyhistidine tagged 
protein. However, it seems likely that the contaminants could have been proteins such as BSA 
from the foetal calf serum. These contaminants could have been removed by the inclusion of a 
primary DEAE cellulose column in the purification protocol or by growing the cells in a serum 
free medium system.
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13.0 Future Work
Observations made by confocal microscopy suggested that there may be 
targeting information contained within the glucose transporter recognised by the Sf9 
cell. The insect cell system could be used to examine any targeting information that may 
be present. The construction of N-terminal deletion mutants followed by insect cell 
expression and analysis by confocal microscopy could help to determine the exact nature 
of any signal sequence present within the transporter.
At present, the baculovirus expression system offers the most rapid way 
forwards for GLUT1 protein purification. However, before the system can be used for 
the purification of the glucose transporter consideration will need to be given to 
re-designing the polyhistidine tagged construct. Purification to homogeneity could be 
achieved by engineering the polyhistidine tag onto the end of the C-terminal tail. It is 
thought that this would result in a protein with a higher affinity towards the immobilised 
nickel Sepharose column. Alternatively, it may be possible to increase the affinity of the 
N-terminally attached polyhistidine tag towards the immobilised metal ions by inserting 
a glycine linker between the polyhistidine tag and the glucose transporter. This would 
prevent the GLUT1 protein from interfering with column affinity. A further increase in 
affinity could be achieved by increasing the length of the polyhistidine tag from six 
histidine residues to either eight or ten residues. However, this may result in a decreased 
level of protein expression. The expression of a polyhistidine tagged glucose transporter 
with an increased affinity towards the column would allow for the use of more stringent 
washing protocol in order to remove contaminating proteins.
To ensure the removal of contaminating proteins (ie. BSA), insect cells should 
be adapted to and incubated in a serum free medium. Furthermore, a DEAE cellulose 
column should be included in the purification protocol as a primary column. If this was 
done in addition to redesigning the polyhistidine tag then pure glucose transporter 
protein may well be obtained from the baculovirus system.
Further thought may be needed with respect to the detergent system used. 
Mascher, (1989) and Haneskog et al, (1996) have determined that human erythrocyte 
GLUT1, solubilized in the detergent octyl glucoside, resulted in GLUT1 protein in the 
dimeric and oligomeric form. Mascher et al, (1989) and Haneskog et al., (1996) have
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further shown that GLUT1 solubilized in the detergents SDS and Thesit (C^Eg) was in 
a largely monomeric form. This is perhaps not such an important consideration during 
the chromatographic step, but it may be a necessary consideration for the attempted 
crystallisation of the protein. Varying amounts of aggregates may make the protein 
difficult or impossible to crystallise. However, crystallisation of the monomeric form 
may prove easier. Boulter and Wang (1997) have had success solubilizing and purifying 
the human erythrocyte GLUT1 using a maltoside detergent. This detergent has been 
used in crystallising many other membrane proteins and may be useful in the 
crystallisation of the glucose transporter, hopefully restricting the formation of GLUT1 
oligomers.
The baculovirus expression system does have disadvantages when expressing 
protein for use in protein crystallisation studies as a substantial amount of pure protein is 
required. The baculovirus expression system requires a lot of time and resources in 
order to produce large quantities of recombinant protein. Researchers are now 
investigating the possibility of expressing large amounts of functional protein in the 
yeast expression system. This offers the advantage of a continuous culture system and 
the economic production of vast quantities of protein in a relatively short period of time.
However, the baculovirus system does have certain advantages over the yeast 
expression system. Insect cells produce a glucose transporter that is glycosylated. This 
may prove to be essential for the correct function of the protein and may even be 
necessary to allow the protein to adopt its true wild-type conformation. Insect cells 
target the polyhistidine tagged protein to the plasma membrane and allow it to fold 
correctly, adopting an active conformation. Finally, glucose transporter expression in the 
insect cell system has been well characterised and functional glucose transporter protein 
is known to be expressed.
The baculovirus expression system has proved to be a useful system in which to 
express the glucose transporter. It has been demonstrated to yield fully functional 
polyhistidine tagged glucose transporter, which can be partially purified on an 
immobilised metal ion Sepharose column. Persistence with this system should result in 
the complete purification to homogeneity of recombinant glucose transporter expressed 







MPDYSYRPTI GPDHA --- GLUT1 -----
Fusion vector pLE14
Histidine tag Enterokinase site (Recognition sequence DDDDK//)
4'  4'  4-
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDPSSRSAAG A - G L U T l -
Non-fusion vector pVL:GLUTl (Full length glucose transporter)
1 MEPSSKKVTG RLMLAVGGAV LGSLQFGYNT GVINAPQKVI EEFYNQTWIH
51 RYGERILPTT LTTLWSLSVA IFSVGGMIGS FSVGLFVNRF GRRNSMLMMN
101 LLAFVSAVLM GFSKLAKSFE MLILGRFIIG VYCGLTTGFV PMYVGEVSPT
151 ALRGALGTLH QLGIWGILI AQVFGLDSIM GNEDLWPLLL SVIFVPALLQ
201 CIVLPLCPES PRFLLINRNE ENRAKSVLKK LRGNADVTRD LQEMKEESRQ
251 MMREKKVTIL ELFRSPAYRQ PILSAWLQL SQQLSGINAV FYYSTSIFEK
301 AGVQQPVYAT IGSGIVNTAF TWSLFWER AGRRTLHLIG LAGMAACAVL
351 MTIALALLEQ LPWMSYLSIV AIFGFVAFFE VGPGPIPWFI VAELFSQGPR
401 PAAVAVAGFS NWTSNFIVGM CFQYVEQLCG PYVFIIFTVL LVLFFIFTYF
451 KVPETKGRTF DEIASGFRQG GASQSDKTPE ELFHPLGADS QV*
pVL941:GT52 (C-terminal portion of GLUT1)
254 EKKVTIL ELFRSPAYRQ PILSAWLQL SQQLSGINAV FYYSTSIFEK
301 AGVQQPVYAT IGSGIVNTAF TWSLFWER AGRRTLHLIG LAGMAACAVL
351 MTIALALLEQ LPWMSYLSIV AIFGFVAFFE VGPGPIPWFI VAELFSQGPR
401 PAAVAVAGFS NWTSNFIVGM CFQYVEQLCG PYVFIIFTVL LVLFFIFTYF
451 KVPETKGRTF DEIASGFRQG GASQSDKTPE ELFHPLGADS QV*
Nucleotides at the start of the GLUT1 cDNA (Taken from Asano et al. (1988)):
GCC ATG GAA CCC AGC AGC AAG AAG GTG ACG GGC CGC CTC ATG CTG GCC GTG
GGA GGA GCA GTG CTC GGC TCC CTG CAG TTT GGC TAC AAC ACT GGA GTC ATC
AAC GCC CCC CAG AAG GTG ATC GAG GAG TTC TAC AAC CAG ACG TGG ATC CAC
CGC TAT GGG GAG CGC ATC TTG CCC ACC ACG CTC ACC ACG CTG TGG TCC CTC
TCG GTG GCC ATC TTC TCC GTC GGG GGA ATG ATT GGC 
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